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ABSTRACT
Proteorhodopsin (pR) is an intrinsic membrane protein with an important role in
solar-energy storage of the biosphere. Earlier work in our lab has shown that
polyhistidine-tagged pR can be purified by means of selective precipitation with citrate
under specific conditions, as can a number of mutants based on this His6-tagged pR.
Purification of a heterologously-expressed trans-membrane protein by a simple salt such
as citrate is novel. However, such a phenomenon leads to several questions: How does
citrate cause pR precipitation? Does the polyhistidine-tag assist in such a precipitation? Is
this precipitation pH-specific? Does citrate affect the function of pR? Does citrateinduced pR precipitation have any biological significance? Are there other ions that could
cause pR precipitation?

This dissertation focuses on understanding the nature of the interaction of pR with
citrate and other anions, and in particular on trying to take advantage of this interaction in
order to develop a novel membrane protein purification method. The end goal that
branches out of these two aims is to utilize the compact citrate interaction site identified
in pR, by incorporating it into other membrane proteins and using it to permit their
purification by similar simple procedures.

In Chapter 1, I briefly provide some background information on the wide variety
of structurally-similar proteins as rhodopsins that include pR. I also describe the general
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importance of developing purification methods for 7-helix membrane proteins, including
pR.

Chapter 2 focuses on the investigation of the nature of citrate-binding site of pR.
To address the main question of how citrate aids in pR purification, site-directed
mutagenesis technique was applied to generate several single, double, triple or quadruple
mutants of pR in a histidine-tag free background, which were then tested for their
reactivity to citrate. Several different anions were tested to examine if precipitation of pR
was specific to citrate or whether the precipitation is susceptible to other negatively
charged salts. Photocycle of pR progresses through several intermediates, each with a
distinct absorption maximum (described in subsection 1.3.1). M-intermediate is detected
at pH ≥ 8 with λmax = 410 nm. Flash spectroscopy involves excitation of pR at a particular
wavelength that leads to transient absorption, thus, signaling the formation of the
corresponding intermediate. Flash-induced transient visible absorption measurements
were used to assay the effect of exposing pR to citrate on its physiological function.

Chapter 3 describes the development of a method of purification of pR using
simple salts, citrate and phosphate. Chapter 4 begins an exploration of a future direction.
The ultimate objective is to apply the above techniques for the general purpose of 7-helix
membrane protein purification, especially for the important class of pharmacological
receptors known as GPCRs. An attempt at heterologous expression in E. coli, and
purification, of a mammalian GPCR, is described therein. Such a method would be
desirable for obtaining proteins for structural, functional and pharmacological studies.
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Chapter 1

1. INTRODUCTION

1.1

General Background

1.1.1

Rhodopsins
Proteorhodopsin belongs to a large group of proteins, called rhodopsins, found in

all domains of life. Rhodopsins are also known as retinylidene proteins, because they
consist of the apoprotein opsin and chromophore retinal. They are hepta-helical transmembrane proteins that form an interior retinal binding pocket in the hydrophobic core of
the protein. The apoprotein is reversibly and covalently bound to its cofactor
chromophore retinal at a lysine residue via a protonated Schiff base (PSB) linkage as
evidenced by the shift in the λmax. Rhodopsins, although they all share this common
architecture, include members of two distinct superfamilies of proteins, with an as-yet
uncertain phylogenetic relationship.

The first rhodopsin superfamily is often referred to as type 1 rhodopsins or,
alternatively, as the microbial rhodopsins. Some of these trans-membrane proteins have a
purely sensory function, apparently including some types of pR [Hillebrecht J. R., et al.,
200; Kunz W., et al., 2004; Spudich J. L., 2006]. However, most pR proteins are
included among the energy-transducing microbial rhodopsins, which act as light-driven
ion pumps. That is, they translocate ions, generally protons or chloride ions, across the
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membrane generating an ion gradient. This electrochemical gradient is then coupled to
ATP synthase that synthesizes the energy-rich molecule ATP. Examples include
bacteriorhodopsin, a proton pump in Archea; halorhodopsin, a chloride pump in Archea;
and proteorhodopsin (pR), a proton pump in Bacteria. The microbial rhodopsins are
distributed broadly among the three kingdoms of life. This widespread distribution raises
the question of whether they were present in the last common ancestor to both Archea
and Bacteria, or even the last universal common ancestor (LUCA) [Lane N. et al., 2010].
There is yet little direct evidence for autotrophy based on microbial rhodopsins [GómezConsarnau L. et al., 2007; Gómez-Consarnau L. et al., 2010] but that does not rule out
the likelihood that, before the advent of chlorophyll-based oxygenic-photosynthesis 2.43.5 billion years ago, these ion pumps served a functional purpose in the process of solar
energy transformation [Hohmann-Marriott M. F. and Blankenship R. E., 2011].

Multicellular animals, including human beings, possess membrane proteins in the
other major family of rhodopsins, often referred to as type 2 rhodopsins. These are the
visual-pigment rhodopsins. The visual rhodopsins are in the G-protein coupled receptor
(GPCR) superfamily, but are also photoreceptor proteins that contain retinal, a vitamin A
derivative, as their photo-pigment. Retinal has an absorption maximum at λmax = 380 nm
when measured as the free aldehyde in ethanol, but exhibits different absorption maxima
when it forms a protonated Schiff base chromophore linked to different opsins. This
absorption maxima shift is also responsible for color vision. Rhodopsins in animals
(including both vertebrates and multicellular invertebrates) are responsible only for the
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function of vision, unlike the microbial rhodopsins that are also involved in phototransformation of energy as discussed above.

Figure 1.1 shows the different regions at which a variety of microbial and visual
rhodopsins, as well as other pigments, exhibit maximum absorption.

Fig. 1.1: Absorption maxima of various rhodopsins and other
photopigments: SR refers to sensory rhodopsin, pR is proteorhodopsin
which is divided into Green-absorbing pR (GPR) or Blue-absorbing pR
(BPR), and HR is halorhodopsin.

1.1.2

Microbial rhodopsins
Only recently were homologs of archaeal rhodopsins discovered in the domains

Bacteria and Eukarya. Proteorhodopsin (pR), the first example of which was found in
oceanic proteobacteria in 2000 [Béjà O., et al., 2000], is a light-driven proton pump that
functions like its homolog bacteriorhodopsin (BR) (see below). However, its absorption
maxima are dependent on the aquatic environment in which it is found. The variants of
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pR are either green-absorbing pR with λmax = 525 nm or blue-absorbing pR with λmax =
490 nm.

There is an extensive older literature on the archaeal homologs of pR, because the
first four microbial rhodopsins were discovered in the domain Archea, specifically in
Halobacterium salinarum and a number of closely related halophilic species. Two of
them are light driven pumps viz., bacteriorhodopsin (BR) and halorhodopsin (HR), and
the other two are phototaxis receptors, namely sensory rhodopsin (SR) I, and SR II.

Archeal rhodopsins show 80% identity in the 22 residues that form the retinal
binding pockets in BR, HR and SRII (Fig.1.2). However, outside the pocket, there is
limited identity between the amino acids. A homolog found in Natronobacteria
pharaonis (NpSRII) shares only 27% identity to BR in the overall primary sequence, and
only ~40% identity with other halobacterial sensory rhodopsins [Spudich J. L. and Jung
K. H., 2005].

The archaeal homolog of pR, bacteriorhodopsin (BR), is the prototype of a
microbial rhodopsin, having been the first one discovered in the 1970s. BR is a lightdriven proton pump whereas HR is a light-driven chloride pump. BR pumps proton to the
outside of the cell whereas HR pumps chloride inside the cell. Both these pumps
hyperpolarize the cell by generating a positive charge outside the cell, thus creating an
inwardly directed proton motive force (pmf). Their absorption maxima are in the green-

4

orange region of the spectrum [Váró G., 2000] with BR absorbing at λmax = 568 nm
[Albeck A., et al., 1989] and HR at λmax = 576 nm [Stenkamp R. E., et al., 2002].

Sensory rhodopsins sense the changes in the intensity or the color of light and
then produce signals that affect the flagellar rotor, i.e. the archaeal cell’s swimming
behavior. SR I attracts halobacteria towards orange light and away from harmful UVlight [Spudich J. L. and Bogomolni R. A., 1984]. SR II is expressed only during the
aerobic growth when the cells are not dependent on light for their energy. It serves only a
repellent function [Takahashi T., et al., 1990]. In H. salinarum, sensory rhodopsin SRI
absorbs maximally at λmax = 587 nm [Spudich J. L. and Bogomolni R. A., 1984] whereas
the SR II absorbs at λmax = 487 nm.

The crystal structure of BR has been elucidated [Subramaniam S. and Henderson
R., 2000], and its photocycle has been understood quite well [Heberle J., 2000; Lanyi J.
K., 2006]. In BR and pR, the retinylidene chromophore alternates between all-trans and
13-cis isomers (Fig. 1.4). Crystal structures of HR [Kolbe M., et al., 2000] and SRII
[Gordeliy V. I., et al., 2002] are also known (Fig. 1.3).
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srIINatronomonas
srIIHaloarcula
srIIHalobacterium
Bacteriorhodopsin
Halorhodopsin
proteorhodopsin
Bovine
srAnabaena

-------------------------MVGLTTLFWLGAIGMLVGT---LAFAWAGRD----------------------------MATITTWFTLGLLGELLGT---AVLAYGYTL-----------------------------MALTTWFWVGAVGMLAGT---VLPIRDCIR-------------------------QAQITGRPEWIWLALGTALMGLGTLYFLVKGMGV------------------------AVRENALLSSSLWVNVA--LAGIAILVFVYMGRTI---MKLLLILGSVIALPTFAAGGGDLDASDYTGVSFWLVTAALLAST---VFFFVERDR-----MNGTEGPNFYVPFSNKTGVVRSPFEAPQYYLAEPWQFSMLAAYMFLLIMLGFPINFLT
------------------------------------------------------------

28
28
27
34
33
53
58

srIINatronomonas
srIIHaloarcula
srIIHalobacterium
Bacteriorhodopsin
Halorhodopsin
proteorhodopsin
Bovine
srAnabaena

--AGSGERRYYVTLVGISGIAAVAYVVMALGVGWVPV----------AERTVFAPRYID--VPEETRKRYLLLIAIPGIAIVAYALMALGFGSIQS----------EGHAVYVVRYVD--HPS-HRRYDLVLAGITGLAAIAYTTMGLGITATTV----------GDRTVYLARYID--SDPDAKKFYAITTLVPAIAFTMYLSMLLGYGLTMVPFGG------EQNPIYWARYAD--RPGRPRLIWGATLMIPLVSISSYLGLLSGLTVGMIEMPAGHALAGEMVRSQWGRYLT--VSAKWKTSLTVSGLVTGIAFWHYMYMR-GVWIETG------------DSPTVFRYIDLYVTVQHKKLRTPLNYILLNLAVADLFMVFGGFTTTLYTSLHGYFVFGPTGCNLEGFFAT
----MHHHHHHSLSIGRTCWAIAEGYIPPYGNGPEPQ-------------------FIS*
:

75
75
73
85
90
97
118
36

srIINatronomonas
srIIHaloarcula
srIIHalobacterium
Bacteriorhodopsin
Halorhodopsin
proteorhodopsin
Bovine
srAnabaena

-------WILTTPLIVYFLGLLAGLD---SREFGIVITLNTV-VMLAGFAGAMVPG----------WLLTTPLNVWFLALLAGAS---REDTVKLVVLQAL-TIVFGFAGAVTPS----------WLVTTPLIVLYLAMLARPG---HRTSAWLLAADVF-VIAAGIAAALTTG----------WLFTTPLLLLDLALLVDAD---QGTILALVGADGI-MIGTGLVGALTKVY---------WALSTPMILLALGLLADVD---LGSLFTVIAADIG-MCVTGLAAAMTTSAL--------WLLTVPLLICEFYLILAAA---TNVAGSLFKKLLVGSLVMLVFGYMGEAGI-LGGEIALWSLVVLAIERYVVVCKPMSNFRFGENHAIMGVAFTWVMALACAAPPLVGWSRY
---------------HETVCILNAGD----EDAHVEITIYYSDKEPVGPYRLTVPAR--. :
.

120
120
118
131
137
145
178
74

srIINatronomonas
srIIHaloarcula
srIIHalobacterium
Bacteriorhodopsin
Halorhodopsin
proteorhodopsin
Bovine
srAnabaena

---------------------IERYALFGMGAVAFLGLVYYLVGP-------MTESASQR
---------------------PVSYALFAVGGALFGGVIYLLYRN-------IAVAAKST
---------------------VQRWLFFAVGAAGYAALLYGLLGT-------LPRALGDD
---------------------SYRFVWWAISTAAMLYILYVLFFG-------FTSKAESM
---------------------LFRWAFYAISCAFFVVVLSALVTD-------WAASASSA
---------------------MAAWPAFIIGCLAWVYMIYELWAG-------EGKSACNT
IPEGMQCSCGIDYYTPHEETNNESFVIYMFVVHFIIPLIVIFFCYGQLVFTVKEAAAQQQ
------------------------------------------------------------

152
152
150
163
169
177
238

srIINatronomonas
srIIHaloarcula
srIIHalobacterium
Bacteriorhodopsin
Halorhodopsin
proteorhodopsin
Bovine
srAnabaena

SSGIK-SLYVRLRNLTVILWAIYPFIWLLGP---------------------PGVALLTLSDIEVSLYRTLRNFVVVLWLVYPVVWLLGA---------------------AGVGLMD-PRVR-SLFVTLRNITVVLWTLYPVVWLLSP---------------------AGIGILQRPEVA-STFKVLRNVTVVLWSAYPVVWLIGS---------------------EGAGIVPGTAEI---FDTLRVLTVVLWLGYPIVWAVGV---------------------EGLALVQS
ASPAVQSAYNTMMYIIIFGWAIYPVGYFTG----------------------YLMGDGGS
ESATTQKAEKEVTRMVIIMVIAFLICWLPYAGVAFYIFTHQGSDFGPIFMTIPAFFAKTS
--RTKHVRFNDLNDPAPIPHDTDFASVIQSN----------------------------:
.

189
190
186
200
205
215
298
103

srIINatronomonas
srIIHaloarcula
srIIHalobacterium
Bacteriorhodopsin
Halorhodopsin
proteorhodopsin
Bovine
srAnabaena

PTVDVALIVYLDLVTKVGFGFIALDAAATLRAEHGESLAGVDTDAPAVADVETATLVVVYLDVVTKVGFGVIALLAMIDLG-----SAGETAEEPTAVAGD
TEMYTIVVVYLDFISKVAFVAFAVLGADAVSRLVAADAAAPATAEPTPDGD
LNIETLLFMVLDVSAKVGFGLILLRSRAIFGEAEAPEPSAGDGAAATS--VGATSWAYSVLDVFAKYVFAFILLRWVANNERTVAVAGQTLGTMSSDD--ALNLNLIYNLADFVNKILFGLIIWNVAVKESSNA----------------AVYNPVIYIMMNKQFRNCMVTTLCCGKNPLGDDEASTTVSKTETSQVAPA---VPIVVQHTRLDSRQAENALLSTIAYANT--------------------

:

239
236
237
248
253
249
348
131

Fig. 1.2: Multiple sequence alignment of rhodopsins: The conserved residues are
shown in red. The following rhodopsins are used for comparison: Sensory rhodopsins II
of Natronomonas pharaonis, Haloarcula and Halobacteria, ion pumps of
bacteriorhodopsin (proton pump), halorhodopsin (chloride pump), proteorhodopsin
(proton pump), sensory rhodopsin of Anabaena and eukaryotic GPCR, bovine rhodopsin.
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Fig. 1.3: Crystal structures of rhodopsins with Protein Data Bank (PDB) numbers:
These rhodopsins serve different functions but share the same overall topology of
heptahelical trans-membrane structure. (a) HR PDB: 1E12(Halobacterium salinarum)
transports chloride into the cytoplasm from extracellular medium, (b) BR PDB: 1FBB
(Halobacterium salinarum) pumps proton from cytoplasmic side to the outside of the
cell, (c) SRII PDB: 1H2S (Natronomonas pharaonis) senses harmful light and repels the
cells away to a safer environment, (d) Bovine rhodopsin PDB: 1F88 is a G-Protein
Coupled Receptor (GPCR). The PDB files show a dimer of bovine rhodopsin crystal. The
above PDB files were manipulated with UCSF Chimera package (described in chapter 2).
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7

8

13 14

11

9
10

15

a. All-trans retinal

12

b. 13-cis retinal

c. Protonated Schiff Base (PSB)

d. 13-cis retinal with PSB
linkage to lysine

Fig. 1.4: Structure of free retinal and retinal covalently bonded to lysine: In
microbial rhodopsins, All-trans retinal (a) is converted to 13-cis retinal (b) upon photon
absorption. c. Structure of 13-cis retinal showing a protonated Schiff base linkage (PSB)
d. Structure of 13-cis retinal bonded to the Lysine via a protonated Schiff base linkage.
These structures were created in ChemSketch [ACD Labs].

8

1.2 Proteorhodopsin
Within the past decade it has been shown that among the type 1 rhodopsins, the
most abundant and widely distributed is proteorhodopsin. Proteorhodopsin was the firstdiscovered eubacterial homolog of archael rhodopsins [Béjà O., et al., 2000]. A bacterial
artificial chromosome (BAC) library of naturally occurring marine bacterioplankton from
Monterey Bay was constructed and sequenced. Sequence analysis of a 130-kb genomic
fragment that encodes ribosomal RNA (rRNA) operon from an as-yet uncultivated
member of marine bacteria revealed a gene encoding a putative rhodopsin [Béjà O., et al.,
2000]. The rRNA sequence on the same fragment identified the organism as γproteobacteria belonging to SAR86 group. Hence, the protein was named
proteorhodopsin.

The native pR consists of 249 amino acids [Béjà O., et al., 2000]. The amino acid
composition as shown in Table 1.1 and the secondary structure is shown in Fig. 1.5A.
The active protein is covalently bound to its choromophore all-trans retinal at the
conserved lysine, Lys231, via a Schiff base linkage (Fig. 1.4). Proteorhodopsin has been
heterologously expressed in E. coli, and addition of retinal to the pR expressing E. coli
bacteria causes a red-coloration of cells (Fig. 1.5B) with an absorption maximum at
520nm or 540nm depending on the pH. The residue that is responsible for the two
spectral forms is Asp97, the homolog of Asp85 in BR [Dioumaev A. K. et al., 2002]. The
Asp97 has to be deprotonated in order for pR to perform the photocycle function. Asp97
is deprotonated at pH 7 or above where pR exhibits λmax = 520 nm. Thus, it is the 520 nm
form of pR that is physiologically important.

9

Table 1.1: Amino acid composition of pR (ProtParam)

Amino acid
Ala (A)
Arg (R)
Asn (N)
Asp (D)
Cys (C)
Gln (Q)
Glu (E)
Gly (G)
His (H)
Ile (I)
Leu (L)
Lys (K)
Met (M)
Phe (F)
Pro (P)
Ser (S)
Thr (T)
Trp (W)
Tyr (Y)
Val (V)
Total

Number of
amino acids
present in pR
28
4
9
8
3
1
7
24
1
19
31
8
10
15
6
16
14
10
14
21
249

Percent
composition
11.2
1.6
3.6
3.2
1.2
0.4
2.8
9.6
0.4
7.6
12.4
3.2
4.0
6.0
2.4
6.4
5.6
4.0
5.6
8.4
100

Total number of negatively charged residues (Asp + Glu): 15
Total number of positively charged residues (Arg + Lys): 12
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Fig. 1.5: Secondary structure and color of pR: A) Secondary structure or pR:
Proteorhodopsin is a hepta-helical trans-membrane protein. The 7-helices are labeled
from A-G. The N-terminus is on the extracellular side whereas the C-terminus faces the
cytoplasmic side of the cell. Lysine231 residue that forms a protonated Schiff base linkage
with retinal is depicted in blue color. Three cysteines depicted in yellow are mutated to
serine, pR is referred to as pR triple cysteine mutant (TCM). B) UT5600 cells expressing
pR: The left tube shows cells that were induced with L-arabinose, the right tube shows
same cells after the addition of all-trans retinal. C) pR TCM at pH 6 and 9: pR TCM
absorbs at different λmax depending on pH. This is due to the titration of D97 at higher
pH. High pH form is the physiologically active form that initiates the photocycle of pR.

A

λmax = 545 nm
B

520 nm

C
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1.2.1

Photocycle of pR
Due to a lack of a three-dimensional crystal structure of pR, the photocycle has

been studied using various biophysical techniques such as time-resolved and static
Fourier-transform infrared (FTIR) or visible spectroscopy, and flash-induced laser
spectroscopy. In summary, the photocycle begins upon photon absorption, the retinal
chromophore undergoes isomerization along C13-C14 bond which leads to a
conformational change in the retinal form from all-trans to 13-cis [Friedrich T. et al.,
2002; Krebs R. A., et al., 2003]. The protein responds to change in the retinal
conformation by cycling through a series of intermediate stages named K, L, M, N and O
[Béjà O., et al., 2000; Dioumaev A. K. et al., 2002; Friedrich T. et al., 2002; Váró G., et
al., 2003]. At the end of the cycle, the protein regains its original state and the retinal
chromophore thermally reisomerizes to an all-trans state. The physical significance of
this photocycle is that a proton is pumped from the cytoplasm to the extracellular side of
the membrane. Fig. 1.6 illustrates the photocycle of pR.

The photocycle of pR is considered to be similar to its archeal homolog
bacteriorhodopsin (BR) [Béjà O., et al., 2000] given the conservation of several
functionally important residues (Fig. 1.2). Lys231 (Lys216 in BR) present in the helix G
(Fig. 1.5A) forms a protonated Schiff base with retinal (Fig. 1.4). The pR with photoisomerized retinal is referred to as the K state [Bergo V., et al., 2004; Dioumaev A. K. et
al., 2002]. There exists an L-state in BR but it has not been isolated kinetically or coldtrapped in pR yet, although its presence was clearly identifiable in time-resolved FTIR
spectral features that decay during the temporal rise of characteristic M spectral features
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[Xiao Y., et al., 2004]. In addition, the multi-exponential pattern of K to M transition
implies the presence of an L-intermediate [Dioumaev A. K. et al., 2002]. In the L-to-M
switch, the proton from the protonated Schiff base is transferred to a proton acceptor
Asp97, the homolog of Asp85 in BR [Béjà O., et al., 2000; Dioumaev A. K. et al., 2003;
Dioumaev A. K. et al., 2002; Friedrich T. et al., 2002]. Asp227 (Asp212 in BR) probably
in concert with another conserved residue Tyr200 (Tyr85 in BR) aids in providing the
environment for the proton channel from the Schiff base to the proton acceptor [Béjà O.
et al., 2000; Heberle J., 2000]. Simultaneously, another proton is released to the
extracellular side during the formation of the M intermediate. Arg94 (Arg82 in BR)
appears to be involved in the proton release mechanism at the extracellular side before
the proton uptake from the cytoplasm [Govindjee R., et al., 1996; Partha R., et al., 2005].
In the M-to-N transition, the Schiff base is reprotonated by the proton donor Glu108
(Asp96 in BR), located toward halfway between the Schiff base group and the
cytoplasmic side of the membrane [Dioumaev A. K. et al., 2002]. The transition from N
to O [Béjà O., et al., 2000] involves protonation of Glu108, 13-cis retinal returns to alltrans state [Dioumaev A. K. et al., 2002] and the proton acceptor D97 becomes
deprotonated thus completing one photocycle. The proton pathway is shown in Fig. 1.7.
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Fig. 1.6: Photocycle of pR: The pR photocycle was elucidated by using
biophysical techniques such as time-resolved and static FT-IR or flash-induced
laser spectroscopy. The existence of some of the intermediates, e.g. L is based
most strongly on evidence from the bR photocycle, and has not been directly
observable in pR. There is a possibility of existence of an intermediate between L
and M, therefore, a space has been left. The same is true of the reversibility of
some of the steps shown. The time constant for K to M state is in tens of
milliseconds. Decay of half of M intermediate to N state is approximately 2 ms.
The recovery of the native pR takes the longest time, approximately
corresponding to 200 ms.
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Fig. 1.7: Proton pathway of pR: Left: Homology model of pR based on
BR is shown with the important residues involved in proton pump colored
in red. The Homology model was made and manipulated as described in
Chapter 2. Right: Only the residues are magnified here to show the proton
pathway. The numbers refer to the different intermediates. K231 is
covalently bonded via protonated Schiff base linkage to retinal
chromophore that undergoes all-trans to 11-cis isomerization upon photon
absorption (not shown). This is referred to as K state. (1) In L to M
transition, the Schiff base proton is transferred to D97, the proton acceptor
and another proton is simultaneously released at the extracellular side (2),
while D97 is still protonated. (3) In M to N transition, Schiff base is
reprotonated from cytoplasmic side by the proton donor E108. (4) In N to O
transition, E108 is reprotonated from the cytoplasm. At the end, the retinal
returns to its all-trans state.

1.2.2

Energy transduction and proton pumping of pR
Several lines of evidence prove that pR functions as a proton pump and not as a

sensory rhodopsin. One characteristic difference between the sensory rhodopsins and
proton-pumps is that the genes for sensory rhodopsins are generally located physically
near to, and co-transcribed with, genes that encode additional transducer proteins needed
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to convert the signals detected by the sensory rhodopsins into physiological responses.
Htr is an example of such a co-transcribed regulator/transducer gene [Seidel R., et al.,
1995; Yao V. J. and Spudich J. L., 1992]. Sensory rhodopsins generally exhibit lightmediated proton pumping activity, but to a lesser degree, and only when the transducer is
removed [Bogomolni R. A. et al., 1994]. The proteorhodopsin gene in γ-proteobacteria
does not sit near any Htr-like gene. Additionally, pR-expressing E. coli cells clearly show
a net outward translocation of protons in the presence of retinal and light [Béjà O., et al.,
2000; Béjà O., et al., 2001]. The transport of protons creates a proton gradient and proton
motive force (pmf) which generates membrane electrical potential, -90 to -100 mV, in
physiologically relevant range [Béjà O., et al., 2000]. The pmf is utilized by the ATP
synthase to synthesize ATP that can be utilized by the cell for its energy needs. Fig. 1.8
illustrates the mechanism of proton pump and energy production.

Furthermore, flash-induced absorption changes determined in heterologously
expressed E. coli produced evidence of the existence of two intermediates, M and O
[Béjà O., et al., 2000]. Flash spectroscopy of native membranes of the bacterioplankton
samples from Monterey Bay also confirmed the photocycle characteristics [Béjà O., et
al., 2001]. This also indicates that marine bacteria have pR as well as endogenous retinal
synthesizing genes for the pR to be able to function as a proton pump. Flash spectroscopy
also showed that pR is present at high density in these membranes to about 2.4 × 104 pR
molecules per cell [Béjà O., et al., 2001]. These facts show that pR is functional as a
proton pump in its native environment.
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The ion pumps differ from sensory rhodopsins with respect to the photocycle
kinetics. The ion pumps such as BR and HR have faster photocycling rates. They show
photocycle with a half-time typically ~20 ms whereas the sensory rhodopsins exhibit
photocycle half-time >300 ms [Hoff W. D., et al., 1997]. This large kinetic difference is
significant because the proton-pumping is efficient at a faster photocycling rate whereas
the slow rate is important for the light-sensing function of the sensory rhodopsins. The
photochemical reaction cycle of pR has been estimated to be 20-45 ms [Béjà O., et al.,
2000], yet another fact that confirms the light-dependent proton-pumping function of pR.

BR and pR contain a proton donor Asp96 (BR) or Glu108 (pR) [Dioumaev A. K.
et al., 2002] whereas the haloarcheal sensory rhodopsins lack a corresponding proton
donor carboxylate group. They contain Tyr or Phe in that position. The significance of
proton donor in the pumps lies in the fact that an immediate proton transfer to the
unprotonated Schiff base intermediate, M, improves the pumping efficiency by speeding
up the decay of M. In the sensory rhodopsins, the M intermediate is a signaling state as
shown for SRI [Spudich J. L. and Jung K. H., 2005]. The longer lifetime of the M
intermediate is advantageous for the signaling efficiency and therefore, the lack of a
proton donor is beneficial.

It should however be noted that although the photocycling rates are considered a
criterion for distinction between the transport proteins and sensory proteins in Archea, it
is not generally true for the proteorhodopsin. The pR proton-pump found on surface
waters of Monterey Bay shows a faster rate of ~20 ms whereas the pR proton-pump
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found at a depth of 75 m from Hawaiian Ocean-Time station exhibits ~10-fold difference
in its rate, showing a slower rate [Wang W. W., et al., 2003].

Fig. 1.8: Proton pump coupled to ATP synthesis: Label 1 shows pR that
absorbs sunlight and functions as a proton pump. Label 2 shows the expelled
protons that generate a proton gradient that creates a proton motive force (pmf).
Label 3 represents ATP synthase that utilizes this pmf to synthesize high energy
ATP (labeled as 5) from a lower energy metabolic intermediate ADP (labeled as
4).
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1.3

Visual rhodopsins
Mammalian rhodopsins are found in the photoreceptor cells, rods and cones, of

the retina and are responsible for vision in vertebrates. They are seven-trans-membrane αhelical proteins that bind to 11-cis retinal. Photon absorption by the chromophore 11-cis
retinal isomerizes it to all-trans form which is the first step of the photochemical reaction
cycle, also known as photocycle. The isomerization of retinal causes conformational
changes in the structure of rhodopsin, eventually leading to the formation of an
intermediate metarhodopsin I which becomes deprotonated to give metarhodopsin II, the
photoactivated rhodopsin which initiates an enzymatic cascade. While the cascade is in
motion, the metarhodopsin II is hydrolyzed into opsin and all-trans retinal which diffuses
away as it cannot fit into the binding site of 11- cis retinal. All-trans retinal is then
converted to 11-cis retinal by the action of several enzymes leading to the regeneration of
rhodopsin. [Stryer L]

Each photoactiavated rhodopsin catalyzes the activation of multiple copies of the
G-protein known as transducin, which initiates a further amplifying cascade of additional
enzymes, eventually leading to the closure of ion channels in the membrane, leading to
the hyperpolarization of the rod cell, a neuronal signal that can be propagated to the optic
nerve. Fig. 1.9 shows the visual cycle of eukaryotes [Fain G. L. et al., 2010].

Mammalian rhodopsins absorb in the green-blue region of the spectrum with
absorption maximum at λmax = 500 nm in the rods. Cones absorb at three distinct
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wavelengths, λmax = 420 nm (blue cones), λmax = 530 nm (green cones) and λmax = 560 nm
(red cones).

Fig. 1.9: Visual phototransduction in Rod cells: (A) Photoreceptors are present in the
disks in the outer segment in a rod cell. (B) In step 1, light (hυ) is absorbed by the
rhodopsin (R) molecule which is converted into an active form (R*). In step 2, R*
activates the downstream G-protein, transducin, to G*. Transducin is a heterotrimer made
up of α, β, and γ subunits, and is bound to a GDP molecule in its inactive form. After
activation, it exchanges a GTP molecule at its α subunit and dissociates from the β, and γ
subunits. In step 3, G* binds to the α-subunit of phosphotdiesterase (PDE) thereby
activating its β, and γ subunits. In step 4 the activated PDE hydrolyzes cGMP to 5’-GMP.
In step 5, guanylyl cyclase (GC) synthesizes cGMP. In step 6, the lower concentration of
cGMP closes the cGMP-gated Na+ channel preventing Na+ and Ca++ from entering the
cells. This leads to hyperpolarization of the cell causing the voltage-gated Ca++ channels
to close. This causes inhibition of release of the neurotransmitter, glutamate which is an
inhibitor of the bipolar cells. The rod cells are connected via bipolar cells to the ganglion.
Since the bipolar cells are released from the inhibition, they begin to release their own
transmitter at the synapse of the bipolar cells and ganglion leading to the excitation of the
synapse. The axons of the ganglion cells form the optic nerve, which relays the impulse
to the brain. This leads to interpretation of the image. This figure is a modified version of
a figure taken with permission from Fain G. et al. [Fain G. L. et al., 2010].
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1.4

Biological significance of pR

1.4.1

Evolutionary basis
The widespread distribution of proteorhodopsins and other microbial rhodopsins

among widely divergent classes of unicellular organisms has evolutionary significance.
The type 1 rhodopsins i.e. the microbial rhodopsins, are found in all three domains of life,
namely Archea, Bacteria and Eukarya. Therefore, it can be assumed that the progenitors
of these proteins may have existed in the common ancestor before these domains
underwent divergence. If this is the case, then the pR and other light-driven pumps may
have been the primary means of solar energy capture and its conversion into cellular
energy. The first chlorophyll-based photosynthetic organisms were the blue-green algae
which date back somewhere between 3.5 and 2.4 billion years ago [Hohmann-Marriott
M. F. and Blankenship R. E., 2011]. Proteorhodopsin-like homologs could have played
an important role in the generation of energy between 3.8 and 3.5 billion years ago before
the advent of chlorophyll-based photosynthesis. With the evolution of multicellular and
complex organisms with more efficient energy conversion systems, pR-like proteins
remained restricted to the simpler unicellular organisms.

1.4.2

pR based phototrophy
The original discovery of pR was from γ-proteobacterium which belongs to

SAR86 clade [Béjà O., et al., 2000]. However, since these bacteria have not yet been
cultured, all the functional properties of pR were originally studied by heterologous
expression in E. coli. Proteorhodopsin was also found in Candidatus pelagibacter
[Govindjee R., et al., 1996], the first cultivated bacteria belonging to SAR11 clade which
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is the most abundant clade of oceanic bacteria [Morris R.M., et al., 2002; Rappé M. S., et
al., 2002]. Studies were conducted on Pelagibacter unique obtained from Oregon coasts,
to examine the effect of pR on cell growth rate or cell yield in the light and the dark
[Giovannoni S. J., et al., 2005]. There results were not conclusive due to the fact that the
composition of the sea water used for the experiments is not known completely.
Therefore, the limiting factors for Pelagibacter growth could not be identified [Govindjee
R., et al., 1996]. In 2007, marine bacteria belonging to the class Flavobacteria were
isolated from the surface water of the Mediterranean Sea and were cultured [GómezConsarnau L. et al., 2007]. Their genome-sequence analysis uncovered the presence of
pR genes and consequent experiments on the growth or cell yield in light and dark
showed the importance of pR in vivo. The bacteria showed increase in number when
exposed to light. An inverse relationship between abundant organic matter and a
functional pR was suggested by both the groups [Giovannoni S. J., et al., 2005; GómezConsarnau L. et al., 2007]. That is, pR-mediated phototrophy is functional only during
the periods when organic food is scarce.

Another group working with heterologously expressed pR in E. coli also showed
the importance of pR in vivo [Walter J. M., et al., 2007]. They demonstrated that pR can
augment cell mobility and increase cell survival when the cells are subjected to energyand oxygen-depletion by azide. This observation confirms the notion that pR is most
functional during lean times. Another lab working with pR in E. coli showed that pR
catalyzes light-dependent proton translocation across the membrane which generates
chemiosmotic potential [Martinez A., et al., 2007]. The proton translocation thus results
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in photophosphorylation in E. coli, i.e., synthesis of ATP in the presence of light
[Martinez A., et al., 2007].

Recently a study of the marine bacteria Vibrio sp. showed that pR enables the
cells to survive starvation much better in the presence of light than in dark [GómezConsarnau L., et al., 2010]. They also showed that the survival ability was abolished
upon deletion of the pR gene, and again restored when pR was supplied in trans (i.e. on
an exogenous plasmid introduced into the cells). This study definitively determined a
physiological role for pR in the native marine bacterium.

The most recent study on marine Flavobacterium concluded increase in cell
yields and growth rates in the presence of light and low carbon growth conditions. This
study showed a significant up-regulation in the pR and retinal biosynthetic genes in light.
[Kimura H., et al., 2011].

These studies show that pR supplements the energy needs of the bacteria in the
presence of light and retinal only when the nutrition supplies are limited. Thus, it enables
the cells to survive in the nutritionally unpredictable environment.

1.4.3

Energy balance
Solar energy is trapped in the biosphere mainly by the chlorophyll-based protein

clusters known as photosystems I and II, found mainly in cyanobacteria and the closelyrelated eukaryotic symbiont organelles known as chloroplasts. However, since the
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discovery of pR from surface waters in the year 2000, numerous pR-directed surveys
have identified a wide variety of similar genes in picoplankton from various geographic
ocean environments including Antarctic, Central North Pacific, Mediterranean Sea, Red
Sea, and the Atlantic Ocean as well as fresh waters [Atamna-Ismaeel N., et al., 2010;
Béjà O., et al., 2001; de la Torre J. R. et al., 2003; Man D., et al., 2003; ManAharonovich D., et al., 2004; Sabehi G., et al., 2003]. Over 4000 variants of pR have
been isolated from both surface and deep-water samples, as well as from both open-seas
and coastal areas. Sea water samples from Sargasso Sea alone identified 782 different
partial sequences homologous to pR. Another global shipping expedition uncovered
2,674 putative pR genes [Rusch D. B, et al., 2007; Venter J. C., et al., 2004].

Given the ubiquity and abundance of pR with an estimated average of at least 1028
pR-producing bacteria in the photic zone [Morris R.M., et al., 2002] and a more recent
estimate of 80% oceanic bacteria harboring pR [DeLong E. F. and Béjà O., 2010] it is
evident that pR can affect the solar energy balance of the Earth.

Fig. 1.10 shows the Earth’s solar energy balance [Walter J. M., et al., 2010].
About 50% is reflected by the Earth or clouds, leaving only 50% of the total solar
irradiance to reach the Earth. According to this article [Walter J. M., et al., 2010], when
average solar illumination of North American latitudes is considered to be 200 watts per
square meter (W/m2) [Programme UND, 2000], and land area is approximated at 1013 m2,
solar illumination of US is estimated to be 2000 trillion Watts (TW). Even if 10% of the
land is illuminated with 2% efficiency, it would produce 4 TW of energy [Walter J. M., et
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al., 2010]. A comparison is made to four different energy resources as described in the
Fig. 1.10 caption.

Conservative calculations, based on the amount of pR present in a liter of ocean
water (using 0.35 µg/L pR, 30,000 Da, 0.1 V electro-potential gradient), show that oceans
can capture at least 1 TW of annual solar energy, compared to 3.5 TW of annual nonbiological energy consumption by the USA [Brenner M. P. et al., 2006]. Proton pumps
such as bacteriorhodopsin and proteorhodopsin have therefore attracted attention for the
purpose of solar energy capture and harvest [Rusch D. B, et al., 2007; Venter J. C., et al.,
2004; Walter J. M., 2010].
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Fig. 1.10: Earth’s solar energy balance: This figure is taken with permission [Walter J.
M et al., 2010] (A) Solar energy that reaches our planet is only 50% of the original
irradiance of the Sun and then 50% of that is absorbed by the Earth’s surface. The
remaining energy could provide enough power to sustain our current needs. (B) Energy
consumption of the USA and world relies mainly on the fossil fuels. However, interest in
renewable sources is on the rise. (C) shows a comparison of four energy resources. The
dashed line represents the minimum energy need of US (4 TW). Ethanol production from
biomass is low efficiency [Brenner M. P. et al., 2006]. Solar panels are efficient at
harvesting sunlight and creating hydrogen fuel but are not cost-effective and lack
hydrogen transportation infrastructure. Photosynthesis has higher energy conversion
efficiency (33%) [Brenner M. P. et al., 2006]. Proteorhodopsin exhibits an energy
conversion efficiency of 21% - calculated using the energy of 525 nm photons and
dividing it by the energy stored in a proton pump across a 0.2 V membrane potential.
However, pR can absorb photons over a wide spectrum, thus capturing higher energy
(50%) compared to only 37% by photosynthesis.

26

1.5

Variants of proteorhodopsin
The pR-expressing variants can be generally classified into two major groups

based on their absorption maxima. The green absorbing pR is termed as GPR (Green
absorbing pR)) with a λmax = 525 nm, and the blue absorbing pR are BPR (Blue absorbing
pR) with a λmax = 490 nm. These absorption maxima correspond to the depth of the
habitat of bacteria; the bacteria that live on the surface of the water can absorb the longer
wavelengths whereas the ones that live in deeper water obtain only the shorter
wavelengths, in accordance with the spectral quality at the depths [Béjà O., et al., 2000;
Man D., et al., 2003]. The difference in the GPR and BPR comes from the ability of the
chromophore, retinal, to undergo “spectral tuning” according to its microenvironment
[Birge R. R., 1990; Ottolenghi M. and Sheves M., 1989]. “Spectral tuning” refers to the
large variation of the absorption spectrum of the chromophore as dictated by its
interaction with the apoprotein or its environment. For example, in methanol, the
protonated retinylidene Schiff base shows a λmax = 440 nm but in the protein
environment, it exhibits an “opsin shift” [Nakanishi K., et al., 1979] to a longer
wavelength such as 525 nm in GPR or 490 nm in BPR.

The various mechanisms attributed to the phenomenon of “opsin shift” as studied
in BR are: (1) Coplanarized conformation of retinal structure induced by the protein
environment from a twisted β-ionone ring/polyene chain in solution [Nakanishi K., et al.,
1979], (2) A weakened PSB/counteranion association resulting either from an increase in
the interionic distance from a solvation of counterion may lead to further shift in the
absorption maximum to longer wavelengths [Blatz P. E. et al., 1972; Blatz P.E. and
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Mohler J. H. 1972], (3) Presence of negative charges i.e., polarizable groups and
permanent dipoles along the polyene chain may lead to stabilization of the excited state
and cause a red shift [Hubbard R. and Kropf A., 1958; Yan B., et al., 1995], (4) The
aromatic retinal binding pocket of the protein [Braiman M. S. et al., 1988; Rothschild K.
J., et al., 1989], composed of Trp residues, stabilizes the excited state of retinal leading
to red shift.

The contribution of chromophore/protein interactions in the process of spectral
tuning and opsin shift has been actively investigated in pR. Based on structural modeling
and site directed mutagenesis studies, the single amino acid that is responsible for the
difference between GPR and BPR was found to be located at the position 105; GPR
contains Leu105 and BPR has Gln105. In BPRs, Gln105 is directly hydrogen-bonded to the
Schiff base (SB) whereas in GPRs, a water molecule bonds to the SB [Kelemen B. R., et
al., 2003; Kralj J. M., et al., 2008; Man D., et al., 2003; Man-Aharonovich D., et al.,
2004; Wang W. W., et al., 2003].

GPRs and BPRs have a similar primary structure but possess some other
differences besides the absorption maximum. GPRs have a faster photocycle (half-time
20-45 ms) whereas BPRs show a slower photocycle (half-time 200 ms) [Béjà O., et al.,
2001; Man D., et al., 2003; Wang W. W., et al., 2003]. Another point of difference was
found in the protonation state of a glutamate residue at the position 142. In GPRs Glu142
is normally protonated but in BPRs, it was found to be deprotonated at pH 7 or above
[Kralj J. M., et al., 2008].
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It has been suggested that spectral tuning could also result from a combined effect
of amino acids that form the retinal binding pocket and those that can impact changes in
the conformation of the binding pocket [Bielawski J. P., et al., 2004]. A recent study
using random PCR mutagenesis to screen for color-tuning mutations found about 20
single residue pR mutants that showed a red- or blue-shift compared to the wild type
[Kim S. Y., et al., 2008]. Quite confirmatory to the above prediction, most of these
mutations are located far from the retinal binding pocket. Other effects that can influence
spectral tuning include factors that influence protein stability [Bielawski J. P., et al.,
2004] or interaction between helices [Shimono K., et al., 2003].

1.6

Applications of proteorhodopsin

1.6.1

Holography and information storage
Information storage is mainly done via electronic memory, magnetic tape or

optical discs. With chip sizes, capacities and speeds approaching the limits of technology,
attention is being directed towards biomolecules with photochromic properties for the
purpose of developing various electronic and computational devices: information storage,
both two- and three-dimensional, and optical processing. The basic criterion for a
molecule to qualify for such applications is the photochromic property, i.e., the ability to
change color upon excitation by light, with two or more intermediates displaying distinct
spectral properties. It should possess photo-cyclicity, meaning that it can undergo
repeated transitions between these various photochromic states. Additionally, the
molecule should also be small in size, as well as thermally and chemically stable.
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Holography refers to use of light for the process of storing data. Photons, as they
travel at the speed of light, enhance the speed at which data can be stored and accessed.
Three-dimensional (3-D) information storage is ideal for high density memories. Proteins
qualify for such an application as they exist as relatively small molecules. Another factor
that is important for holographic application is the refractive index and change in the
light-induced refractive-index [Hampp N. A., 2000]. The refractive index of
bacteriorhodopsin is 1.47-1.55 [Zeisel D. and Hampp N. A., 1992; Zhang C., et al.,
1994], compared to 1.33 for water.

Bacteriorhodopsin (BR) is found in halobacteria that survive in extreme
conditions of salt, such as 25% (5 M) NaCl [Wise K. J., et al., 2002]. BR is found densely
packed in the cell membranes of these cells arranged as uniformly oriented hexagonal
crystalline arrays occurring as a two-dimensional crystal. BR is a small photochromic
molecule that undergoes photocycle through several intermediates, each with a distinct
spectral property. For example, BR (B state) absorbs at 570 nm whereas its most longlived intermediate with deprotonated Schiff base (M state) exhibits an almost separated
absorption maximum at 409 nm. These different wavelength maxima are the source of
difference between written and blank spots. Despite the fact that M intermediate is the
most stable intermediate for cellular proton pump function, it is not necessarily the
optimal stability for the storage applications. A mutant, D96N, was found to increase the
lifetime of this intermediate [Hampp N. A., 2000]. Therefore, the D96N mutant of BR
has received more attention as a holographic memory material [Hampp N. A., 2000]. The
optical properties of B and M states confer on BR the ability of being applied as
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photochromic optical recording, long term information storage and holographic
biomaterial.

A 3-D memory system was built by placing BR inside polyacrylamide gel in a
cuvette [Birge R. R., 1995]. A combination of two one-photon excitations is crucial for
applications. One wavelength can be used for writing information into BR and the other
can be used for erasing it. The system was read by two lasers, one to activate the protein
in a section of the cuvette and the other to read/write information in that section. The
information is stored similarly to binary code where the initially excited state is assigned
a binary value of 0 and the long-lived intermediates are designated 1. The storage
capacity is enhanced because multiple sections can be activated and multiple data
locations can be written simultaneously. [Birge R. R., 1995]

Proteorhodopsin is a homolog of BR with added advantages. Unlike BR, pR has
been expressed heterologously in E. coli which divides every 20-30 minutes. Thus, pR
can be made in larger quantities in relatively less time than BR. Detergent-solubilized pR
has been found to be as stable as BR in the purple membrane. Proteorhodopsin exhibits a
photocycle with similar intermediates and therefore, pR is also being tested for
application in 3-D information storage and holography [Ranaghan M. J., et al., 2010; Xi
B., et al., 2008].
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1.6.2 Cosmetic ingredient
Color changing technology is the future of personal care and cosmetics. Some
examples of such items have already been around for a while. Examples are “mood
lipstick” that contains weak acid pigments and a conjugate base that absorbs at a different
wavelength than the acid pigments; luster pigments that are refractive and reflective;
thermochromic pigments that change color when exposed to heat found in the nail-polish;
paint or kids’ garments; interactive cosmetics that change color to complement the
complexion of the skin, interactive toothpastes with magnetic cleaning action [Narang R.,
2008]; and photochromic pigments, such as the AgCl used in the TransitionsTM lenses
from Bausch and Lomb.

Photochromic materials such as metal oxides, for example, molybdenum and
tungsten oxides, have been suggested for use in cosmetics [Chaiken J. and Birge R. R,
2002]. The idea is that upon light absorption, these photochromic materials would
maintain or evolve a particular coloration. These materials are light-dependent; therefore,
they would change the color depending upon where the person is. BR was also included
in this patent as a cosmetic application. BR exhibits a wide absorption in the visible
region, 350-630 nm. By selecting certain mutations, the coloration effect can be
manipulated to last for a longer duration. These inorganic metal oxides or protein-based
formulations are relatively risk-free compared to organic dyes such as azo-dyes or
quinolines. Additionally, due to the fact that BR contains 8 tryptophan, 11 tyrosine, and
13 phenylalanine residues, it absorbs strongly in the UV region, 180-330 nm. This has an
added advantage of making BR also effective as a UV blocking agent.
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Proteorhodopsin exhibits similar photochromic properties as BR. Therefore, it can
also be used for such an application. It is a brightly purple colored protein with an
intermediate (M) that has a blue-shifted λmax. The M-intermediate can be made to live
longer by creating a mutation in the proton donor group (E108Q). The corresponding
lifetime increases by 10-20 times that of the wild type pR [Dioumaev A. K. et al., 2002].
Additionally, proteorhodopsin contains 10 tryptophan, 14 tyrosine, and 15 phenylalanine
residues (Table 1.1) which renders it suitable as a sun-blocking agent, similar to BR.

1.6.3

Bioenergy production
The increasing demand for energy is a global issue. Concerns of security and

longevity of traditional energy sources has directed research towards alternative fuels and
energy production. The annual energy consumption of the US is close to 3.5 Terawatts
(TW), and the world energy consumption is approximated at 16 TW. More than 80% of
the world energy supply is dependent upon fossil fuels and the current level of CO2
emissions is 380 ppm compared to the pre-industrial values of 280 ppm. If the current
levels are maintained, the CO2 levels have been projected to rise to 550 ppm by the end
of the century [Brenner M. P. et al., 2006]. In the year 2010, the nation’s energy supply
was dominated by petroleum, followed by natural gas, coal and nuclear power in that
order (Fig. 1.11). Compared to these traditional energy resources, the renewable energy
consumption was relatively low. However, its use has grown dramatically over years.
Renewable alternatives, such as wind, solar, thermal power, and biofuels have attracted
much attention in the recent times, both to help achieve fuel-independence and to limit
CO2 emissions.
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Fig. 1.11: Energy chart: Left: Various energy sources available in the US, Right:
Types of renewable energy sources. The consumption values are based on the
year 2010. Figure is taken from U. S. Energy Information Administration website
(www.eia.gov).

In recent years, research on the use of microorganisms for energy production has
been on the rise. For example, ethanol is produced as a metabolic by-product and is being
used as an alternative fuel. The aim is to manipulate these microorganisms for the
production of liquid hydrocarbons. Since the biological systems are regulated by
numerous feedbacks, there are technical engineering hurdles to be overcome. Meanwhile,
we can focus on the microorganisms or systems with relatively simpler modes of energy
production.

Bacteria and Archea use relatively simple light driven proton-pumps to harvest
solar energy. The proton pumps generate proton motive force (pmf) which can then be
used to synthesize energy in the form of ATP. The facts that pR can transform solar
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energy into useful cellular energy and that it can be functionally expressed in a
heterologous system make pR a potential candidate for use in energy production [Walter
J. M., 2010]. There is an issue of coupling pR to another protein or system that would
synthesize a useful form of energy instead of ATP. Another issue is that pR functions
only under circumstances where the cells are limited for ATP or pmf. Furthermore, pR
functions to increase the pmf only when the pmf falls below the threshold pmf [Walter J.
M., 2010; Walter J. M., et al., 2007]. Metabolic engineering of microbes has had some
success, for example, introduction of a glucose transporter gene into an obligate
photoautotroph converted it into a heterotroph. It was shown that this microalga survived
on glucose in the dark instead of light [Zaslavskaia L. A., et al., 2001]. Proteorhodopsin
therefore has great potential for being used in conjunction with another enzyme(s) to
produce energy.

1.7

Purification of protein
Why is purification of pR important? The closest relative of pR is the archeal BR

which has been a popular protein for applications such as the development of
optoelectronic, 2-D and 3-D optical storage, cosmetics and potentially for bioenergy
production. However, growth of halobacteria is quite slow with doubling time typically at
least 10-12 h [Deshpande A. and Sonar S., 1999; Seehra J. S. and Khorana H. G., 1984].
At the same time, heterologous expression and purification of the native BR has been a
considerable challenge due to the inadequate accessibility to the genetic systems for
optimization of BR production [Wise K. J., et al., 2002]. On the other hand, pR has been
successfully expressed in E. coli, possesses similar properties as BR and therefore, has
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attracted much attention for similar applications [Ranaghan M. J., et al., 2010; Xi B., et
al., 2008].

In addition, the three-dimensional structure of pR has not been solved yet. In
order to study the 3D structure, one needs a good quality crystal that can diffract light. To
utilize the protein for either its application purposes or carry out crystallography, one
needs a significantly high amount of functionally active and pure protein, typically 10-15
mg/ml to at least >90% homogeneity. Since pR is readily expressed in E. coli, it is easy
to grow these cells in larger volumes. The next step is the isolation and purification of the
protein.

1.7.1

General Process of Purification of Protein
Protein purification is the process of isolation and separation of a particular

protein from the cellular extract that contains thousands of proteins. Each protein has its
own physical and chemical properties and therefore, they can be separated from each
other on the basis of the properties such as solubility, size, charge, isoelectric point,
hydrophibicity, binding-affinity, post-translational modification, etc. Different methods
of purification are used, depending on the property of the protein.

Generally, for purifying intrinsic membrane proteins, the cells that express the
proteins are lysed and the membranes are subjected to solubilization in a detergent, either
before or after a centrifugation step to separate the membranes from water-soluble
cytosolic components. The crude detergent-solubilized protein is then subjected to a
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series of steps that gradually isolate the protein from the mixture and eventually yield the
pure protein. Traditional protein purification methods include the use of salts or solvents
that aid in fractionating the protein of interest from the extract. It is followed by a
combination of different column chromatography methods, dialysis and filtration.

Solubility of proteins is one of the properties that is utilized in the initial steps of
protein purification. The differing solubilities of proteins depend on pH of the solution,
ionic strength of the salts, polarity of the solvent, nature of the ions, temperature, and
isoelectric point. Proteins are generally least soluble at their isoelectric point, since there
is less Coulombic repulsion between identically-charged molecules of the protein.

The aim is to either get the best yield of the protein of interest or to have the most
pure form of protein. In order to keep a track of the protein of interest, one needs an
activity assay to measure the protein’s concentration and activity. At each step, the
different fractions are assayed for protein. Then, that particular fraction that contains the
protein is subjected to chromatography technique(s) to separate it from the other
contaminant proteins.

1.7.2

Membrane protein purification
Membrane proteins are the proteins that are found associated with the membranes

of a cell or its organelles. They are generally categorized as trans-membrane proteins,
also known as integral proteins, and peripheral membrane proteins. Since the membrane
proteins are surrounded by lipids, their isolation is considerably challenging as compared
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to the soluble cytoplasmic proteins. The membrane proteins are hydrophobic and
therefore, when they are separated from the membranes, they tend to aggregate and
precipitate from an aqueous solution. In order to keep the membrane proteins solubilized,
one has to employ detergents. Detergents have affinity for water as well as the
hydrophobic amino acid residues. They can break down the phospholipid bilayer of the
membrane and solubilize the lipids and proteins. In this process, they form micelles and
therefore prevent the protein from forming aggregates.

Integral and peripheral membrane proteins are involved in vital roles in cellular
functions, such as cell signaling, cell adhesion, transport of molecules, and maintenance
of cell or organelle structure, to name a few. About 30% of the mammalian genome Open
Reading Frames (ORFs) has been found to encode integral membrane proteins [Stevens
T.J. and Arkin I.T., 2000]. Despite their importance in the key functions, only 290
membrane proteins have had their three-dimensional (3D) structure elucidated to date
[Stephen W., membrane protein structure database] compared to the available 3D
structures of >43000 soluble proteins [NCBI database].

About 2-4% of the human genome has been predicted to code for G-protein
coupled receptors (GPCRs), which are trans-membrane proteins. They are involved in a
variety of functions such as visual sensing, smell sensing, regulation of the immune
system etc. Many diseases involve the malfunctioning of GPCRs, some of which are
blindness, allergies, diabetes, cardio-vascular defects. Approximately 50% of currently
marketed drugs target GPCRs [Lundstrom K., 2006]. Yet, the 3D structures of only the
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following six GPCRs are known so far: Bovine rhodopsin [Palczewski K., et al., 2000],
β2 Adrenergic Receptor [Cherezov V. et al., 2007; Rasmussen S. G., et al., 2007], β1
Adrenergic Receptor [Warne T., et al., 2008], human A2a Adenosine receptor [Jaakola V.
P., et al., 2008], CxCR4 chemokine receptor [Wu B., et al., 2010] and, Dopamine D3
receptor [Chien, E.Y. et al., 2010].

The major obstacles in obtaining structures of GPCRs, or membrane proteins in
general, involve protein expression, large scale production and purification, protein
stability, and homogeneity. Selecting the appropriate detergent is one of the challenges
that faces the process of membrane protein purification. The chosen detergent should
keep the protein solubilized and stable, but also not interfere in the crystal formation. For
example, the detergent, nonyl-β-glucoside, that was used for rhodopsin crystallization
[Stenkamp R. E., et al., 2002] is not suitable for the crystal formation of another GPCR,
β2 adrenoceptor (β2AR). Similarly, the detergent, dodecyl maltoside, used for β2AR was
not found to be suitable for rhodopsin crystallization.

1.7.3

Salting out: the Hofmeister series
When an impure protein solution is subjected to an increasing amount of salt it

begins to precipitate out of the solution. This phenomenon is known as “salting-out”.
The salt concentration at which the precipitation begins is different for different types of
protein. Thus, different proteins are separated from the solution at different
concentrations of the salt and are thus fractionated.
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Ammonium sulfate is often used for the salting-out of proteins because it is highly
water soluble, and does not denature the proteins. It also utilizes two ions, ammonium
and sulfate, that are high in the Hofmeister series (see below), which gauges the relative
effectiveness of different types of ions at causing salting-out of proteins. At a fixed salt
concentration, ions higher in the Hofmeister series are more likely to cause salting out.

Specific ion effects were long ago found to display recurring trends in the saltingout of proteins [Hofmeister F., 1888; Kunz W., et al., 2004]. Such trends are more
pronounced for anions than for cations.

Hofmeister measured the concentration of various salts needed to precipitate the
proteins from the whole egg white. He arranged the salts as a series of anions and cations
referred to as the Hofmeister series. More salts have been examined and added to the
series, a partial list is shown below.

For the same cation with different anions, the order is:
SO42- > HPO42- > acetate > citrate > tartarate > bicarbonate > chromate > Cl- >
NO3- > ClO4For the same anion, the order for cations is:
Li+ > Na+ > K+ > NH4+ > Mg2+

Ions in the Hofmeister series were originally thought to cause their effects
indirectly by influencing the structure of water, specifically by changing its hydrogen-
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bonding properties [Collins K. D. and Washabaugh M. W., 1985]. Therefore, the
Hofmeister series is arranged in the order of these ions’ ability to make or break
hydrogen-bonded water structures. The species to the left of Cl- are known as
cosmotropes, while those to its right are called chaotropes. Cosmotropes were believed to
promote hydrogen-bonded water structure. They are strongly hydrated, stabilize the
macromolecules and exhibit salting-out effects on proteins. Chaotropes are the ‘water
structure breakers’; they destabilize and cause salting-in of the macromolecules.
Hofmeister [Hofmeister F., 1888; Kunz W., et al., 2004] concluded that the better the
capacity of a salt to order the water i.e., to be solvated (hydrated), the more effective it is
in precipitating the protein.

Recently, it has been shown by various research groups that ions do not affect the
bulk water properties. It was shown using femtosecond mid-infrared pump-probe
spectroscopy that anions have no influence on the hydrogen bonding network outside the
direct vicinity of the anion [Omta A.W. and Bakker H.J., 2003]. It was concluded that, at
least at the relatively low concentrations that can lead to salting-out phenomena, neither
cosmotropes nor chaotropes are involved in long-range structure making or structurebreaking effects. Another group [Batchelor J.D., et al., 2004] conducted thermodynamic
studies by using different solutes known for their stabilizing or destabilizing effects on
proteins. They collected data as a function of temperature and calculated the coefficient
of thermal expansion. Their results showed no obvious correlation between
cosmotropes/chaotropes and their sign (+/-) of the coefficient value. Yet one more
challenge to Hofmeister’s conclusion came from a study of the effect of Hofmeister

41

anions on phase transition of a surfactant monolayer of octadecylamine and its adjacent
water structure. Gurau et al. [Gurau M. C., et al., 2004] showed that anions followed the
Hofmeister series in the stabilization of the monolayer, but showed a significant deviation
when it came to the structuring of water. The ordering of the monolayer by the anions is
suggested to be due to their ability to penetrate the headgroup region and cause disruption
in the hydrocarbon packing [Aroti A., et al., 2004].

It has been suggested that direct ion-macromolecule interactions are responsible
for the phenomenon of salting-in or salting-out behavior [Zhang Y. and Cremer P. S.,
2006]. Anions show two trends in the way they effect protein precipitation, depending
upon the pH of the solution [Bostrom M. et al., 2005]. At a pH above the isoelectric point
(pI) of the protein, the protein possesses a net negative charge and a direct Hofmeister
series is observed. “Direct Hofmeister series” refers to the phenomenon where the
cosmotropes stabilize the folded state of the protein and lead to the salting-out effect,
whereas the chaotropes lead to destabilization and salting-in of proteins. At a pH below
the pI, the net charge is positive. In this range, an inverse Hofmeister effect is observed,
where Hofmeister’s “cosmotropes” lead to salting-in and “chaotropes” cause the protein
to salt-out of the solution.

The above mentioned effects of salts are observed mostly on soluble proteins. The
effects of the Hofmeister series on membrane proteins have only recently become a
matter of interest. Conformational equilibrium studies were performed on the artificial
visual pigment 9-demethyl-rhodopsin (9dm-Rho), where the retinal was replaced by 9-
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demethyl retinal [Vogel R. and Siebert F., 2001]. It was found that the well known
Hofmeister cosmotropes were unsuccessful in stabilizing 9dm-Rho because it was mainly
stabilized by the phospholipid bilayer. All the salts also caused an equilibrium shift from
the MI intermediate to the less compact MII intermediate. Another study on
bacteriorhodopsin led to similar conclusion [De´r, A. and Ramsden J. J., 1998]. The
denaturant, NaSCN, accelerated the decay of the M intermediate of bR whereas the
stabilizer, NaF, did not show any kinetic effect. Thus, the effect of Hofmeister salts on
the membrane protein is not as strong as the soluble proteins.

1.8

Widely used method of pR purification
Proteorhodopsin was originally cloned into the plasmid pBAD TOPO TA which

adds a polyHis-tag at the C-terminus of pR. The purification of proteorhodopsin has
normally depended on the use of the polyHis-tag that binds to the Nickel column or
Nickel-nitroloacetic acid (NTA) agarose resin beads [Bergo V., et al., 2004; Friedrich T.
et al., 2002; Gourdon P. et al., 2008; Jung J. Y., et al., 2008; Kelemen B. R., et al., 2003],
where Nickel is bound to agarose via NTA. In short, Histidine-binding to Ni2+ is a type of
affinity binding that has been exploited as a column chromatography for purification
purposes. The His-tagged protein binds to the Ni2+ on the resin, the other proteins are
washed away with a very low concentration of imidazole, and thus removed. The bound
protein is then eluted with a high concentration of imidazole that competes with the polyhistidine group on the target protein. This type of purification yields a fairly pure protein.
However, there can be some contamination from the rare proteins that contain polyhistidine residues or from non-specific binding to Ni2.
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1.9

Our method of pR purification
Our lab developed an inexpensive method of pR purification using citrate as the

precipitant [Partha R. and Braiman M.S., 2003; Partha R., et al., 2005]. The utility of
citrate was discovered serendipitously. Citrate was initially employed as one of the
buffers during the pH titrations in order to determine the pKa of the proton acceptor group
Asp97 [Partha R., et al., 2005]. It was observed that upon incubation with citrate, pR
begins to precipitate out of the solution. This observation led to the hypothesis that citrate
could be used as a selective precipitant of pR and thus, aid in pR purification. It was
found that a detergent concentration of 0.3% at pH 5.5 with a 50 mM citrate
concentration yielded the most intense purple pellet of pR.

His-tagged pR and several select site-directed pR mutants have been purified with
citrate to 50% purity and 48% yield. The advantages of using citrate include its ability to
purify the protein in a few steps, eliminating the need for high-speed centrifugation,
which is typical in membrane protein purification procedures. Thus, overall, the citrate
method of protein purification is inexpensive at various levels, easy and fast. Further
purification was carried out using Nickel-column to yield 95% purity and 41% yield.

1.10

Citrate
Citric acid is a tricarboxylic acid. Its conjugate base is known as citrate. Citric

acid is a weak organic acid and is found in citrus fruits. The IUPAC name of citric acid is
2-hydroxypropane-1, 2, 3-tricarboxylic acid. The structure of citrate and its pKa values
are shown below:
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pK1 = 3.13
pK2 = 4.76
pK3 = 6.40

Citrate appears as an intermediate in the citric acid cycle, also known as
tricarboxylic acid (TCA) cycle or Krebs cycle. After the food has been broken down into
glucose, glucose enters a cycle known as glycolysis. Glycolysis occurs in the cytosol of
the cell, it precedes the TCA cycle which is followed by the electron transport chain. The
end product of glycolysis is pyruvate. Pyruvate is oxidatively decarboxylated to form
acetyl CoA which enters TCA cycle. A four-carbon compound, oxaloacetate, condenses
with a two-carbon acetyl unit, acetyl CoA, to generate a six-carbon tricarboxylic acid
compound known as citrate. Citrate undergoes a series of reactions to generate energy
rich molecules, NADH, FADH2 and GTP. NADH and FADH2 are oxidized in the
electron transport chain to generate ATP. Besides, the intermediates of TCA cycle also
serve as a source of building blocks for biosynthesis. For example, α-ketoglutarate and
oxaloacetate, the intermediates of TCA, are the source of many amino acids. [Stryer L]

1.11

Citrate does not degrade pR
The purification process requires that the reagents do not destabilize and

inactivate the protein. Proteorhodopsin is a retinal protein and absorbs at λmax = 520-545
nm depending on the pH. Citrate precipitated pR is found to remain stable, evident from
the 545 nm absorption maximum at pH 7.0. This indicates that pR is properly folded and
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is bound to its chromophore retinal. A similar absorption maximum and an identical pKa
of 8.1±0.2 was obtained for the protonated Schiff base counterion Asp97 from partially
purified citrate extracts as from a freshly-prepared pR purified by using other methods
[Partha R., et al., 2005].

1.12

My Research
My research has focused on two main issues. One was on understanding the

nature of the interaction of pR with citrate and other anions. The other was to extend this
study to develop a simple method for the purification of membrane proteins. The final
goal of my study is to apply these methods first to other similar membrane proteins and
then to extend it to all the membrane proteins.

Study of the nature of pR-citrate interaction revealed the importance of four
positively charged amino acid residues found in the first intracellular loop of pR. Study
of interaction of several other anions led to the development of a purification protocol of
a membrane protein pR exclusively using simple salts.

The future prospect of this study lies in the application of these two findings for
the purification of other membrane proteins of general and pharmaceutical importance.
An attempt was made first to express mammalian trans-membrane protein in E. coli and
then to purify it using our established citrate method of protein purification. There are
several hurdles that remain to be overcome before the protocol can be standardized.
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Chapter 2

CITRATE BINDING SITE IN PROTEORHODOPSIN INVOLVES TWO
LYSINES IN THE FIRST CYTOPLASMIC LOOP

2.1

ABSTRACT
Proteorhodopsin (pR) has one or more binding sites for citrate, as evidenced by

aggregation of native purified pR from octylglucoside detergent solutions, at citrate
concentrations as low as ~10 mM (pH 5.5-7.5). The aggregation is reversible by dilution
of citrate and addition of detergent, at pH>9. Other anions, e.g. glutarate, glutamate,
phosphate, and chloride, also cause aggregation, but only at higher concentrations.
Citrate binding requires lysines 57 and 59, two of the four cationic residues in the first
intracellular loop. That is, citrate no longer causes precipitation of pR when these lysines
are mutated. The loss of citrate sensitivity is nearly complete for the quadruple mutant
R51Q/R53Q/K57Q/K59Q, the triple mutant R53Q/K57Q/K59Q, and the double mutant
K57Q/K59Q, even with 1 M citrate. In contrast, the single-site mutant R51Q shows only
a ~2-fold increase in the citrate concentration required to induce pR aggregation (to ~30
mM), while R53Q appears not to fold stably. Thus, the 2 arginines play a less certain
role in the citrate binding site.
proteobacteria.

Lysines 57 and 59 are conserved among disparate γ-

Aggregation of pR in detergent micelles requires citrate or glutamate

concentrations similar to endogenous levels, ~10 mM and ~100 mM respectively, that
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have been measured inside thriving bacteria. However, we have obtained no evidence for
citrate binding for pR in a reconstituted lipid bilayer environment. In particular, flash
photolysis of pR liposomes shows no effect of citrate on the yield or kinetics of the M
intermediate.

2.2

INTRODUCTION
Proteorhodopsin (pR), originally discovered in an as-yet uncultivated species of

the SAR86 group of γ-proteobacteria, was the first-discovered eubacterial homolog of
bacteriorhodopsin [1, 2]. It is estimated that the world’s oceans contain at least 1028 pRproducing bacteria in the photic zone [3]. Since its first discovery, numerous pR-directed
surveys of marine DNA samples have been conducted, and subjected to metagenomic
analysis. Variants of pR genes have been found widespread in diverse bacterioplankton
groups from widely-dispersed geographic locations [4-9]. A global ocean sampling
expedition uncovered more pR related genes from the surface marine environment [9].
More recently, new pR genes have been discovered in estuarine and inland bodies of
water, leading to the conclusion that pR genes are widespread, i.e., not just confined to
marine environments [10].

When heterologously expressed in E. coli, pR functions as a light-driven proton
pump, with a net outward transport of protons, but only in the presence of exogenously
added retinal [1]. The ubiquity of pR in the Earth’s oceans and fresh water bodies, and its
ability to pump protons resulting in photophosphorylation, i.e. ATP formation [1, 11-13],
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together raise the possibility that pR photochemistry contributes a considerable fraction
of solar energy utilization by the biosphere.

Recently, our lab discovered that citrate, at concentrations of 20 mM, i.e., only a
bit above those previously measured intracellularly [14], selectively precipitates pR from
a detergent extract of pR-expressing E. coli cells, making this a useful step in the
purification of a membrane protein [16, 17].

The current work was aimed primarily at identifying the structural basis for pR
aggregation in the presence of citrate, specifically, the nature of interaction of pR with the
three carboxylate groups of citrate. The degree of specificity of such an interaction is
studied by altering the primary structure of the pR protein through site-directed
mutagenesis. It was found that a positively-charged cluster of amino acid residues in the
first loop, between the 1st and 2nd helices of pR, is involved in mediating the interaction
between citrate and pR.

It was also found that besides citrate, pR can also be precipitated by other
polycarboxylates, phosphate and chloride, albeit at concentrations that are higher,
especially relative to their physiological levels.

Aggregation of pR from detergent solutions is initiated over the physiological
concentration range of citrate in bacteria. This is of particular interest in light of the
conclusion [11] that marine bacteria might also employ pR as a solar energy transducer
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selectively under conditions associated with low respiratory rates, as a result of such
conditions triggering pR expression or activity [11]. Citrate is a key intermediate in the
tricarboxylic acid (TCA) cycle and is an allosteric regulator of many enzymes in
bioenergetic pathways. Therefore, it was hypothesized that the utility of citrate as an in
vitro precipitant for pR might in fact reflect an in vivo interaction between citrate and pR,
i.e., citrate might mediate an “on/off” switch for pR activity as a function of respiratory
state of the bacteria.

However, experiments on pR in reconstituted liposomes failed to support this
hypothesis. In fact, flash photolysis of the reconstituted pR shows no effect of citrate on
the millisecond kinetics or amplitude of the photocycle. This kinetics result casts doubt
on the hypothesis that citrate could be regulating pR activity in the bacterial cell
membrane.

2.3

MATERIALS AND METHODS

2.3.1

Protein Expression
Proteorhodopsin triple cysteine mutant (pR-TCM), i.e. the protein corresponding

to accession number AAG10475 but with all 3 cysteines mutated to serine, was expressed
from a pBAD-TOPO plasmid in E. coli, with minor modifications to protocols described
previously [18, 19]. The pR-TCM was expressed in the native form i.e. without the Cterminal polyhistidine tag.

Cultures (50-500 mL) were grown in an enriched LB

medium (0.5% yeast extract, 1% peptone, 50 mM KH2PO4, 50 mM Na2HPO4, 1%
glycerol, pH-adjusted to 7.0).
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For induction of pR, the temperature of the shaking incubator was reduced to
15°C, L-arabinose was added to a final concentration of 0.2%, and all-trans-retinal was
added to a final concentration of 5 µM [19]. The culture was left shaking at 50 rpm in the
dark at 15°C overnight [19]. Cells were harvested by centrifugation in 500-mL bottles
(6000 rpm, 4°C, 10 min).

2.3.2

Protein Purification
A crude detergent extract of pR was prepared by gently resuspending the cell

pellet in 10 volumes of 10 mM HEPES buffer, pH 7.1, containing 3% n-octyl-β-Dglucoside (OG), 0.08% lysozyme, 1 mM phenylmethylsulfonyl fluoride (PMSF) protease
inhibitor, and 0.01 mg/mL DNAse, and incubating at room temperature for 3 h or at 4°C
overnight. Cellular debris was removed by centrifuging the lysate at 2500 × g.

To the purple-colored supernatant, a 1/3-volume of 100 mM citrate buffer (pH
5.5) was added with gentle mixing, to give a citrate concentration of 33 mM. This
sample was incubated on ice for 15 min, and then centrifuged at 3000 × g, 4°C to
precipitate out whitish impurities. Addition of a same-sized second volume of the same
100 mM citrate buffer (to 40 mM) was followed by incubation and centrifugation to
remove more of the uncolored contaminants, while losing at most a small amount of the
pR as precipitate. A third addition of 100 mM citrate, to a final citrate concentration of
50 mM and final OG concentration of 1.5%, followed by centrifugation, yielded a bright
purple pellet containing most of the pR, with almost no color left in the supernatant.
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The volume of the purple pellet was estimated, then it was gently re-solubilized in
a 10-fold larger volume of 50 mM Tris-Cl buffer, pH 9.1, containing 3% OG. This
sample was then centrifuged to remove grayish insoluble material. If any significant
purplish color remained in the pellet, it was re-extracted with the same pH 9.1 buffer
containing 3% OG. The (combined) clear purple supernatant was again subjected to
selective precipitation by addition of aliquots of 100 mM citrate, pH 5.5, as described in
the preceding paragraph. However, with increasingly pure pR, the total citrate
concentration needed to precipitate the pR decreases, so smaller relative volumes were
used.

A total of 3-4 cycles, each consisting of selective precipitation of pR by citrate
followed by resolubilization in Tris buffer/detergent, yielded pR with A280/A520 ratio of
4-10. This sample was then applied to a freshly-poured 10 cm×1 cm hydroxylapatite,
Ca10(PO4)6(OH)2, (BioGel HTP, BioRad) column, poured in 500 mM KCl, 100 mM
acetate (pH 6). The bound protein was eluted with a 0–600 mM phosphate gradient (pH
6) containing a constant 0.4% OG. The uncolored eluate was discarded and 2 mL
fractions were collected as soon as the purple color began to elute.

The eluted purple fractions were pooled, concentrated with Amicon filters (MW
cut-off 10,000 kDa), and washed in the filters with 10 mM HEPES, 0.4% OG. The
concentrated sample was further dialyzed in a Tube-O-dialyzer (Gene Mate, MW cut–off
4,000 kDa) against 10 mM HEPES 0.4% OG, with several changes, to remove the
phosphate completely.
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For the quadruple mutant R51Q/R53Q/K57Q/K59Q, the triple mutant
R53Q/K57Q/K59Q, and the double mutant K57Q/K59Q, even at 1 M citrate it was not
possible to get the pR to precipitate from the crude cell extract. For these mutants, ~1
mL of this crude detergent extract of the cell pellet was applied directly to the
hydroxylapatite column, and eluted as described above. This yielded only partial
purification, i.e. an A280/A520 ratio of ~10.

2.3.3

UV-visible absorbance measurements
A Shimadzu UV-265 spectrophotometer was used to measure quantities of pR

remaining in the supernatant of pR samples purified as above, both before and after
addition of various amounts of 100 mM citrate buffer (pH 5.5), followed by
centrifugation to remove aggregated pR. The data collected were analyzed using
MIDAC-GRAMS.RTM. (Galactic Industries) software. The concentration of pR in the
sample was determined by the value of A520, after correction of the baseline by
subtraction of the absorbance reading at 700 nm.

2.3.4

Site Directed Mutagenesis
Proteorhodopsin mutants, based on the pR TCM template DNA, were generated

using a QuikChange Site Directed Mutagenesis kit (Stratagene), with primers synthesized
by Integrated DNA Technology. The mutated plasmid DNA was recovered from E. coli
cultures and was sequenced at the Sequencing Facility of SUNY Upstate Medical
University.
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2.3.5

Test for aggregation with diverse anions
Proteorhodopsin was purified with several rounds of citrate buffer as mentioned

above. It was resolubilized in Tris 50 mM, pH 9 and also containing 3% OG. It was tested
for precipitation with anions of various monocarboxylates (acetate), dicarboxylates
(succinate, dodacanedioate, aspartate, glutamate and glutarate) and tricarboxylates (isocitrate and cis-aconitate); as well as with monovalent and polyvalent ions such as
phosphates, sulfates (ammonium sulfate, sodium sulfate, sodium thiosulfate), chlorides
(sodium chloride, potassium chloride), sodium chlorite, larger polyvalent ions such as
glucose-6-phosphate (G6P), adenosine triphosphate (ATP), and adenosine diphosphate
(ADP). All of the above salts and acids were buffered to pH 7.5 with Tris, 10 mM. The
final concentration of OG was 1%. Proteorhodopsin was incubated at 4°C with above
mentioned buffers ranging from 5 mM to 200 mM. Then the samples were centrifuged at
2000 rpm, 20°C, 5 minutes.

2.3.6

Reconstitution of pR into DOPC liposomes
Proteorhodopsin was purified with citrate (as above) to an A280/520 ratio of about 3.

The resolubilized pR was diluted to a concentration of 1 mg/mL in 50 mM Tris-Cl, 3%
OG, pH 9. Reconstituted membrane vesicles of pR were prepared with some
modifications of protocol described previously [20]. OG (800 mg) was added to 10 mL of
20 mg/mL dioleoylphosphatidylcholine (DOPC) in chloroform, and the mixture was
dried using SpeedVacTM. The dry powder of the lipid-detergent mixture was resuspended
in 40 mL of 50 mM MES and 300 mM NaCl, pH adjusted to 6, to achieve a final lipid
concentration of 5 mg/mL. It was then sonicated until a clear solution was obtained. This
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lipid-detergent solution (60 µL) was added to the partially pure pR (1 mL, 1mg/mL). The
lipid-protein mixture was incubated at room temperature for 1h, then transferred to
dialysis tubing (4,000 kDa cut-off) and dialyzed for 1 week at room temperature against
50 mM Tris-Cl, 100 mM NaCl, 10 mM MgCl2, 3 mM NaN3, and 5 mM DTT, pH 8.5.
Unlike in reference 20, Methyl 2-4, Pentanediol (MPD) was not included in the dialysis
buffer. After a week of dialysis, the reconstituted sample was washed several times with
50 mM Tris buffer containing 3 mM NaN3, pH 8.5.

Citrate-containing pR vesicles were made by including 20 mM citrate in the
vesicle-forming dialysis step.

2.3.7

Flash spectroscopy and kinetic analysis
Flash-induced kinetics of the M intermediate of the reconstituted pR vesicles were

measured in a custom-built system using a 3-mL quartz cuvette. The excitation laser
was a frequency-doubled Nd+-YAG laser flash (532 nm, 8 ns, ~10 mJ cm-2). The
measuring light was a battery-powered 400-nm light-emitting diode, using a series of
lenses to focus its output first through the illuminated region of the cuvette, and then onto
an AC-coupled silicon photodiode detector. A 532-nm notch filter was used to reduce
the size of the laser flash artifact. Phototransients in the millisecond time range were
acquired by using a LeCroy Model 9400A Dual 250 MHz Digital Oscilloscope. The
total number of points measured was 25000 at a spacing of 4 µs, for a total duration of
100 ms. Each sample’s transient intensity-change signal was obtained by averaging 5000
acquisition sweeps, then converted to a percent transmission change by dividing by the
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intensity drop produced with a mechanical chopper wheel blocking the measuring beam
intermittently at ~30 Hz.

After removal of the first 0.1 ms of data following the flash, to

remove the flash artifact and the rise of the M intermediate, each averaged absorption
transient was fitted to a first-order kinetic equation for M decay, A400(t)= B + A0 e-kt by
using the solver function in Excel, optimizing for values of the baseline absorbance B ,
the transient amplitude A0 , and the first-order decay constant k.

2.3.8

Homology modeling and molecular graphics imaging
Homology modeling of pR was based on the crystal structure of

bacteriorhodopsin (bR) from Halobacterium salinarum (PDB: 1FBB). It was produced
using Geno3D, an automated protein-modeling Web server [21]. Molecular graphics
images of pR-citrate interactions were produced using the UCSF Chimera package from
the Resource for Biocomputing, Visualization and Informatics at the University of
California, San Francisco [22].

2.3.9

Distance Tree of proteorhodopsin related proteins
A distance tree of bR/pR homologs was generated using BLAST pairwise

alignment [23]. The protein sequence of pR was aligned against the protein database
using the BLASTp algorithm, and the distance tree was produced using fast minimum
evolution tree method. The resulting file (newick format) was manipulated with
TreeViewX [24].
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2.4

RESULTS

2.4.1

Purification of proteorhodopsin without His-tag
Proteorhodopsin (pR) with the polyHis-tag has previously been purified by

selective precipitation with sodium citrate, from a level of 0.1% of total protein in the
crude cell lysate to 20-25% [16, 17]. Those earlier results were confirmed now also with
pR TCM lacking the non-native C-terminal His6-tag, thereby showing that citrate is not
likely interacting with these histidines. By using this rapid citrate purification method,
followed by a single column step using hydroxylapatite (BioGelHTP), pR-TCM (without
any non-native His tag) can be routinely purified to give an A280/A520 ratio of <3.0. When
extra care is taken, this can be improved to a ratio of 2.0, indicative of >95% purity (Fig.
2.1). With an elution buffer containing 0.4% OG, most of the pR elutes from the
hydroxylapatite at 570-600 mM phosphate (pH 6.0).

Fig. 2.1: Absorption spectrum of pR triple cysteine mutant without the His6tag: The protein was purified by 3 repeated cycles of citrate aggregation followed
by resolubilization, then loaded on hydroxylapatite column, eluted with phosphate
gradient containing 0.4% OG, and dialysed against 10mM HEPES, 0.4% OG. The
A280/A520 ratio for this sample is 2.1, indicating >90% purity.
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It was also of interest to confirm that this column purification did not strip the pR
of any co-factors that might be required for precipitating it with citrate. To establish that,
the samples of pR purified by the BioGel HTP column were concentrated, phosphate was
removed by extensive dialysis against 10 mM HEPES containing 0.4% OG, then 1/3
volume of 100 mM citrate buffer (pH 5.5) also containing 0.4% OG was added, i.e. to a
final citrate concentration of 33 mM. After incubation on ice for 10 min followed by
centrifugation, the purified pR TCM sample precipitated out of the solution
quantitatively. This indicates that pure pR specifically interacts with citrate, with no
dependence on co-precipitating protein(s) or other co-factors. Thus, pR itself has binding
site(s) for citrate.

It is of interest that failure to remove phosphate after the hydroxylapatite column
results in insensitivity to citrate. That is, even at fairly low (50 mM) concentrations,
phosphate competes for the citrate binding site on pR, completely inhibiting the ability of
similar (50 mM) citrate concentrations to precipitate pR. This observation establishes
definitively that the citrate-induced aggregation of pR is not merely a salting-out of the
protein. A salting-out process by 50 mM citrate should be enhanced, rather than
inhibited, by the additional presence of 50 mM phosphate.

2.4.2

Lysines in the first cytoplasmic loop on pR mediate citrate interactions
It was hypothesized that citrate, a tricarboxylate with average charge of -2.5 in

aqueous solution at pH 5.5, would interact with positively charged amino acid(s) on pR.
There are 12 positively charged lysine and arginine residues in the entire primary
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sequence, of which 8 are on the cytoplasmic surface, and 4 are grouped in the first
intracellular loop (IC1): Arg51, Arg53, Lys57 and Lys59 (Fig. 2.2). A reasonable hypothesis
to explain the citrate-induced aggregation of pR is that it may be mediated by some of
these 4 cationic residues on IC1. There was also a possibility of other lysines or arginines
being involved in such an interaction, but the ones present in the membrane-spanning
helices were ruled out easily. That is, direct interaction of citrate with two of the
arginines (Arg80 and Arg94) and one lysine (Lys231) were thought to be very unlikely, on
the grounds that these residues are buried within the membrane protein, and Lys231 is the
site of Schiff base formation with the retinal chromophore. Additionally, our lab had
previously made the R94C mutant [16] and shown it to be susceptible to citrate-induced
precipitation.
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Fig. 2.2: Locations of cationic residues in pR: The native sequence of SAR86
pR (accession #AAG10475) is shown, with approximate division into helices AG, resulting in 3 interhelical loops on each side of the membrane. The 3 cysteines
(yellow) were all mutated to serine in Triple Cysteine Mutant proteorhodopsin
(pR TCM), which served as a baseline for all of the further pR mutations studied
in the current work. Positively charged residues (lysine, arginine, and histidine)
are colored blue.

To test the role of the four amino acids in loop IC1 in binding to the citrate
molecule, pR mutations were generated at these residues by using site-directed
mutagenesis. Then these mutants were examined for the amount of pR remaining in the
supernatant, after standardized additions of increasing amounts of citrate. The results are
summarized in Fig. 2.3.
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Fig. 2.3: Citrate precipitation of wild type pR and mutants: “Wild
type” pR (TCM without His6 tag) and mutants were purified by means of
citrate precipitation and subsequent hydroxylapatite column. The pR
content of an aliquot of the sample was determined by measuring the 520nm absorbance. Each sample was then subjected to increasing
concentrations of citrate, and with centrifugation at 4°C (6000 × g, 10
min) prior to measurement of the visible absorption spectrum. The portion
of the initial pR remaining in the supernatant, as measured by 520-nm
absorbance, is plotted as a function of the citrate concentration. Dashed
line represents wild type pR; ■ mutants R51Q, K125Q/K126Q, K172Q
and K244Q, which superimpose; ♦ triple mutant R53/K57/K59; ● double
mutant K57Q/K59Q; and▲ quadruple mutant R51Q/R53Q/K57Q/K59Q.

The initial mutation was carried out to change all four residues simultaneously,
allowing to rapidly screen for any effect on citrate precipitation. Specifically, the
quadruple mutant pR R51Q/R53Q/K57Q/K59Q (on a background pR sequence
containing no His tag, but with the 3 native cysteines all mutated to serine) was tested for
its reaction to citrate. It exhibited a remarkable difference compared to the control,
unmutated protein (pR TCM). Unlike the control (pR TCM lacking His6), which
completely precipitated from 0.4% OG solution at 50 mM citrate, pH 5.5, the quadruple
mutant did not precipitate even at citrate concentrations of 100 mM or higher (Fig. 2.3).
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This result with quadruple mutant indicates strongly that one of more of these four amino
acid residues in IC1 play a role in mediating the interaction between the pR and citrate.

In order to identify the amino acids most directly responsible for citrate
interaction with pR, single mutants R51Q, R53Q, K57Q and K59Q, the double mutant
K57Q/K59Q and the triple mutant of pR R53Q/K57Q/K59Q were made. These mutant
proteins were purified as above, and then precipitated with varying concentrations of
citrate buffer. With the triple mutant R53Q/K57Q/K59Q, even though a small fraction of
it precipitated at 50 mM citrate, the pR never completely precipitated, even at higher
(~100 mM) concentrations of citrate. The double mutant K57Q/K59Q also showed a
similar effect as the triple and quadruple mutants. Only a minute fraction of the total pR
precipitated with 50 mM citrate, 0.4% OG; and the precipitation did not increase with
increasing concentrations of citrate. This suggests that the two lysines are most likely
involved in the citrate interaction for the process of pR aggregation.

To assay the individual roles of Arg51 and Arg53 in the pR binding site for citrate,
the single-site arginine mutants, R51Q and R53Q, were tested for sensitivity to citrateinduced precipitation. The R51Q mutant did not show significant alteration with respect
to its citrate sensitivity. That is, most of this mutant protein precipitated with about the
same concentration of citrate as required for precipitating pR TCM. Thus, Arg51 is not
required for citrate interaction. On the other hand, cells expressed with the single mutant
R53Q did not exhibit a normal purplish color. This appears to be due to an inability of
this single-site pR mutant to express and/or fold properly.
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Since the double lysine mutant showed a dramatic decrease in the precipitation, it
was interesting to know whether a single lysine residue mutation would also show a
similar decrease and help pinpoint the citrate interaction to just one residue. It was hoped
that a single residue might bring about a significant change in citrate sensitivity. The
single lysine mutants, K57Q and K59Q were generated and the mutant proteins were
expressed. However, these mutants were also not as strongly colored as the wild type and
most other mutants, either in cell pellets or at any point during purification. That is, they
appeared not to be as stably folded; and the purified proteins lost their faint brown-purple
color completely when citrate was added.

The remaining lysines present on the cytoplasmic side of the pR, such as
Lys125/Lys126 near the second loop, Lys172 on the third intracellular loop and Lys244 near
the C-terminal end of pR, were also mutated to glutamine individually or in pairs, in
order to examine their role in citrate-mediated pR aggregation. Lys125/Lys126, Lys172 and
Lys244 pR mutants were expressed as colored proteins and precipitated out of the
detergent containing solution at 100 mM citrate concentration, similar to the Arg51 mutant
as well as the unmutated control (pR TCM). These results indicate that lysines 125, 126,
172, and 244 do not help mediate citrate-induced aggregation of pR.

2.4.3

Proteorhodopsin interacts with several anions
Interaction of pR with citrate appears to involve a specific region of the protein,

namely the positively charged IC1 loop. In order to investigate the degree of specificity
for citrate as the anion, several different anions were tested under similar conditions. As
an initial investigation mono-, di-, and tri-carboxylic acids anions were tested in the range
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of 10-100 mM, always buffered with 10 mM Tris-Cl at pH 7.5 and in the presence of 1%
OG. The control experiment--adding 10 mM Tris-Cl, pH 7.5 while maintaining the
detergent concentration at 1%--caused no precipitation. Table 2.1 shows the results of
interaction of all anions tested with pR. The possible physiological significance of the
values is represented as a physiologically indexed concentration required to initiate
precipitation. A value near physiological index means that the concentration of that
particular anion required to induce precipitation of pR is close to the physiological
concentration of that anion inside healthy growing bacteria.

Acetate, a mono-carboxylate with a negative charge of 1 at pH 7.5, did not cause
precipitation, even at the highest concentration measured, 200 mM (see Table 2.1). This
was the case even at pH of 5.2, closer to its pKa (data not shown.). Likewise, several
dicarboxylic acids (succinate and dodecanedioate) also failed to precipitate pR under
similar conditions, even at a concentration as high as 200 mM.

However glutarate, which has a similar spacing between its carboxylate groups as
citrate, did cause pR precipitation, at a slightly higher concentration than citrate.
Glutamate, which is just α-amino glutarate, showed a similar pattern of precipitation as
glutarate. Interestingly, aspartate, which is α-amino succinate, was more similar to
glutamate and glutarate than to succinate. However, both dicarboxylic amino acids
(glutamate and aspartate) were unable to cause complete precipitation of pR; even at the
most effective concentrations, they always left a substantial fraction of the pR in the
supernatant. These results suggest that the spacing between a pair of carboxylate groups
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is the major, but perhaps not the only, structural determinant of anion-induced
precipitation of pR

Given that several divalent anions precipitated pR, albeit not as well as citrate
itself, it was important to examine whether other simple trivalent anions, like isocitrate
and aconitate, might interact with the citrate binding site, and thereby cause pR
precipitation. In addition to citrate itself, two other tricarboxylic acids showed evidence
of binding. That is, precipitation of pR was observed for cis-aconitate and isocitrate at
50 mM (but not at 10 mM, and notably not at the higher concentration of 100 mM).

Phosphates are multiply-charged anions pervasive in biological systems. Some
evidence of a possible interaction between pR and phosphate was already seen while
trying to precipitate pR eluted from a hydroxylapatite column. Therefore, pR samples
were treated with increasing concentrations of phosphate, buffered at pH 7.5 and at
constant 1% OG concentration. It was found that pR precipitation was not observable
until phosphate reached 100 mM phosphate. In order to determine if phosphate was
interacting at the same site on pR as the citrate, partially purified quadruple
(R51Q/R53Q/K57Q/K59Q) and double (K57Q/K59Q) mutants were also tested with
increasing concentrations of phosphate at pH 7.5. It was found that, as with citrate, these
IC1 mutants failed to precipitate. This remained true at even higher (200 mM)
concentrations of phosphate, strongly suggesting that phosphates may bind to the same
site on pR as the citrate.
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Larger phosphate-containing molecules were also tested that are found
intracellularly, such as glucose-6-phosphate (G6P), ADP, and ATP. G6P has a single
phosphate group, ADP has two, and ATP has three. G6P showed precipitation of pR at 50
mM, but not at concentrations above 100 mM. ADP showed precipitation up to 40 mM
while ATP exhibited no precipitation at any of the concentrations tested (20-150 mM).
Additionally, concentrations of ADP or ATP above 50 mM led to denaturation of the pR
with white precipitation. That is, while no pR remained in the supernatant, the precipitate
showed a yellow color instead of the characteristic red-purple. It would be interesting to
investigate any further details of this intriguing behavior.

Inorganic anions such as sulfate, chloride, and chlorite were investigated for their
ability to cause pR to aggregate. Sulfate (sodium or ammonium), sodium thiosulfate and
sodium chlorite did not cause any precipitation even at 100 mM. Chloride showed
initiation of pR precipitation at 40-50 mM, depending on whether the counter-ion used
was potassium or sodium. These results suggest that chloride also may have a specific
effect on the IC1 anion-binding site, even though it is monovalent.
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Table 2.1: Precipitation of pR with diverse anions: Anions were buffered to pH 7.5,
also contained 10 mM Tris-Cl at pH 7.5, and a sodium counterion. The concentration of
OG was maintained at a constant 1% for all tests.

Anion tested

Citrate
Cis-aconitate
Isocitrate
Succinate
Dodecanedioate
Acetate
Aspartate
Glutamate
Glutarate
Sulfate
Thiosulfate
Phosphate
ATP
ADP
Glucose-6phosphate
Chloride
Chlorite
•
•

•
•

Min.
concentration,
mM (pR
precipitation)
++ (10)
+ (50)
+ (50)
+ (50)
+ (50)
+ (50)
++ (100)
-*
+ (20)*
++ (50)
++ (40)
-

Physiologicallyindexed
concentration

Physiological
concentration
(mM)14, 15, 25, 30

0.76, 5
3125
2.5
N/A
N/A
N/A
12
0.52
N/A
N/A
N/A
13.3
4.2
71.4
62.5, 41.6

1314 , 215,
0.01614, 15
2014
0.5715
N/A
N/A
4.214, 15
9614, 15
N/A
N/A
N/A
7.530
9.614, 15
0.5614, 15
0.814, 1.215

0.07
N/A

53525
N/A

++ indicates complete precipitation of pR, + indicates partial precipitation leaving significant color
in the supernatant, - indicates lack of precipitation with all the color in the supernatant.
The references for concentrations for physiologically important anions available are labeled as
superscripts. Concentration of phosphate is from Streptococcus bovis [30] and that of chloride is
from marine bacteria Pseudomonad [25]. All other anion concentrations are from E. coli [14, 15].
N/A refers to data Not Available
* indicates anomalous behavior. ATP showed white precipitate with faintly colored supernatant up
to 40 mM. It started to show degradation of pR beginning at 50 mM with yellow precipitate and a
colorless supernatant. ADP showed similar behavior starting at 60 mM
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2.4.4

Model for pR-citrate interaction
A homology model of pR was created using Geno3D molecular modeling web

server [21] based on the crystal structure of bR (PDB: 1fbb). Based on the results of the
double lysine mutants, it can be speculated that two of the negatively charged carboxylate
groups of citrate bind to the positively charged ε-amino groups of the two lysines, Lys57
and Lys59 through H-bonded salt bridges. Using the homology model of bR, a structural
model for pR-citrate interaction was built by using the UCSF Chimera package [22] (Fig.
2.4). It can be seen that Lys57 and Lys59 are likely close enough for such an interaction to
occur. The distance between the farthest carboxyl groups of citrate is about 6 Å, while the
distance between the ε-amino groups of the two lysines, Lys57 and Lys59, is
approximately 8 Å in the homology model. At physiological pH, citrate is completely
dissociated and has a charge of -3, while the lysine side chains each carry a +1 charge.
Assuming an H-bonding distance between the proton donor nitrogen of lysine and proton
acceptor oxygen of citrate to be 2.5-3Å, the two lysines can easily form salt bridges to a
single citrate molecule.
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Fig. 2.4: Model of pR-citrate interaction: a. The homology model of pR, based on the
crystal structure of native conformation of bR from Halobacterium salinarum (PDB:
1FBB), was produced using Geno3D. Molecular graphics images of pR-citrate
interactions were produced using the UCSF Chimera package from the Resource for
Biocomputing, Visualization and Informatics at the University of California, San
53
Francisco. Arg51, Arg , Lys57, and Lys59 side chains are depicted in blue. The lysine side
chain bond torsion angles were manually adjusted to permit reasonable H-bonding
interactions with two of the carboxylates of a citrate molecule, shown in pink and red. b.
Close-up image of the citrate-lysine interaction.

2.4.5

Citrate precipitates pR at physiological pH
Proteorhodopsin shows precipitation at pH 5.5 from a 3% detergent solubilized

extract or Tris-Cl buffered solution also containing the detergent. To assess if pR
precipitates at a pH higher than 5.5, especially near the physiological pH, a detergent
extract of pR containing cells was made and subjected to several rounds of citrate
precipitation. The precipitated pellet was resolubilized in 3% OG buffered at pH 9. The
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detergent extract and the resolubilized pellet were then treated with equal volume of 100
mM citrate buffered at pH 5.5, 6.0, 7.0, and 7.5. The protein completely precipitated out
of the solution at all the pH values indicating that pR precipitation likely occurs
throughout the physiological pH range.

Another aim was to find out the exact concentration of citrate that can cause pR
precipitation out of the detergent solubilized solution at the likely physiological pH (7.5).
In order to avoid possible effects of dilution of the OG detergent, the same 1% (34 mM)
concentration of OG was used in all the precipitant solutions as in the starting pR sample.
This concentration is just above the critical micellar concentration (CMC) of OG (23-25
mM). The pR in detergent solution was subjected to an increasing concentration of
citrate, buffered at pH 7.5 (with Tris), while maintaining 1% OG. It was found that pR
precipitates within minutes at a citrate concentration of 10 mM, and indeed nearly
quantitatively at all 5 concentrations measured between 10 and 200 mM. It was also
observed that upon incubation at 4°C for several h, even 5 mM citrate proved sufficient to
cause pR precipitation.

Another significant question regarding the role of pH is whether the lysine and
arginine mutations of IC1 would react similarly to citrate precipitation at pH 7.5 as they
do at pH 5.5. Partially purified samples of quadruple and double lysine mutants were
tested with an increasing citrate concentration at pH 7.5 at 1% OG concentration. It was
found that both the quadruple and the double mutants failed to precipitate, even at citrate
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concentrations as high as 100 mM. This supports the hypothesis that Arg51, Arg53, Lys57
and Lys59 are part of a citrate-binding site in pR.

2.4.6

Effect of citrate on pR physiological activity
Based on site-directed mutagenesis, the citrate binding site on pR appears to be

located on the intracellular side of the membrane. This site appears to interact with citrate
at a concentration close to that of the endogenous citrate concentration inside bacteria
[14, 15]. These findings led to the consideration of the possibility that citrate could
potentially have a physiological significance in the regulation of pR photocycle activity.

To assess this possibility, pR was purified (by using the citrate purification
method described), and reconstituted in citrate-free DOPC vesicles. The pR-containing
liposomes were then subjected to flash photolysis. An observed transient 410-nm
absorbance signaled the formation of the M intermediate. A representative plot of
transient absorbance against time is shown in Fig. 2.5A. A curve fit to the single
exponential is also shown along with the residual plot. A log plot of absorbance vs. time
(Fig. 2.5B) yielded a straight line, consistent with a first-order exponential decay. The
exact value of the 410-nm absorbance decay constant was calculated from a nonlinear
least-squares curve fit as 45 ms-1, which corresponds to a half-life of 22 ms. This is very
similar to that reported previously [26].
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Fig. 2.5: Flash photolysis: Flash-induced transient absorbance changes in pR-containing
DOPC liposomes (buffered at pH 8.5) show the decay of the M intermediate. These data
were obtained from a sample containing no citrate. In part A, the measured absorbance
data were fit to a first-order kinetic equation, A400(t)= B + A0 e-kt, by using the solver
function in Excel, optimizing the values of B, A0 and k. The fitted exponential curve is
superimposed on the measured transient absorbance at 410 nm. The residual trace
(lightly-dotted line) demonstrates the high quality of the fit. Part B shows a log plot of
absorbance against time. This plot yielded a straight line signifying a first-order
exponential decay of the M intermediate. The decay constant, k, calculated from the slope
of this curve matches that obtained from the non-linear least-squares optimization. (In B,
and for the exponential fitting procedure in A, all digitized points up to the
commencement of the M decay phase, corresponding to a total of ~8 ms of time, were
omitted in order to allow the approximation of a single-exponential process.)
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These results by themselves indicate that the use of citrate-induced aggregation as
a step during pR purification does not significantly alter the photocycle, i.e. the resultant
pR retains its native functionality. As a further control, we added increasing amounts of
citrate to the external solution surrounding the pR-containing liposomes and subjected
them to flash photolysis. No effect of citrate addition on the kinetics (Fig. 2.6) or
amplitude (not shown) of the 410-nm (M) absorbance decay was observed. This was as
expected, since pR has been found to insert right-side-out in vesicles [27, 28], and
citrate added after vesicle formation would therefore not be expected to be able to reach
the intravesicular binding site on IC1.

Fig. 2.6: Dependence of the fitted half-life for M (410-nm absorbance)
decay on external citrate concentration: The 410-nm absorbance
transient for each citrate concentration was fitted as in Fig. 2.5.

Finally, to test the effect of intra-vesicular citrate, the experiment was repeated
but with citrate buffer included during the vesicle-forming dialysis step. If intracellular
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citrate binding had a physiological role in regulating pR activity, then intravesicular
citrate might be expected to affect either the amplitude or kinetics of the M intermediate.
However, this was not observed (data not shown). That is, citrate inclusion in the
reconstituted liposomes did not significantly alter the M-intermediate amplitude or its
decay rate. Overall, the flash spectroscopy experiments with pR liposomes provide no
evidence for a physiological role for citrate.

2.4.7

Conservation of the citrate binding site
Based on the protein sequence alignment of pR to the members of the microbial

rhodopsin superfamily and the resulting distance tree of proteins (Fig. 2.7), it is evident
that the pR representatives belonging to the proteobacteria group share conserved amino
acid residues at the citrate binding site we have identified on loop IC1. That is, while
there is no evidence for conservation of these residues in the archaeal branch of this tree
(corresponding roughly to the top half of this figure), both the lysines, K57 and K59, are
highly conserved among the members of bacteria belonging to the γ-proteobacteria. In
less closely-related α-proteobacteria, the conservation is not as strong, e.g. Candidatus
pelagibacter lacks both the lysines, and possesses just one arginine instead.

At least one of the two lysines is conserved in other members of phylum
Bacteroidetes, such as Flavobacteria, Cellulophaga and Polaribacter. The other lysine is
generally substituted by arginine. This is the most conservative possible substitution,
since arginine conserves both the positive charge of lysine and its ability to donate
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protons to an H-bond. Thereby, pR in Bacteroidetes would be predicted also to interact
with citrate. This large phylum Bacteroidetes, previously known as the CFB (CytophagaFlexibacter-Bacteroides) group of bacteria, diverged from a common ancestor about 2.5
Ga [29], and from the γ-proteobacteria even more distantly in the past. The significant
degree of conservation of the cluster of two charged cationic residues in loop IC1 among
such distantly-related bacteria is worth noting.

Fig. 2.7: Conservation of citrate-binding lysine pair in pR: pR and bR
sequences from multiple organisms were aligned with BLASTp algorithm, and a
distance tree was produced using fast minimum evolution tree method. The
following color code is used to indicate the degree of conservation of the two
lysine residues in loop IC1, associated with the putative citrate binding site of the
proteins. K.K K.R ..R R.R ..K.
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2.5

DISCUSSION

2.5.1

Purification of pR TCM without His-Tag
It was shown previously that selective precipitation of pR with citrate works even

better and more reproducibly when the 3 native cysteines are mutated to serine [16, 17].
Furthermore, the resulting protein is somewhat more stable. The reasons for this are still
unclear, but TCM was used as the background “wild type” for the studies here of the
citrate-induced aggregation phenomenon.

Nearly all previous studies on purified pR were carried out on protein expressed
with six non-native histidine residues added to its C-terminus. This method of
purification of pR using citrate as a selective precipitant is equally effective with pR in its
native form, i.e., without the His6-tag. This finding is significant because it has the
potential of being applied for purification of pR from natural source organisms, which of
course lack the His-tagged version of the protein. Additionally, this method also
eliminates the use of expensive Ni2+-derivatized resin, instead using a relatively
inexpensive hydroxylapatite column.

Besides, it has been observed that the non-native

His6-tag is unstable over long periods of storage at 4°C (our unpublished data). It also
shows that pR can be purified to A280/540 ratio of less than 3 (>50% purity) with only
citrate and hydroxylapatite column. The pR purified by using citrate aggregation steps
shows normal M decay kinetics, and is therefore likely to represent the same native
structure as for pR prepared by other methods.
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2.5.2

pR–citrate interaction and aggregation
Citrate-induced aggregation of pR occurs at concentrations around the

endogenous free citrate concentrations that range between 2 mM and 13 mM, that have
been measured inside healthy bacterial cells [14, 15]. The apparent citrate concentration
required for aggregation of pR TCM from crude cell extract is ~50 mM, but the required
free citrate concentration is considerably less than this, because a significant portion is
likely consumed by other proteins present in the crude extract that bind citrate, either
specifically or randomly. Thus, with purified pR less citrate is needed to aggregate the
protein, indeed approaching the physiological levels of citrate inside the cell.
Specifically, it has been observed that nearly-quantitative precipitation of pure pR in
0.4% OG can be achieved with as low 10 mM citrate at pH 5.5 (data not shown). The
experiments at pH 7.5 and in the presence of 1% OG also showed that precipitation of pR
can be achieved rapidly at 10 mM citrate. Prolonged incubation of pR under above
mentioned conditions has also shown a precipitation at 5 mM citrate. The intracellular
concentration of citrate inside a healthy growing bacteria ranges from 2 mM to 13 mM.
An intracellular concentration of 2 mM was obtained from cells growing on filters which
made them grow slightly slower than those in liquid media [15]. This could partially
explain why Bennett B.D. et al., [15] obtained a lower concentration of citrate compared
to the previous value of 13 mM by another group [14]. It should also be noted that native
pR is found in γ-proteobacteria, and in other bacteria from oceanic or fresh water
environment. The difference in the environment as well as the genotype might also
probably affect the metabolism and metabolite concentrations in cells yielding different
numbers than those estimated in the E. coli cells under standard lab conditions.
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In this study, two lysine residues of pR have been specifically identified that help
mediate its interaction with citrate. The two lysine residues appear to function together to
form a binding site for citrate. However, the binding that was observed was a highly
cooperative process, rather than simple equilibrium involving a 1:1 stoichiometry.
Therefore it was not easy to define the binding reaction so as to permit fitting to a simple
binding isotherm.

The quadruple mutant of R51Q/R53Q/K57Q/K59Q shows the clearest reduction
in citrate-induced aggregation, followed by the triple mutant R53Q/K57Q/K59Q. The
R51Q single mutation does not show any effect on citrate-induced precipitation. But
when only the two lysines, Lys57 and Lys59, are mutated, then the protein behaves like the
quadruple mutant, i.e., citrate does not cause aggregation. This strongly suggests that the
two lysines are critical for the citrate mediated aggregation, and thus form the essential
locus of initial citrate binding to pR.

Interestingly, single mutations at either of the 2 lysines in IC1 (K57Q or K59Q)
or at one of the arginines (R53Q) did not express cells with their normal strong pink
color, but at most a much more subdued brownish-orange. Furthermore, it was much
more difficult, or impossible, to purify pR from any of these 3 single-site mutants than
for the triple- or quadruple-mutants, and the resulting purified pR proteins lost all pinkish
color to give an absorption conforming to free retinal, with λmax=380 nm, upon addition
of as little as ~30 mM citrate. This suggests that pR is unable to fold stably when certain
of these mutations are present individually. It is not clear why these mutations, especially
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that of Arg53, should cause such protein instability only when present invidually, and not
in combination. However, as a result of such protein instability, the degree of
involvement of R53 in citrate-mediated pR-aggregation cannot be clearly defined.

Phylogenetics comparisons show that these 4 cationic residues in IC1 are quite
strongly conserved, even among pR sequences from organisms that likely diverged nearly
2.5 billion years ago. Such a degree of conservation is usually a sign of physiological
function. It seems unlikely that these residues are a requirement merely for structural
stability, since they are not conserved in the somewhat more-distantly-related retinalbinding proteins found in archaea (bacteriorhodopsin, halorhodopsin, and sensory
rhodopsin), nor in their fungal homologs. Our site-directed mutagenesis experiments and
the phylogenetic comparisons together hint at a possible physiological role for citrate
binding at IC1 in pR.

2.5.3

pR interaction with diverse anions
Citrate induces pR aggregation at a pH ranging from 5.5 to 7.5, in the presence of

1% OG. Since citrate causes pR aggregation at a physiological pH 7.5, other organic and
inorganic anions were tested at the same pH, and in the presence of detergent up to a
concentration of 1% OG. Monocarboxylates such as acetate, and several dicarboxylates
such as dodacanedioate and succinate, could not induce pR precipitation. Other
dicarboxylates such as glutarate, aspartate, and glutamate, and tricarboxylates (iso-citrate,
cis-aconitate) appear to induce considerable precipitation of pR at particular
concentrations. The concentration of glutamate and isocitrate required to induce

80

precipitation is higher than that of citrate. In each case, however, it is close to their
physiological concentrations.

If we look closely at the structures of di- or tri-carboxylates, there appears to be a
pattern in the structures of those that are capable of inducing pR precipitation. Acetate
has a single carboxylate group that is insufficient to cause precipitation and aggregation.
Dodecanedioate is a dicarboxylate but the separation of the two carboxylic acid groups
by a distance of 10-carbon atoms renders it incapable of causing precipitation.

acetate

dodecanedioate

Tricarboxylates (isocitrate and cis-aconitate) possess a similar structure as citrate
with respect to the position of the carboxylate groups. Glutamate is a dicarboxylate;
however, the separation between its two carboxylate groups resembles that of citrate.
Glutarate is similar to glutamate without the amino group. This shows that the presence
of amino group has relatively little effect on the precipitation. It appears that the distance
between the carboxylate groups has to be within a certain distance for the anion to
interact with the citrate-binding site.

There is a quantitative difference in the amount of precipitation effected just by
the tricarboxylates, citrate and isocitrate, although their carboxylate groups have nearlyidentical spacing. Citrate can achieve a complete precipitation of pR at a mere 10 mM,
but isocitrate begins to precipitate pR only at 50 mM. The only structural difference
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between these two tricarboxylates is in the placement of the OH group. This suggests that
pR-citrate interaction is very specific. The spacing between the carboxylates might be
only a part of the steric requisite to produce precipitation of pR.

citrate

glutarate

glutamate

iso-citrate

cis-aconitate

The results that most contradicted a simple model of carboxylate-distance as
determinant of binding were those from aspartate, a dicarboxylate that resembles succinic
acid except for the additional presence of an amino group. Succinate lacks the ability to
induce pR precipitation, whereas aspartate precipitated pR, albeit only partially.

aspartate

succinate

Nevertheless glutamate does interact considerably strongly with pR than
aspartate, although not as strongly as citrate. The concentration required to induce pR
precipitation by glutamate is only half of its physiological concentration. In E. coli
cultures fed on glucose, acetate or glycerol, glutamate was found to be the most abundant
intracellular metabolite, constituting over 40% of the total metabolome [15]. In
comparisons of glucose-fed cultures, glutamate was followed by glutathione, fructose1,6-bisphosphate (FBP) and ATP. The abundance of glutamate is justified on two
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grounds. First, it is the major nitrogen donor in the cell, involved in ~88% distribution of
nitrogen that is donated via transamination reactions [31]. Second, it acts as the major
intracellular counterion to potassium [32]. It can be speculated that a high concentration
of glutamate could potentially aid in the regulation of pR activity intracellularly. In the
nutrient-limited conditions, glutamate could potentially support the bacteria up to a
certain period of time while also keeping the pR inactive. Only under conditions where
glutamate concentration falls below the levels that signals starving conditions, then the
pR pumping activity takes control of the energy provision.

Other anions such as phosphate and chloride completely precipitated pR, at higher
concentrations compared to citrate, albeit within their physiological ranges. It appears
that pR-anion interaction is quite specific, in the sense that only a few anions can cause
the pR to aggregate and precipitate.

The aggregation phenomenon observed is unlikely to be merely a salting-out of
the protein. Salts typically used for salting-out (e.g. 10-100 mM ammonium sulfate) do
not cause aggregation of pR, whereas a mere 10 mM concentration of citrate suffices,
measured under a specific set of similar conditions, namely at pH 7.5 and in 1% OG. It
should be noted, however, that at lower pH and either higher or lower detergent
concentrations, there is less distinction in the behavior of pR with sodium citrate and
other salts. Salting-out certainly appears likely to be occurring under such conditions. It is
also possible that the precipitation of pR by higher concentrations of other salts, e.g. 40-
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50 mM chloride or 100 mM phosphate at pH 7.5 and 1% OG, could be a salting-out
phenomenon.

Furthermore, NaCl caused pR aggregation at a lesser concentration than KCl,
indicating some possibility of cation-specific effect/interaction. However, this trend too is
opposite of what is expected from the Hofmeister series, if these salts are merely causing
salting-out. This might suggest a cation-dependent protein interaction. Likewise,
potassium phosphate precipitated pR at a lesser concentration than sodium phosphate.
However, there is not a monotonic dependence of the pR precipitation phenomenon on
KCl concentration: KCl precipitates pR at 50 mM but not at 100 mM. However, neither
potassium nor sodium acetate causes any precipitation, so the cation appears to have
much smaller effect than the anion.

Hofmeister [33, 34] showed that different ions show a consistent trend in
effecting precipitation of wide variety of proteins. For the same cation with different
anions, the order is SO42- > HPO42- > acetate > citrate > tartarate > bicarbonate >
chromate > Cl- > NO3- > ClO4-. For the same anion, the order for cations is Li+ > Na+ >
K+ > NH4+ > Mg2+. Additional salts have been studied by subsequent workers. It has also
been shown that the order of both, the anions and cations, is reversed depending upon the
pH. Proteins show a “direct order” i.e. the order as shown by Hofmeister, at a pH above
their isoelectric point (pI) whereas the order is reversed at a pH below the pI [35, 36].
This reversal is theoretically explained by a combination of Coulombic screening effect
and ion-surface interactions [37]. The order of cations may reverse with different cations,
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due to ion pairing [38, 39]. The order of anions may also reverse depending on the
hydrophobicity and hydrophilicity of the surface of the peptide. Ions that are repelled and
depleted from the hydrophobic surface (such as F-) raise the interfacial tension strongly
and enhance the precipitation of a protein. Such a repulsion is directly proportional to the
ionic-surface charge density [40, 41]. For a surface that possesses both hydrophobic and
hydrophilic patches or groups, a smaller anion, Cl- binds strongly to the cationic surface
compared to a larger anion, I- [42].

Proteorhodopsin precipitation with diverse anions has been carried out at a pH
higher than the pI of pR, estimated to be 4.6 (Braiman M. S., unpublished data) indicating
that the anions should have exhibited a direct order of Hofmeister series. The reversal of
trend suggests something more than Hofmeister effect as a cause of citrate-induced
precipitation.

Of the anions beside chloride and polycarboxylates, the one that appears to
interact most strongly with pR is phosphate, which causes precipitation at concentrations
somewhat higher than citrate, i.e. a few times greater than the physiological range. The
physiological concentration of phosphate varies between a wider range depending on the
metabolic status of the cell. Although the precipitation of pR by phosphate occurs at a
concentration higher than that of citrate, it is still within the physiological range of the
phosphate. Intracellular concentration of phosphate is affected by the metabolic state of
the cell; when the glucose consumption is high, the inorganic phosphate concentration
decreases from 45.5 mM to 7.5 mM [30]. At higher concentration of phosphate, i.e., 45.5
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mM, the cells are probably at metabolic rest or at a level of lower metabolic activity. That
is possibly the concentration at which phosphate shows its inhibitory effect on pR by
precipitating it. It should be noted that these values of inorganic phosphate concentrations
are derived from Streptococcus bovis as those of E. coli are not available. It is quite likely
that they might be different from E. coli and, from oceanic bacteria which harbor pR.

The two mutants that most clearly interfere with citrate binding (K57Q/K59Q and
R51Q/R53Q/ K57Q/K59Q) also interfered with phosphate-induced precipitation. This
indicates that phosphate and citrate likely interact with pR through the same site.
Interestingly, phosphate at a higher concentration (>400 mM) not only fails to precipitate
wild type pR, but can also suppress its interaction with citrate, even when the detergent
concentration is lower (~0.4%), a condition that usually promotes the citrate-induced
aggregation. This was observed previously when pR eluted from a hydroxylapatite
column with phosphate gradient failed to undergo citrate-induced precipitation, and
required dialysis to remove the phosphate prior to use of the citrate. Competition of
phosphate and citrate for the same site could help to explain why citrate loses the ability
to precipitate pR when the phosphate concentration is high.

Phosphate esters and anhydrides that are found intracellularly gave surprising
results. G6P showed no precipitating effect at higher concentrations, whereas ADP and
ATP led to pR denaturation.
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Anion binding has been studied in bacteriorhodopsin (bR) [43], halorhodopsin
(hR) [44] and mammalian rhodopsin [45]. A recent study on anion binding and its effect
on the pKa of proteorhodopsin [46] included sulfate, phosphate and chloride as well as
other anions. Based on the effect on pKa of pR, it was proposed that chloride and sulfate
have a binding site on pR. However, these workers [46] did not report any precipitation
effect on pR by any of these salts, even at a 300 mM anion concentration. This likely
arises from the use of dodecyl maltoside for their measurements on pR, at 5-6 times its
critical micelle concentration (CMC). Citrate-induced precipitation of pR solubilized in
such concentrations of dodecyl maltoside, or even with OG concentrations at 5 times its
CMC fails to cause pR precipitation. Our lab’s initial experiments with pR and citrate
were standardized with OG near its CMC, and therefore the studies were carried out with
these conditions.

However, there is clearly a dependence of the aggregation phenomenon on the
detergent as well as the anion. At even lower concentrations of OG, e.g. 0.5%, pR
precipitation from OG solutions has been observed by using tricarboxylates (iso-citrate,
cis-aconitate) as well as numerous other salts such as sodium sulfate, sodium chlorite,
potassium chloride, sodium thiosulfate, G6P, ATP and ADP. When OG concentration
was maintained at 0.5%, most of the salts and carboxylates showed at least a scanty
precipitation of pR, even at quite low anion concentration. This interplay between salt
and detergent concentration is somewhat surprising. Increasing salt concentration
normally has the effect of increasing micellar size and reducing CMC of non-ionic
detergents such as OG. Thus addition of salt to pR in 0.5-1% OG might be expected to
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lead to formation of more stable mixed micelles containing pR and detergent, rather than
leading to aggregation.

Citrate has already been employed in the process of purification of pR and the
possibility of using some of these other salts as alternative purifying agents is being
explored. The salts that are most attractive are NaCl and phosphate. They are inexpensive
and easily available in abundance and based on our preliminary experiments, do not show
any effect on the characteristic absorption of pR at 520 nm.

2.5.4

Citrate has no discernible effect on pR reconstituted in a membrane
Normal kinetics following pulsed-laser photolysis of the reconstituted pR vesicles

prepared in the presence of citrate, suggest that citrate fails to exert an aggregation effect
on proteorhodopsin in DOPC liposome environment, just as it apparently does not have
an effect when non-ionic detergents are used well above their CMC. It may be that the
geometry adopted by the lipid and/or detergent molecules interferes with the contact of
the some of the pR surfaces involved in aggregation.

The absence of a measurable effect of citrate on the pR photocycle in
reconstituted phospholipid vesicles makes it very unlikely that citrate binding is involved
in any simple binary regulation scheme. However, these experiments in purified
reconstituted systems from heterologously-expressed pR may have excluded some
necessary component, e.g. another bacterial protein found in the oceanic γproteobacterium, that is involved in a ternary interaction involving also pR and citrate.
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Thus, the possibility cannot be excluded, that the binding and self-aggregation of pR in
detergent micelles in the presence of citrate (and phosphate) is a non-physiological effect
that is nevertheless reflective of anion binding involved in a more complicated
physiological regulatory process.

2.6

CONCLUSIONS
Citrate in a physiological concentration range can cause aggregation and

precipitation of proteorhodopsin from detergent solution, without denaturation or loss of
function. In this study, the structural basis for the interaction between pR and citrate was
investigated. Site-directed mutants of a number of positively charged amino acids in pR
shows that those found in the first intracellular loop (IC1), R51/R53/K57/K59, are clearly
involved in binding to citrate, with the strongest effect from the lysines. Phylogenetic
comparisons indicate that these four amino acid residues are strongly conserved among
pR sequences belonging to organisms that diverged more than 2.5 billion years ago. In
the physiological pH range of oceanic bacteria, the concentration of citrate required for
selective pR precipitation from OG detergent solution, 10 mM, is also in the intracellular
physiological range. However, flash spectroscopy experiments with pR liposomes
showed no effect of citrate on photocycle yield or kinetic, and thus fail to support the
hypothesis of a physiological role for citrate in pR regulation.

Besides citrate, pR also interacts with other anions such as phosphate, glutamate
and chloride, all of which can also lead to selective precipitation under certain conditions.
However, at high concentrations phosphate not only fails to cause precipitation, but also
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blocks citrate-induced precipitation, suggesting that both may bind at the same site in
IC1. Thus, in addition to citrate, manipulation of phosphate and chloride concentrations
is potentially useful in the purification of pR by selective precipitation.
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Chapter 3

COLUMN-FREE PREPARATION OF PROTEORHODOPSIN, AN INTEGRAL
MEMBRANE PROTEIN, BY SELECTIVE PRECIPITATION WITH SIMPLE
SALTS

3.1

INTRODUCTION

3.1.1

Membrane proteins—heterologous expression and purification
Membrane proteins are involved in essential roles in cellular functions, such as

cell signaling, cell adhesion, transport of molecules, and maintenance of cell or organelle
structure. About 30% of the mammalian genome open reading frames (ORFs) have been
found to encode integral membrane proteins [1].

Despite their key functions, only 290 membrane proteins have had their threedimensional (3D) structure elucidated to date [2] compared to the available 3D structures
of >42000 soluble proteins. One major difficulty lies in the inability to achieve successful
expression and purification of membrane proteins. These goals are generally more
challenging than for soluble proteins.

Selective precipitation of proteins with various salts has been traditionally used as
one of the earliest steps in the process of purification of soluble proteins. The process of
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salting out was originally proposed and studied by Hofmeister [3, 4]. Ions are thought to
cause their effect indirectly by influencing the structure of water [5]. Therefore, the ions
are divided as cosmotropes that promote hydrogen-bonded water structure leading to
salting-out of proteins, and chaotropes that break the water structure consequently
causing salting-in of proteins. Solubility of proteins also depends on the salt
concentration in the solution. At lower concentrations, the salts stabilize the charged
groups of the proteins thus assisting in protein solubility or salting-in. However, at higher
concentrations, they bind to the water molecules apparently causing a decrease in the
water activity that leads to protein precipitation or salting-out of proteins.

Hofmeister established a series of anions and cations according to their efficacy in
inducing protein precipitation from aqueous solutions [3, 4]. Despite continued
differences in opinion about the mechanism of salting out, it is nevertheless a valuable
method for protein biochemists. Ammonium sulfate is a prime example of a salt used for
salting out, mostly for soluble proteins. Other commonly used salts include sodium
chloride, sulfate and phosphate [6].

The effect of Hofmeister ions on membrane proteins has only recently gained
some attention. Studies performed on membrane proteins such as rhodopsin [7] and
bacteriorhodopsin [8] showed that membrane proteins tend to show deviations from the
Hofmeister series. It was suggested that these deviations could be due to the presence of a
membrane environment that prevents the ions from exerting their influence on local water
structure as strongly as in bulk aqueous phase. Salt-induced precipitation of proteins
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requires that they be capable of existing in a soluble form. For membrane proteins, a
suitable detergent is required to keep the membrane proteins stable as well as soluble, in
particular to prevent them from aggregating prior to addition of a salt.

There are general guidelines that can be followed when choosing a detergent to
solubilize membrane proteins during their purification. However, these cannot be used
strictly [9]. The general guidelines use a classification of detergents as mild or harsh.
Mild detergents have a good chance of maintaining a physiologically active protein
structure. Harsh detergents exhibit a high probability of denaturing membrane proteins.
Two structural factors that are most important in determining mildness or harshness of a
detergent are the head group and the hydrophobic tail. Harshness increases as the polar
head group is altered from large to small and from polar to zwitterionic to charged. It also
increases as the hydrophobic tail decreases in length. However, there are additional
factors to consider before selecting a particular detergent. There is also often a specific
“chemical effect” between the detergent and the protein; for example, thermostabilized
β1- adrenergic receptor is very stable in a relatively harsh detergent decylmaltoside (DM)
[10] but is extremely unstable in a mild polyoxyethylene detergent like C12E8. In
contrast, another protein, the sarcoplasmic reticulum Ca2+-ATPase was found to be
especially stable in C12E8 and indeed has been successfully crystallized in C12E8 [11].

At the same time as it maintains a significant degree of solubility by mimicking a
membrane environment, the detergent ideally should not interfere with the protein
crystallization process. However, a detergent that works for crystallizing one membrane
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protein does not necessarily perform equally well with another protein. For example, the
detergent, nonyl-β-glucoside, that was used for rhodopsin crystallization [12, 13] is not
suitable for the crystal formation of another membrane protein, β2 adrenoceptor (β2AR).
Similarly, the detergent, dodecyl maltoside, used successfully for crystallizing β2AR was
not found to be suitable for rhodopsin crystallization.

3.1.2

Use of citrate in proteorhodopsin purification
It was discovered serendipitously several years ago in the Braiman lab that citrate

can selectively induce the precipitation of the transmembrane protein, proteorhodopsin
(pR) under certain conditions [14, 15]. Beginning with pure solutions of pR solubilized in
octylglucoside (OG) detergent, the precipitation occurred maximally, with minimal
protein denaturation, at a detergent concentration of 0.3% OG, a pH of 5.5, and a citrate
concentration exceeding 50 mM.

In chapter 2 of this thesis, the mechanism of citrate-induced pR precipitation was
discussed. It was shown that citrate can induce pR precipitation at a broad range of pH as
well as OG concentrations; and also that pR does not depend on the non-native His-tag
for its precipitation by citrate. In the course of working with His-tag-free pR, a
purification method was developed which included the use of citrate followed by a
hydroxylapatite column chromatography. This method was originally developed due to a
need to purify pR mutants that had to be prepared without the His-tag. However,
producing pR without a His6 tag is advantageous for other reasons: Firstly, the His-tag
tends to be unstable over periods of days as evidenced by lower molecular weight bands
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gradually appearing on SDS-PAGE gels (data not shown) with apparent self-cleavage
occurring; whereas non-His-tagged pR is stable over many months of storage. Secondly,
this method should be applicable for the eventual purification of homologously-expressed
pR, which is produced at a low concentration in γ-proteobacteria.

3.1.3

Overview of the development of using phosphate in conjunction with citrate
for pR preparation
For the original method of purification of His-tag-free pR, a phosphate gradient

was used in order to elute pR from a hydroxylapatite column [15] (see also preceding
chapter). The pR was eluted at 540 mM phosphate when using an OG concentration of
0.4%. While attempting to ascertain that the eluted pR was still susceptible to citrate
induced precipitation, it was found that no amount of added citrate could precipitate pR
out of the 540 mM phosphate solution. This led to a hypothesis that the phosphate has a
binding site on pR, and that this binding site overlaps with the citrate binding site,
resulting in competitive inhibition. As a result, phosphate can keep pR solubilized, and
the presence of phosphate inhibits or prevents pR from being precipitated by citrate. This
hypothesis was tested, and confirmed as described herein.

The ultimate aim has been to take advantage of this set of properties, by
employing phosphate in combination with citrate in the process of pR purification. In
addressing this aim, it is first important to know whether phosphate, by itself, can induce
pR precipitation. This was answered, in the affirmative, in the preceding chapter. At 1%
OG concentration, phosphate precipitates pR over a concentration range of 100-250 mM.

95

Several questions remain: (1) Does phosphate-induced precipitation depend on the
detergent (OG) concentration? (2) Does phosphate-induced precipitation lead to further
purification of pR i.e. beyond what can be achieved with citrate alone? After answering
these questions, I proceeded to find a combination of citrate and phosphate that would
yield a substantially pure pR, without requiring columns. A short protocol was
established for preparation of E. coli-expressed pR using only selective precipitation with
inexpensive salts of phosphate and citrate.

Preparations of pR using citrate and phosphate are likely to be directly usable for
many commercial purposes, such as for holography and cosmetic applications.
Combination of citrate and phosphates and perhaps other salts, may conceivably result in
pR crystallization. However, use of these salts will need to be fine-tuned before a purer
form of pR can be obtained that would be appropriate for structural studies.

3.2

MATERIALS AND METHODS

3.2.1

Protein Expression and Purification using citrate and hydroxylapatite
column chromatography
Protocols as described in chapter 2 were followed for protein expression and

purification of pR. Plasmid pBAD TOPO TA containing pR triple cysteine mutant
(TCM) without the C-terminal His-tag was used for all the experiments. Mutants were
prepared using this background sequence. Mutants were made using site directed
mutagenesis as described in chapter 2.
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3.2.2

Partial purification of pR
Initial partial purification of pR TCM was carried out using citrate buffer only.

The detergent extract of pR-expressing E. coli was made using lysis buffer described in
chapter 1. A 1/10 volume of 100 mM citrate buffer, pH 5.5 was added to the extract.
After incubation on ice for 30 min, the citrate-treated extract was centrifuged at 5000
rpm, 4˚C. The whitish impurities were discarded and another 1/10 volume of citrate
buffer was added to the pink supernatant. More white impurities sedimented upon
centrifugation and were discarded. To the pink supernatant, an equal volume of citrate
was added and it was incubated overnight at 4˚C. The pink precipitate was then
resolubilized in 50 mM Tris buffer pH 9 also containing 3% OG. The solution was
centrifuged at 5000 rpm, 4˚C. Any impurities were discarded. A 1/10 volume of citrate
buffer was again added to the reddish-pink supernatant. Impurities were discarded with
each addition of citrate buffer. A bright pink pellet was finally obtained which was again
resolubilized in Tris buffer pH 9 containing 3% OG. Addition of a 1/10 volume of citrate
buffer was repeated one last time. This last addition yielded an intense purple pellet. If
needed, this pellet was subjected to another round of Tris buffer resolubilization and
consequent precipitation with citrate buffer. Two or three rounds of such purification by
citrate-precipitation produced a pellet, which when resolubilized in 3% OG gave an
A280/520 ratio of 4-6.
Partial purification of pR TCM with mutations at IC1 cationic residues was done
as described in chapter 2.
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3.2.3

Preparation of pR using phosphate-citrate buffers in competition
Proteorhodopsin was partially purified as described in the preceding subsection,

to A280/520 ratio of 6. This pellet was resolubilized in 100 µL of 50 mM Tris-Cl buffer, pH
9 containing 3% OG. To this solution, 70 µL of a buffer containing 600 mM potassium
phosphate and 30mM citrate, pH 7.0, also containing 0.4% OG, was added and it was
incubated on ice for 1 h. Another addition of 70 µL of the above solution yielded a white
pellet that was discarded. To the pink colored supernatant, 240 µL of 100 mM citrate, pH
7.0 also containing 0.4% OG was added that yielded a purple pellet.

3.2.4

Polyacrylamide Gel Electrophoresis
A 13% and an 18% SDS-polyacrylamide gel were used to analyze the purification

of the protein. The purity level was estimated using the Kodak gel documentation system
or BioRad Molecular Imager® ChemiDocTM XRS+ Imaging System.

3.2.5 Absorption Spectroscopy
UV-vis spectra measurements were recorded on Shimadzu UV-265
spectrophotometer and the data were analyzed using MIDAC GRAMS (Galactic
Industries) software.
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3.3

RESULTS

3.3.1

Phosphate precipitates pR between 50-400 mM phosphate concentration and
0.3-0.5% OG concentration
An initial aim was to confirm the conditions, described briefly in Chapter 2, for

using phosphate by itself to cause the precipitation of pR. It was also of interest to see
whether this phenomenon could be used to aid in the purification of pR, or if phosphate is
acting simply as a non-specific protein precipitant. Another aim was the determination of
the lowest detergent concentration that allows pR to be precipitated by phosphate without
undergoing denaturation.

From prior work in which pR was eluted from hydroxylapatite columns at 540
mM phosphate 0.4% OG, and pH 7.0, it was apparent that pR is not susceptible to
precipitation at this concentration of phosphate—at least at this pH and in this range of
OG concentration. Nevertheless, it was found that pR in 0.3-0.5% OG was precipitated
by a lower phosphate concentrations, specifically in a range of 50-400 mM phosphate
buffered at pH 7.0 (See table 3.1). Once again, no precipitation was seen at 500 mM or
600 mM phosphate. On the other hand, increasing the OG concentration to 0.6% or above
led to a much scantier precipitation when using 50-400 mM phosphate. Table 3.1 shows
the effect of increasing concentration of OG on the precipitation of pR by phosphate
buffer.

To summarize, phosphate by itself has the capacity to induce precipitation of pR
throughout the tested concentration range of 50 - 400 mM, when using 0.3% to 0.5% OG.
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However, higher concentrations of phosphate clearly inhibit precipitation of pR. As
noted previously in section 3.1.2, this inhibition persists even when a different precipitant
such as citrate is added at a concentration normally sufficient to cause precipitation. This
suggests some kind of competitive inhibition is occurring, at least in this detergent
concentration range.

Table 3.1: Determination of an optimum OG concentration under increasing
concentration of phosphate at pH 7.0
Phosphate
concentration
OG
concentration
0.3%
0.4%
0.5%
0.6%
0.7%
0.8%
0.9%

50 mM

100 mM

200 mM

300 mM

400 mM

500 mM

++
++
++
+/-

++
++
++
+/-

++
++
++
+/-

++
++
++
+/-

++
++
++
+/-

-

++ signifies essentially complete precipitation; +/- indicates scanty precipitation with much pR
remaining in the supernatant; - refers to absence of precipitation

3.3.2

Determining the minimum phosphate concentration that induces pR
precipitation
In order to pinpoint the minimum concentration of phosphate that induces

precipitation of pR at pH 7 and at 0.4% OG, phosphate concentrations between 10 mM
and 50 mM were tested for their ability to induce precipitation of pR, while holding the
OG concentration constant at 0.4% (in both the pR sample and in the added phosphate
buffer). It was found that 40 mM potassium phosphate is sufficient to cause complete pR
precipitation at this detergent concentration and at pH 7 (Table 3.2).
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Table 3.2: Determination of minimum concentration of phosphate that
induces precipitation of pR at 0.4% OG
Phosphate
10 mM 15 mM 20 mM 25 mM 30 mM 35 mM 40 mM 50 mM
concentration
Precipitation
detected

-

-

-

-

-

-

++

++

++ indicates complete precipitation with a colorless supernatant; + indicates partial precipitation,
leaving significant pink color in the supernatant, - indicates no precipitation.

3.3.3

Phosphate precipitation by itself does not eliminate impurities left behind by
citrate-induced precipitation
The simplest possibility of using citrate and phosphate in a complementary

fashion to purify pR would be to alternate these two precipitants. In order for the strategy
to work however, it would be necessary for phosphate alone to selectively increase the
purity of pR, beyond what had been achieved with citrate alone.

That is, it was necessary to determine whether precipitation with phosphate alone
leads to further purification of pR, or simply co-precipitates pR along with the same
contaminant proteins left after selective precipitation with citrate. This was measured by
analyzing the purity level after successive precipitations with citrate alone, then
phosphate alone, at 0.4% OG concentration. After each precipitation, pR was resolubilized in Tris-Cl, pH 9, also containing 3% OG; and its UV-vis spectrum was
obtained after a 10-fold dilution with water.
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The A280/520 ratio provides an estimate of purity (Fig. 3.1). There was not a
significant difference in the A280/520 ratio between the two samples, suggesting that
additional precipitation with phosphate, by itself at 0.4% OG concentration, does not lead
to any further purification of pR beyond what can be achieved with citrate precipitation
alone.

Fig. 3.1: UV-vis spectra of pR before and after phosphate
precipitation: Spectrum (A) represents citrate-precipitated pR solubilized
in 3% OG buffered with 50 mM Tris-Cl, pH 9. Spectrum (B) represents
the this same pR sample, subsequently re-precipitated with 50 mM
potassium phosphate buffer pH 7, also containing 0.4% OG, then
resolubilized in 3% OG buffered with 50 mM Tris-Cl, pH 9.
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3.3.4

Combination of phosphate inhibition with citrate-induced precipitation
promotes the selectivity of pR precipitation (Done in collaboration with
Jonathan Kim)
As discussed above, it was observed that pR precipitation is inhibited by

phosphate at concentrations higher than 500 mM or at OG concentrations 0.6% or higher.
Therefore, while the precipitation by phosphate alone does not lead to any further
purification, it was hypothesized that the inhibition might be utilized for purification
purposes.

That is, the next question to be addressed was whether the inhibitory effect of
phosphate on citrate-induced precipitation was selective for pR, and in particular whether
it was more selective than the citrate-induced precipitation itself. If so, it could be
exploited in a purification step by combining phosphate and citrate treatment. In order to
test this possibility, the phosphate concentration was maintained at 200 mM, high enough
in order to inhibit the citrate-induced precipitation. Meanwhile, the concentration of OG
was maintained more than 0.7% to prevent phosphate-induced pR precipitation. Higher
concentrations of phosphate, such as 500 mM, were not used because addition of even a
very high citrate concentration fails to precipitate pR under these conditions.

Partially purified pR samples, with an initial A280/520 ratio of 5, were treated with
three citrate concentrations - 15 mM, 30 mM, and 65 mM - while maintaining a constant
concentration of 0.4% OG and 200 mM phosphate buffered at pH 7.0. All the three
samples produced pR precipitates. These were then resolubilized in 50 mM Tris buffer,
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pH 9.0 containing 3% OG, and UV-visible spectra were obtained. Citrate concentrations
of 15 mM and 65 mM yielded A280/520 ratio of 4 whereas 30 mM citrate sample produced a
ratio of 3 (Fig. 3.2). These results show that phosphate at 200 mM aids most in the
purification process of pR in combination with an optimum concentration of citrate. A
concentration of 30 mM citrate is required to achieve the greatest degree of purification:
lower or higher citrate concentrations than 30 mM of citrate, as tested above, do not yield
as good results.

Fig. 3.2: Combination of phosphate inhibition with citrate-induced pR
precipitation promotes pR purification: Citrate-purified pR was resolubilized
in 50 mM Tris also containing 3% OG, pH 9. Equal volume of phosphate (400
mM, pH 6 also containing 0.4% OG), was added and it was divided into three
parts. Citrate, buffered at pH 5.5, and also containing 0.4% OG was added to a
final concentration of 15, 30 or 65 mM; then the three samples were centrifuged.
The three pellets were separately resolubilized in 50 mM Tris buffer, pH 9,
containing 3% OG, and UV-vis spectra were obtained as described in the text.
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3.3.5

Phosphate likely binds to pR at the same site as citrate
Citrate binds to pR at the positively charged residues found at the first

intracellular loop (see Chapter 2). Since phosphate appears to compete with the citrate,
the citrate-binding sites were examined for phosphate-pR interaction. Partially purified
double (K57Q/K59Q) and quadruple (R51Q/R53Q/K57Q/K59Q) mutants as well as a
control wild type (pR TCM) were treated with increasing concentrations of phosphate
ranging from 40 mM and 200 mM, buffered at pH 7 while maintaining 0.4%
concentration of OG. Proteorhodopsin TCM was confirmed to precipitate at phosphate
concentration of 40 mM, as shown in Tables 3.2 and 3.3. However, the mutants failed to
precipitate with phosphate (Table 3.3). This observation strongly suggests that phosphate
binds to the same site on pR as the citrate, since the same mutations eliminate binding
effects. Other mutants will need to be examined to determine all the sites that are
involved in phosphate binding.

Table 3.3: Determination of phosphate-pR interaction site using two citrate-binding
site mutants
Phosphate concentration

40 mM

75 mM

100 mM

200 mM

Wild Type, pR TCM
Double
mutant(K57Q/K59Q)
Quadruple mutant
(R51Q/R53Q/K57Q/K59Q)

++
-

++
-

++
-

++
-

-

-

-

-

++ means complete precipitation; - refers to absence of precipitation
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3.3.6

Optimization of purification conditions, using phosphate in combination with
citrate
To explore the possibility of using phosphate in combination with citrate for the

purpose of pR purification, initially a high phosphate concentration was maintained to
keep the other contaminant proteins in solution while incrementally increasing the
concentration of citrate to selectively precipitate the pR. The concentration of OG was
also maintained above 0.7% to avoid any phosphate-dependent pR precipitation.

For an optimized purification protocol, solutions were simplified so as to contain
fewer ingredients. This also resulted in higher yields of pR in a shorter time, as it was
possible to simultaneously increase citrate and decrease phosphate, with the addition of a
single concentrated citrate solution acting as precipitant.

Proteorhodopsin was initially purified to an A280/520 ratio of 5-6 using two cycles
of citrate precipitation followed by resolubilization in 10 mM Tris pH 9 containing 3%
OG. Then to the Tris-OG-resolubilized pR, an equal volume of 500 mM phosphate also
containing 0.4% OG was added, and the mixture was incubated at 4˚C for 30-45 min.
Centrifugation yielded a white pellet and a pink supernatant.

To the supernatant initially containing 250 mM phosphate and 0 mM citrate, a
100 mM citrate buffer, pH 5.5 was incrementally added. An initial addition of 1/10
volume produced a white pellet, corresponding to contaminants, and pink supernatant
corresponding to pR. Repeated addition of similar volumes of citrate buffer caused
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additional white impurities to precipitate. Fig. 3.3 shows the incremental purification of
pR with citrate, in the presence of phosphate. The top panel summarizes the experiment:
as the concentration of citrate increases, the concentrations of phosphate and OG
decrease. When the concentration of citrate reached 34 mM and that of phosphate
decreased to 165 mM, a light pink pellet was obtained. Upon further additions of the
citrate buffer, each followed by centrifugation, it was noticed that the pellet improved
both in size (yield) and intensity of color (purity). It was also observed that a point was
reached where no amount of citrate could precipitate any additional pR from the faintly
pink supernatant.

It can be seen that precipitation of whitish impurities begins with the first addition
of about 9 mM citrate and 228 mM (Fig. 3.3 lane 2). However, most of the pR remains
solubilized. The purity level of pR is 5.3% at this stage, as judged by SDS-PAGE
analysis, meaning that 5.3% of the total precipitate is pR This level of purity and yield
clearly demonstrate that phosphate competes with citrate, i.e. phosphate blocks citrateinduced precipitation.

However, with each further addition of citrate and concomitant dilution of
phosphate, more impurities are precipitated out, while leaving increasingly pure pR in the
supernatant. The cause of the precipitation of these impurities is not clear; they could be
binding to citrate either non-specifically or by specific protein-citrate interaction.
Addition of citrate also causes precipitation of pR leading to loss of pR.
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It can be seen that with the progress of citrate addition and simultaneous dilution
of phosphate, more pR is precipitated while also being purified (Fig 3.3). The majority of
impurities are removed at the earlier phase of purification leaving few residual
contaminants. It is intriguing that three contaminants co-precipitate with pR at apparent
molecular weights of ~31, 45, 66 and about 97 kDa (See appendix 3.9 for the identity of
contaminants). It should also be noted that the amount of sample loaded in lane 7 is half
of the amount loaded in lanes 3-6. This observation means that the pR yield may be
under-estimated.

Fig 3.3 (lane 7) also demonstrates that pR TCM can be substantially purified with
124 mM phosphate and 50 mM citrate. Fig. 3.4 shows the UV-vis spectra and an intense
purple pellet of the precipitate obtained with 124 mM phosphate and 50 mM citrate.
Phosphate aids in the purification of pR; part of the reason for this is that phosphate raises
the concentration of citrate required to precipitate pR by 5-fold, but does not increase the
citrate concentration needed to precipitate impurities. Note that complete precipitation of
pR is obtained with 10 mM citrate in the absence of phosphate (chapter 2). The
purification thus arises from the competing nature of phosphate for citrate, and the
selectivity of this competition process for pR.

It should be pointed that even 50 mM citrate is unable to completely precipitate
pR in the presence of phosphate, yet more evidence of phosphate-citrate competition. The
precipitation reaches a saturation point leaving a faint pink pR in the supernatant adding
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to the loss of recovery. Conditions will need to be explored to minimize the overall losses
of pR recovery.

Changing the concentrations of phosphate and citrate simultaneously provides a
sharp solubility transition for pR. With the above conditions, this occurs at a
concentration of 149 mM phosphate and 40 mM citrate (Fig. 3.3 Lane 5).

The yield and purity results at each step of citrate-phosphate purification are
summarized in Table 3.4. Calculation of yield and purity of the supernatant was done
using the spectra (data not shown) obtained from the supernatants. The corresponding
precipitate obtained after removing the supernatants was analyzed on SDS-PAGE. Purity
of the precipitates was estimated from the gel. Fig. 3.5 shows the increase in purity of pR
in supernatant and precipitate. Initially, the supernatant contains more pR that becomes
purer as more impurities are removed. The precipitate contains more impurities with a
small fraction of pR. As purification progresses, the precipitate contains most pR,
achieving 40% purity.
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Fig. 3.3: SDS-PAGE analysis of citrate-phosphate purification of pR:
Each lane (in the third panel) contains the proteins in the pellet obtained
by sequential precipitations of a single sample of partially-purified pR.
The pR was initially in a buffer containing 50 mM Tris-Cl, 250 mM
sodium phosphate, pH 7 containing 1.7% OG, and was subjected to
sequential additions of a 1/10 volume of 100 mM citrate buffer, pH 5.5, to
attain the final concentrations as shown in the top panel. The wavy shape
of the bands in the first 3 lanes is due to the presence of high concentration
of OG. Detergent tends to cause spreading and anomalous behavior of
protein bands.
The second panel shows the variations in the concentrations of citrate,
phosphate and OG as more citrate was added. Column colored
represents concentration of phosphate,
depicts citrate concentration
and shows the concentration of OG.
The last panel shows the color of the pellets obtained at various stages
with citrate-phosphate purification.

Fig. 3.4: Citrate-phosphate purified pR TCM: Proteorhodopsin TCM was purified
using the protocol described in the text. The spectrum (at left) and the purified protein
pellet (at right) correspond to lane 7 of Fig. 3.3. This is an uncorrected spectrum showing
A280/520 ratio of 2.57. The yield of the pellet, relative to the total pR present in the original
cell culture, is 34.68%; and the purity is 40-48% as judged by SDS-PAGE (with
Coomassie Blue staining and optical scanning) and UV-vis spectra.
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Fig. 3.5: Purity of supernatant and precipitate: Progress of purification of pR
using citrate-phosphate buffers. depicts progress of purity in supernatant,
depicts progress of purity in precipitate.

Table 3.4: Yield and purity of pR at various stages of purification with
citrate and phosphate
Lanes
1
2
3
4
5
6
7
Yield of pR in
53
49
46
44
42
38
-supernatant, %
(from spectra)
Purity of pR in
13.6
14
14.5
17.3
21
22
supernatant, %
-(from spectra)
Purity of pR in
precipitate, %
<4.5
5.3
7
12
7.8
25
40
(from gel)
The yield is calculated by considering the total pR (mg) of the lysate as 100.
Purity refers to the fraction of pR present in the total protein, expressed as
percent.
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3.3.7

Scaled-up test of a simplified citrate/phosphate protocol for preparation of
pR
A 1200 mL E. coli culture of pR-expressing cells was subjected to purification

using citrate and phosphate buffers. A summary of this process is as follows: a buffer,
containing both a high concentration of phosphate and a low concentration of citrate, was
added initially to a partially purified pR, in order to selectively precipitate the impurities.
High initial concentration of phosphate and effective OG ensured pR was soluble at the
start. At this stage, citrate was kept to a minimum concentration in order to prevent any
citrate-induced pR precipitation early in the process. However, whitish impurities
precipitated allowing their removal. Subsequently, phosphate-free citrate buffer was
added to compete with phosphate, and thereby selectively precipitate pR.
Detailed protocol
As described in the preceding subsection, proteorhodopsin was partially purified
with two cycles of citrate precipitation, each followed by 3% OG/Tris buffer
resolubilization, to an A280/520 ratio of 6. The pellet was again resolubilized in minimal
volume of 3% OG buffered with 50 mM Tris-Cl, pH 9.0. A buffer of 600 mM phosphate
and 30 mM citrate, pH 7.0, containing 0.4% OG was added gradually with gentle mixing,
followed by centrifugation. When the concentrations of phosphate and citrate reached
350 mM and 17.5 mM, respectively, whitish impurities settled out while pR remained in
the solution. Complete precipitation of pR was observed by adding to this solution an
equal volume of phosphate-free citrate buffer, 100 mM, pH 7.0. This yielded final
concentrations of 175 mM phosphate and 58.75 mM citrate. The final concentration of
OG was close to 1%. Results above, showing that a similar concentration of phosphate
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by itself in the presence of 1% OG fails to cause precipitation, show that it is citrate, and
not phosphate, that led to precipitation at this point. But the competition by phosphate is
what leads to purification of pR.

In support of these conclusions, increasing the concentration of citrate while
proportionately increasing the phosphate in the same ratio, does not lead to precipitation
of pR. Furthermore, a phosphate:citrate concentration ratio of 20:1 is adequate to provide
partial, but not complete inhibition of the citrate induced precipitation.

Fig. 3.6 shows the spectra of pR at various stages of purification, and Fig. 3.7
shows an SDS-PAGE analysis. Proteorhodopsin is easily purified to A280/520 ratio of 6
(Fig. 3.7, B) with two cycles of citrate only to a purity level of 35% (Fig. 3.7, lane B).
This ratio was improved to 3.3 (Fig 3.7, C) and to a purity of 67% as measured by SDSPAGE analysis (Fig. 3.7, lane C) after hydroxylapatite column chromatography. Fig. 3.7
also demonstrates that pR with A280/520 ratio of 6 can be enhanced to an even better A280/520
ratio of 2.6 (Fig. 3. 7, D), corresponding to a purity level on SDS gel of 50% (Fig 3.7,
lane D), by simply using a combination of phosphate and citrate. These results suggest
that phosphate can be used in the method of pR preparation, mainly as a selective
competitor of the precipitating citrate.

Table 3.5 shows the purification yield and purity of pR obtained using citrate
method followed by either hdyroxylapatite column chromatography or a combination of
citrate and phosphate buffers. The amounts of pR, total protein and yields were calculated
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using the A520 and A280 values from the spectra (Fig. 3.6) as described in the footnote of
Table 3.5. Comparison of purity levels obtained from the spectra and those from the
SDS-PAGE shows a discrepancy between the values. This could be attributed to the fact
that the specific A280 value at the earlier steps of purification reflect that most of the
protein content was average soluble proteins, for which A280 = 1 for a 1 mg/mL solution,
with a smaller contribution from pR, for which A280 = 1 for a 0.4 mg/mL solution.
However, as the purity of pR increases, the A280 value due to contaminants is smaller
compared to that by pR. For the purity calculations, since the amount of pR is added to
the total protein content, and then the amount of pR purity is obtained by dividing the
entire protein content, the values appear smaller.

Besides the above explanation, it is also possible that the protein undergoes
denaturation and loses its chromophore retinal. Therefore, the absorption at 520 nm is
relatively low giving it a low ratio of A280/520. However, the protein still shows up on the
SDS-PAGE even though it has lost its chromophore retinal, giving an impression of
higher yield.
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Fig. 3.6: UV-visible absorption of pR at various stages of purification
using different methods: All the spectra were measured in the presence
of 3% OG at pH 9 buffered by 50 mM Tris-Cl. Spectra A, B, C and D
correspond to pR samples in Lanes A, B,C and D of Fig. 3.2.

Fig. 3.7: SDS-PAGE analysis of pR purification: Left, 18% SDS-PAGE: Lane
A contains pR purified by one cycle of citrate precipitation and resolubilization,
Lane B shows pR purified by two cycles of citrate precipitation/resolubilization,
Lane C is the hydroxylapatite-column-purified pR, Lane M contains broad-range
SDS-PAGE molecular weight markers, BioRad. Right, 13% SDS-PAGE: Lane B
and Lane C are the same samples as correspondingly labeled in the 18% gel. Lane
D depicts the pR sample purified exclusively through differential precipitations
with different combinations of citrate and phosphate buffers, as described in the
text.
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Table 3.5: Proteorhodopsin purification using citrate followed by
hydroxylapatite column chromatography or combination of citrate and
phosphate buffers

Purification
stage

A280/520
Ratio

Total
protein
(mg)

Amount
of pR
obtained
(mg)

Purity
(total
pR/total
protein)
(%)
1.47

Enrichment Yield
Factor
(%)

1. Whole cell 44.4
406
6.0
1
100
extract*
2. After 1
28
251
5.67
2.3
1.5
94.5
citrate
precipitation
cycle
(spectrum A)
3. After 2
6.36
41
4.95
12
8.2
82.5
citrate
precipitation
cycles
(spectrum B)
†
4a. After
3.33
5.4
1.66
31
21
28
hydroxylapat
ite column
(spectrum C)
†
4b. After
2.6
4.34
2.08
48
32.4
35
citratephosphate
purification
(spectrum D)
Proteorhodopsin TCM was expressed in E. coli UT5600. Purification was carried
out as described in the text. The amount of pR obtained at each step was
calculated based on A520, the absorbance due to retinylidene Schiff base at pH 9,
of an appropriately diluted aliquot. Molar extinction coefficient at A520 considered
was 50, 000 M-1 cm-1, molecular weight of pR was considered to be 30,000 Da.
The non-pR contaminants of the same sample were estimated based on the
amount of A280 that could not be contributed to pR, estimating 1 mg/mL for A280 =
1.0, this was added to the concentration of pR to determine the total protein
content. Purity was calculated by dividing the amount of pR by the total protein.
†
The sample from step 3 was divided into two parts: one part was subjected to
hydroxylapatite column purification while the other was purified with a
combination of citrate and phosphate buffers. Total yield is a combination of both
4a and 4b.
*The A520 of whole cell extract was corrected by adjusting the baseline to negate
the effect of light scattering.
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3.4

DISCUSSION

3.4.1

Phosphate-induced pR precipitation
Precipitation of pR by phosphate suggests that either there is a binding site on pR

for phosphate, like citrate, or that phosphate has a salting-out effect [3, 4]. At 0.3-0.5%
OG phosphate effects precipitation of pR only within a range of 40 – 400 mM. With only
these two species present, i.e., phosphate and OG, at any concentration above the
indicated ranges, pR precipitation is inhibited. This behavior, taken by itself, could be
consistent with a salting-out effect (and salting-in at the higher phosphate
concentrations).

However, it is more likely that a specific binding site for phosphate is present on
pR, because of an observed competition between phosphate and citrate. Specifically, it
was found that 250 mM phosphate in 1.7% OG causes precipitation only of impurities,
but not pR. This concentration of phosphate also inhibits citrate from binding and
leading to pR precipitation, but in a competitive fashion. That is, an increase in the
concentration of citrate can overcome the inhibitory effect of phosphate. Under At 0.30.5% OG, and in the absence of phosphate, pR can be completely precipitated with 10
mM citrate. However, in the presence of phosphate, the citrate concentration required for
pR precipitation is increased to about 35 mM. This competitive effect of elevated citrate
would not be expected if the high level of phosphate were simply causing a “salting-in”
effect.
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An even more important piece of evidence favoring a specific competitive
binding is that the two IC1-loop mutants that we examined for effects on phosphate
binding - both the double (K57Q/K59Q) and quadruple (R51Q/R53Q/K57Q/K59Q)
charge neutralization - eliminated both citrate and phosphate induced precipitation at all
concentrations (at pH 7 and 0.4% OG).

This observation strongly suggests that phosphate binds to pR at the IC1 loop,
specifically at the positively charged residues. We conclude further that phosphate at
higher concentrations likely binds at the same site (and possibly others); and this form of
binding by phosphate can inhibit precipitation of pR; also, that a 3-4 fold higher-thanusual concentration of citrate can out-compete the phosphate binding on the IC1 loop,
and thereby restore the citrate-induced precipitation. Thus the phosphate and citrate
binding sites overlap, and phosphate binds to that site preventing 10 mM citrate from
binding to it. Therefore, pR cannot be precipitated by citrate, except at significantly
elevated concentrations, in the presence of the inhibitory phosphate.

It has previously been shown that 300 mM phosphate binds pR and lowers the
pKa of Asp, the counter-ion of Schiff base of pR [16]. Other anions such as chloride,
sulfate and halogeno-acetates were also shown to influence the pKa of pR at even lower
concentrations and were suggested to have a binding site on pR. These anions are
assumed to bind away from the active site, Asp97, based on the fact that none of them
affects the absorption maxima of pR. They are speculated to bind either at the
extracellular side or possibly cytoplasmic side of pR. The results of my experiments with
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the pR mutants is consistent with these earlier conclusions, and in particular indicates a
binding site at the cytoplasmic side on the intracellular loop, IC1.

In a previous study with bovine rhodopsin, the presence of solute anions,
including sulfate, chloride and nitrate, was shown to increase the pKa of Schiff base group
of the chromophore [17]. These anions were also shown to influence the conformational
equilibrium of Meta I/Meta II intermediate states, suggesting a well-defined ion binding
site at or within the protein. It has been observed that several anions, including sulfate
and chloride, cause the precipitation of pR under select counterion conditions, as
mentioned in chapter 2.

Phosphate-induced pR precipitation is dependent on the concentration of OG. In
the presence of 0.7% OG, which is the critical micelle concentration (CMC), or higher,
phosphate loses its ability to precipitate pR. Phosphate groups perhaps bind to or interact
with certain amino acid groups that become buried inside the pR-detergent micelle as
more detergent is added.

The presence of phosphate does not affect the absorption maximum of pR, as
evidenced by the presence of a peak at 520 nm at pH 9. The effect of phosphate on the pR
photocycle remains to be examined. Sharaabi et al. [16] showed that pR binding of other
anions such as chloride, sulfate and halogeno-acetates affects the photocycle by altering
the decay rate of the M intermediate.
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3.4.2

Preparation of pR using citrate-phosphate buffers
The combination of citrate and phosphate for the purpose of pR preparation has

many of the same advantages as the citrate method by itself, including low cost and
rapidity. The combination of citrate and phosphate gives a higher purity than citrate
alone, and can effectively eliminate the requirement of any chromatography column in
order to obtain pR samples suitable for some research purposes, e.g. for simple
spectroscopic measurements screening for alterations in absorption maximum.

A pR band is present in all the lanes in Fig. 3.3, showing that pR is partially lost
along with the bulk of the impurities, before a relatively pure pR band can be precipitated
with a higher concentration of citrate. Conditions need to be explored where the
impurities or contaminant proteins can be either precipitated before pR, or that they can
be kept solubilized in the phosphate solution while pR selectively and completely
precipitates out.

3.5

CONCLUSIONS
Phosphate by itself precipitates pR selectively but does not purify pR beyond

what is achieved with citrate alone. However, it binds to the impurities allowing citrate to
selectively precipitate pR. Phophate shares at least one of its binding sites of pR with
citrate, i.e. the lysines and arginines located at the IC1. There might be other binding sites
of phosphate but this particular overlap of the interaction sites explains why citrate
cannot precipitate pR in the presence of phosphate.
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While proteins have been studied for their binding to various salts, there is no
report yet on the use of salts in the purification of membrane proteins. This study
underscores the application of inexpensive salts for the purification of membrane protein
such as pR, more importantly, without the use of any chromatographic columns. The
entire process of pR production is rendered extremely inexpensive, beginning with the
protein expression because pR is expressed in E. coli making the protein production fast
and less labor-intensive.

Proteorhodopsin purified by citrate-phosphate method lacks the polyHis-tag
which makes the process applicable to the purification of pR from natural source. The
three-dimensional structure of pR has not been solved yet. Because pR is a proton pump
and the His6 tag would be expected to affect binding of protons to various groups with the
protein, it is desirable to produce pure protein without the tags for structural and
functional studies [18]

Proteorhodopsin shares properties with BR that make them both attractive
biomaterials for certain applications, e.g. as a holographic recording medium [19, 20].
Unlike BR, pR can be expressed rapidly in E. coli in a fully functional form, which
makes it more attractive for such uses. Due to its photochromic properties, pR is also
being pursued as a cosmetic ingredient as was suggested in a patent issued for similar use
of BR [21]. These applications demand significant amount of protein. The above method
of pR preparation has the potential to produce such quantities in short time period.
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This method of purification might also potentially be applied toward the
purification of pharmaceutically important membrane proteins known as GPCRs. This
somewhat-speculative potential application will be explored further in the next chapter of
this thesis.
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Chapter 4

HETEROLOGOUS EXPRESSION OF BOVINE RHODOPSIN, A MAMMALIAN
RHODOPSIN, IN E. coli

4.1

INTRODUCTION
Based on the identification of a short compact motif responsible for pR-citrate

interaction, it was hypothesized that it might be possible to exploit this motif for the
purification of other membrane proteins. This chapter describes a strategy that was
developed to test this hypothesis, and preliminary attempts to express a mammalian
membrane protein, bovine rhodopsin, in E. coli with the aim of adapting the citrate
purification method to G-protein-coupled receptors (GPCRs). Similar to pR, GPCRs
generally contain a cluster of positively charged amino acid residues in their first
intracellular loop (Fig. 4.1 and 4.2). If their spacing in the native primary sequence is
inadequate, site directed mutation(s) can be carried out on the amino acids present in the
loop to generate positively charged amino acid (s) with spacing matching that is present
in pR.
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Fig. 4.1: Primary structure of bovine rhodopsin showing positively charged
residues: The underlined segments represent the loops, beginning with the
extracellular loop and ending with the cytoplasmic loop. The first intracellular
loop is shown in bold and the positively charged residues are highlighted.

To use citrate for the purpose of GPCR purification, the first step was to express a
GPCR protein in bacteria. E. coli was chosen as the expression tool because it multiplies
fast, with a doubling time of ~30 minutes, consequently producing the protein in large
quantities in a shorter time period. Also, with E. coli, the behaviors of lipids and cocontaminants that are co-purified at each step when using the citrate purification method
for pR are recognizable. Switching to a different expression organism would be expected
to introduce complications resulting from a different mix of contaminant proteins and
lipids.

However, membrane proteins, especially integral membrane proteins, are difficult
to express in E. coli. High-level expression of such proteins is often toxic to the host cell.
To circumvent such difficulties, it is often possible to take advantage of the technique of
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gene fusion. Another membrane protein, native to E. coli, is genetically fused to the
protein of interest at either the C- or N-terminus. These fusion proteins are also known as
tags which are either short fragments or the entire length of protein. Bacteriorhodopsin
(BR), an archaeal homolog of pR, has been expressed in E. coli using tags such as
maltose-binding protein (MBP) [1] or β-galactosidase [2]. These larger fusion proteins
allow efficient expression of the protein of interest. The drawback of tag-fusion is that it
adds another step in the process of purification; the tags typically need to be cleaved in
order to produce a pure protein in the native form for structural studies.

Because it is possible to obtain relatively high levels of pR expression in E. coli up to 10 mg per liter of culture, an uncommonly high level of expression for an
heptahelical membrane protein - fusion with pR or with pR segment(s) appears as an
attractive strategy for expression of GPCRs.

As a first candidate for heterologous expression of a GPCR in E. coli, an attempt
was made to express mammalian rhodopsin, specifically bovine rhodopsin. GPCRs are of
great pharmacological importance, with about 30-50% of drugs being targeted at GPCRs
[3]. Some of the drugs that target GPCRs are shown in Table 4.1 [4]. Table 4.2 shows
some of the hereditary diseases associated with malfunctioning GPCRs [4].

The binding sites of GPCR ligands are buried in between the seven
transmembrane helices. Structure-guided design of drugs that target GPCRs has been
limited due to the lack of three-dimensional structures of these binding sites. This is

126

largely due to the challenge in purification of these proteins in sufficient quantities to
carry out crystallization studies. Bovine rhodopsin was the first GPCR to be crystallized
mainly due to its abundance and high concentration in an easily-obtained tissue, cow
retinas [5]. Methods for purification of it were first developed in the 1940s, allowing
widespread research attempts on its crystallization. However, it still took a span of
around 50 years to get the protein pure enough that is suitable for three-dimensional (3D)
structural studies.

Homologous expression of most other mammalian GPCRs in large quantities is
difficult, since they are generally expressed in very low quantities in the cell.
Considerable effort is being applied into heterologous expression of functional GPCRs,
but production of even modest quantities of membrane proteins is a challenge. Rat
neurotensin receptor is a GPCR that has been expressed in E. coli as a dual fusion protein
with MBP-tag at the N-terminus and thioredoxin (Trx)-tag at the C-terminus. This
yielded 10 mg of the fusion protein from 200 L of culture [6]. (It should be noted that
only half of the 10 mg was attributable to the native rhodopsin sequence; the other half
was MBP itself). Another example of E. coli expression of a GPCR is that of chemokine
receptors, CR, CCR3, CCR5, and CX3CR1 [7]. The final yields of purified receptors
obtained were between 0.1 to 3 mg/L of culture.

Our lab and others have been successful in expressing 5-10 mg/L of pR in E. coli.
[8]. It should be noted that while expression of pR is by definition considered
heterologous in E. coli, the native pR was originally found in E. coli related bacteria, γ-
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proteobacteria. This might explain the ease and the high success rate of expression of pR
in E. coli. If a membrane protein such as a GPCR could be expressed in E. coli and
purified with the citrate method, the consequences of such results could be immense, as
the protein could be obtained in larger quantities and purified with a simple, inexpensive
and labor-easy method.
Table 4.1: GPCR-targeted drugs

Allegra
Atrovent
Axid
Betaloc
BuSpar
Cardura
Claritin
Cozaar
Diovan
Duragesic
Gaster
Hytrin
Imigran
Lupron
Neurotonine
Pepcidine
Plavix
Prepulsid
Prostap SR
Risperdal
Seloken
Serevent
Singulair
Tagamet
Tenormin
Ventolin

Generic name
of drug
Fexofenadine
Ipratropium
Nizatidine
Metoprolol
Buspirone
Doxazosin
Loratidine
Losartan
Valsartan
Fentanyl
Famotidine
Terazosin
Sumatriptan
Leuprolide
Gabapentin
Pamotidine
Clapidogrel
Cisapride
Leuprorelin
Risperidone
Metoprolol
Salmeterol
Montelukast
Cimetidine
Atenolol
Salbutamol

Zantac
Zofran
Zoladex
Zyprexa

Ranitidine
Ondansetron
Goserelin
Olanzapine

Allergies
Asthma
Renal dysfunction
Asthma/COPD
Depression
hypertension
Allergies
Hypertension
Hypertension
Pain
Ulcers
Hypertension
Migraine
Cancer
Neurogenic pain
Ulcers
Stroke
Digestion
Prostate cancer
Psychosis
Hypertension
Asthma
Asthma
Ulcers
Hypertension
Asthma/breathing
problems
Ulcers
Antiemetic
Cancer
Schizophrenia

Zyrtac

Cetirizine

Allergies

Trademark

Disease

Target receptor
H1 antagonist
Mixed muscarinic antagonist
H2 antagonist
Beta1 antagonist
5-HT1 agonist
Alpha1 antagonist
Antihistamine H1 antagonist
AT1 antagonist
AT1 antagonist
Opioid agonist
H2 antagonist
Alpha1 antagonist
5-HT1 agonist
LH-RH agonist
GABA B agonist
H2 antagonist
P2Y12 antagonist
5-HT4 ligand
LH-RH agonist
Mixed D2/5-HT2 antagonist
Beta1 antagonist
B2 agonist
LTD4 antagonist
H2 antagonist
Beta2 antagonist
Beta2 agonist
H2 antagonist
5-HT3 antagonist
LH-RH agonist
Mixed D2/D1/5-HT2
antagonist
Antihistamine H1 antagonist

Source: The table is a redrawn version of the table taken with permission from Flower D. R [4].
More drugs and the diseases have been added to this table.

128

Table 4.2: Diseases associated with malfunctioning GPCRs

Disease

Receptor

Color blindness

Red and green
opsins
Rhodopsin

Type/function of
mutation
X chromosome
rearrangements
Missense mutation

Rhodopsin
V2- receptor
ACTH receptor

Apoptosis of rod
cells
Null mutations
Loss of function
Loss of function

TSH receptor

Missense

LH receptor

Missense

Ca2+-sensing
receptor

Missense

Ca2+-sensing
receptor

Missense

Stationary night
blindness
Retinitis pigmentosa Rhodopsin
Retinitis pigmentosa
Nephrogenic DI
Isolated
glucocorticoid
deficienty
Hyperfunctioning
thyroid adenomas
Familial precocious
puberty
Familial
hypocalciuric
hypercalcaemia
Neonatal severe
hyperparathyroidism

Source: The table is a redrawn version of the table, taken with
permission from Flower D. R. [4].

4.2

Methods and Rationale

4.2.1

Construction of chimera plasmid coding for bovine rhodopsin fused to Nterminal leader sequence from pR
Initially, the unmodified bovine rhodopsin gene (originally obtained from Jeremy

Nathans) was cloned into the expression site of commercially available plasmid pBADTOPO-TA from Invitrogen. The resulting recombinant plasmid pBAD TOPO-TA had its
sequence verified in order to confirm the correct direction of insertion, then was
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transformed in E. coli Strain UT5600, the same that has been used for pR expression. In
this construct, bovine rhodopsin is under the control of arabinose promoter. However,
even after addition of 0.2% arabinose and 11-cis-retinal, the protein failed to express,
fold, and/or form a holoprotein, as evidenced by lack of a reddish chromophore.

This was a generally-expected result, as it has not been possible in general to
express GPCRs in E. coli. A widely-accepted reason for this is that E. coli is unable to
insert the N-terminal (N-T) region of bovine rhodopsin into its membrane and therefore is
incapable of expressing it without an N-terminal fusion to a native E. coli protein.

Therefore, we adopted the strategy of fusing bovine rhodopsin to an N-terminal
leader sequence from pR. Since pR is successfully expressed by E. coli, it is apparent that
the N-terminal portion of pR is able to translocate through the membrane and
consequently lead the entire protein to span the membrane seven times. It was
hypothesized that if the N-T region of bovine rhodopsin that forms the extracellular
segment was replaced by the N-terminal portion of pR corresponding to the extracellular
segment of pR, then bovine rhodopsin might also express and properly fold in E. coli.

Fig 4.2 and 4.3 show the secondary structures of bovine rhodopsin and pR
respectively. Construction of the chimeric protein was accomplished by performing a
site-directed mutagenesis using pBAD TOPO TA containing bovine rhodopsin as the
cloning vector and replacing the N-terminal extracellular loop of bovine rhodopsin with
that of pR. To be specific, the first 33 amino acids at the N-terminus in bovine rhodopsin
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were replaced by the first 27 amino acids of pR. The gene and protein sequences of pR
and bovine rhodopsin are shown in Fig. 4.4 and 4.5.

Fig. 4.2 Secondary structure of bovine rhodopsin: This figure is based on
Sakmar T. P. [10], taken with permission. The 33 amino acids at N-terminal
region on the extracellular side, labeled as extracellular loop, were replaced by Nterminal 27 amino acids of pR. The positively charged amino acids in the
intracellular loop 1 (C1) are marked in red.
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Fig. 4.3: Secondary structure of pR: The first 27 amino acids at the Nterminus of pR on the extracellular side were used to replace the first 33
amino acids of N-terminal extracellular loop of bovine rhodopsin.

The mutagenesis was accomplished by using a polymerase chain reaction (PCR)mediated method [9]. This method utilizes overlap extension methodology. The overall
reaction is divided into two steps: the first step involves synthesis of a double-stranded
linear DNA insert containing the desired new sequence, with sequences at both ends that
overlap the existing target gene; the second step uses the double-stranded insert as a pair
of primers for thermal-cycling DNA synthesis (as in the polymerase chain reaction). The
overlapping sequences at the ends of the synthetic DNA are identical to portions of the
template for the DNA synthesis in the second step (Fig. 4.6). Thus, the insert becomes
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incorporated into the cloning vector in the second step. The PCR-mediated cloning
method uses a polymerase known as Phusion®, a high-fidelity DNA polymerase that can
potentially insert up to 6.7 kb of insert [9].

A set of primers were designed for the purpose of generating a chimera of bovine
rhodopsin with the N-terminus of pR. The sequences of the primers are shown in Fig. 4.7.
Schematic diagram of the strategy of primer design is shown in Fig. 4.8. Both the primers
included a portion of plasmid pBAD TOPO TA on left side of N-T pR and, a portion of
bovine rhodopsin gene on the right side of N-T pR. An extra fragment, known as
overhang, was also included in the primers to ease the process of annealing in the second
step; the overhang on the 5' side of pR matched a portion of the pBAD-TOPO
commercial plasmid sequence, and the overhang on the 3' side corresponded to a portion
of bovine rhodopsin sequence.

The overall methodology is summarized in Fig. 4.6. For the first step, the Nterminal portion of pR with overhangs on both its sides was synthesized commercially
(Integrated DNA Technology). An approximate portion of pR that was synthesized is
shown in Fig. 4.6a. The synthesized linear fragment is shown in Fig. 4.6b. It has the
aforementioned overlapping regions on both sides of pR. This linear fragment served as
the insert that primed the second step of PCR (Table 4.3 and Fig. 4.6c). Plasmid pBADTOPO with bovine rhodopsin (cloning vector) served as the template; thus the overhang
and the overlapping sequences of the insert are complementary to segments of this
template. The pR sequence that is a part of the primer automatically becomes inserted.
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Since the N-terminal portion of bovine rhodopsin is not a part of the insert, it is replaced
by pR. The final product obtained is the recombinant plasmid pBAD TOPO TA with
N.T. pR-bovine rhodopsin chimera (Fig. 4.6d).

4.2.2

Transfection of supercompetent E. coli with the chimera plasmid
pBAD TOPO TA plasmid containing the chimera was digested with DpnI to

eliminate the template plasmid. It was then transfected into supercompetent E. coli cells
(Agilent technologies). Plasmid DNA was isolated for analysis on 0.8% agarose gel as
well as DNA sequencing.

4.2.3

Transfection of E. coli UT5600 with the chimera plasmid
Plasmid containing chimera DNA was transfected into UT5600 cells for the

purpose of protein expression.

Fig. 4.4a: Sequence of Bovine rhodopsin gene (Nucleotide accession number:
AH001149): The red region is the sequence included in the primers. The region, 99 bp, 5'
side to the red region (italics) is the sequence on the N-terminus that forms the first
extracellular loop, which was replaced by N-terminus of pR.
ATGAACGGGACCGAGGGCCCAAACTTCTACGTGCCTTTCTCCAACAAGACGGGCGTGGTGCGCAGCCCCT
TCGAGGCCCCGCAGTACTACCTGGCGGAGCCATGGCAGTTCTCCATGCTGGCCGCCTACATGTTCCTGCT
GATCATGCTTGGCTTCCCCATCAACTTCCTCACGCTGTACGTCACAGTCCAGCACAAGAAGCTGCGCACA
CCCCTCAACTACATCCTGCTCAACCTGGCCGTGGCCGACCTCTTCATGGTCTTCGGGGGCTTCACCACCA
CCCTCTACACCTCTCTGCACGGGTACTTCGTCTTTGGGCCCACGGGCTGCAACCTGGAGGGCTTCTTTGC
CACCTTGGGCGGTGAAATTGCACTGTGGTCCTTGGTGGTCCTGGCCATCGAGCGGTACGTGGTGGTGTGC
AAGCCCATGAGCAACTTCCGCTTCGGGGAGAACCACGCCATCATGGGCGTCGCCTTCACCTGGGTCATGG
CTCTGGCCTGTGCCGCGCCCCCCCTCGTCGGCTGGTCCAGGTACATCCCGGAGGGCATGCAGTGCTCGTG
CGGGATTGACTACTACACGCCCCACGAGGAGACCAACAATGAGTCGTTCGTCATCTACATGTTCGTGGTC
CACTTCATCATCCCCCTGATTGTCATATTCTTCTGCTACGGGCAGCTGGTGTTCACCGTCAAGGAGGCGG
CTGCCCAGCAGCAGGAGTCGGCCACCACTCAGAAGGCCGAGAAGGAGGTCACCCGCATGGTGATCATCAT
GGTCATCGCTTTCCTAATCTGCTGGCTGCCCTACGCTGGGGTGGCGTTCTACATCTTCACCCATCAGGGC
TCTGACTTTGGCCCCATCTTCATGACCATCCCGGCTTTCTTTGCCAAGACTTCTGCCGTCTACAACCCCG
TCATCTACATCATGATGAACAAGCAGTTCCGGAACTGCATGGTCACCACTCTCTGCTGTGGCAAGAACCC
GCTGGGTGACGACGAGGCCTCCACCACCGTCTCCAAGACAGAGACCAGCCAAGTGGCGCCTGCCTAA
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Fig. 4.4b: Sequence of pR (Nucleotide accession number: AF279106): Note: The
sequence provided with this accession number is the reverse complement of the following
sequence. Here, the underlined sequence represents the sequence used for the primers. It
is the portion of pR, the N-terminus pR, that replaced the N-terminus of bovine
rhodopsin.
ATGAAATTATTACTGATATTAGGTAGTGTTATTGCACTTCCTACATTTGCTGCAGGTGGTGGTGACCTTGA
TGCTAGTGATTACACTGGTGTTTCTTTTTGGTTAGTTACTGCTGCTTTATTAGCATCTACTGTATTTTTCT
TTGTTGAAAGAGATAGAGTTTCTGCAAAATGGAAAACATCATTAACTGTATCTGGTCTTGTTACTGGTATT
GCTTTCTGGCATTACATGTACATGAGAGGGGTATGGATTGAAACTGGTGATTCGCCAACTGTATTTAGATA
CATTGATTGGTTACTAACAGTTCCTCTATTAATATGTGAATTCTACTTAATTCTTGCTGCTGCAACTAATG
TTGCTGGATCATTATTTAAGAAATTACTAGTTGGTTCTCTTGTTATGCTTGTGTTTGGTTACATGGGTGAA
GCAGGAATCATGGCTGCATGGCCTGCATTCATTATTGGGTGTTTAGCTTGGGTATACATGATTTATGAATT
ATGGGCTGGAGAAGGAAAATCTGCATGTAATACTGCAAGTCCTGCTGTGCAATCAGCTTACAACACAATGA
TGTATATTATCATCTTTGGTTGGGCGATTTATCCTGTAGGTTATTTCACAGGTTACCTGATGGGTGACGGT
GGATCAGCTCTTAACTTAAACCTTATCTATAACCTTGCTGACTTTGTTAACAAGATTCTATTTGGTTTAAT
TATATGGAATGTTGCTGTTAAAGAATCTTCTAATGCTTAA

Fig. 4.5a: Sequence of bovine rhodpsin protein (Protein accession number:
AAA30674): The N-terminal 33 amino acids of bovine represented in bold italics form
the first extracellular loop. They replaced by N-terminus of pR in the chimera plasmid
construction.
MNGTEGPNFYVPFSNKTGVVRSPFEAPQYYLAEPWQFSMLAAYMFLLIMLGFPINFLTLYVTVQHKKLRT
PLNYILLNLAVADLFMVFGGFTTTLYTSLHGYFVFGPTGCNLEGFFATLGGEIALWSLVVLAIERYVVVC
KPMSNFRFGENHAIMGVAFTWVMALACAAPPLVGWSRYIPEGMQCSCGIDYYTPHEETNNESFVIYMFVV
HFIIPLIVIFFCYGQLVFTVKEAAAQQQESATTQKAEKEVTRMVIIMVIAFLICWLPYAGVAFYIFTHQG
SDFGPIFMTIPAFFAKTSAVYNPVIYIMMNKQFRNCMVTTLCCGKNPLGDDEASTTVSKTETSQVAPA

Fig. 4.5b) Sequence of pR protein (Protein accession number: AAG10475): The Nterminal 27 amino acids of pR represented in bold italics form the extracellular loop.
They replaced the N-terminus of bovine rhodopsin in the chimera plasmid construction.
MKLLLILGSVIALPTFAAGGGDLDASDYTGVSFWLVTAALLASTVFFFVERDRVSAKWKTSLTVSGLVTG
IAFWHYMYMRGVWIETGDSPTVFRYIDWLLTVPLLICEFYLILAAATNVAGSLFKKLLVGSLVMLVFGYM
GEAGIMAAWPAFIIGCLAWVYMIYELWAGEGKSACNTASPAVQSAYNTMMYIIIFGWAIYPVGYFTGYLM
GDGGSALNLNLIYNLADFVNKILFGLIIWNVAVKESSNA
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Fig. 4.6: PCR-cloning method: First step is shown in (a) which involves synthesizing a
linear insert. The primers used for this step include a sequence of pR to be synthesized
flanked by overlapping sequences as described in the text. (b) is the product of the first
step that serves as an insert for the second step. NOTE: The first step was omitted, and
the linear fragment was directly obtained as a commercially synthesized product
(Integrated DNA Technology). (c) Second step uses cloning vector as the template into
which the insert (linear product) becomes inserted. (d) shows the final product with N-T
pR-bovine rhodopsin chimera.
a

b

c

d
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Fig. 4.7: Sequences of primers, obtained commercially, used for construction of
chimera plasmid N-T pR-bovine rhodopsin
a) Forward primer: Fwd/pBAD_overhang-pR-BovR: Blue portion represents the
sequence of pBAD TOPO TA plasmid, black underlined sequence is the N-T of pR, red
portion represents that of bovine rhodopsin sequence beginning at amino acid # 34. The
first 19 bases on the 5' side (blue bold part) is the sequence of pBAD TOPO TA that
serves as an overhang, i.e., it does not have a complementary sequence in the reverse
primer.
5'TCCATACCCGTTTTTGGGCTAGAAATAATTTTGTTTAACTTTAAGAGGAGA
TATACATACCCATGAAATTATTACTGATATTAGGTAGTGTTATTGCACTTCCT
ACATTTGCTGCAGGTGGTGGTGACCTTGATGCTAGTGATCCATGGCAGTTCTC
CATGCTGGCCGCCTACATGTTCCTGCTGATC-3'
b) Reverse primer: Rev/BovR_overhang-pR-pBAD: The color coding is same as the
Forward primer. Similar to the Forward primer, there is an overhang on the 5' side of
reverse primer. However, this 19 bases overhang is the sequence of bovine rhodopsin that
is in continuation with the sequence used in the Fwd primer. It does not have a
complementary sequence in the Fwd primer.
5'TGATGGGGAAGCCAAGCATGATCAGCAGGAACATGTAGGCGGCCAGCAT
GGAGAACTGCCATGGATCACTAGCATCAAGGTCACCACCACCTGCAGCAAAT
GTAGGAAGTGCAATAACACTACCTAATATCAGTAATAATTTCATGGGTATGT
ATATCTCCTTCTTAAAGTTAAACAAAATTATTTCTAG-3'

c) The following is a reverse sequence of the Reverse primer. The 3’to 5’ sequence of the
above Rev primer to show where it complements the Fwd primer. Note: the bold portions
do not have a complementary sequence.
3'GATCTTTATTAAAACAAATTGAAATTCTTCCTCTATATGTATGGGTACTTTA
ATAATGACTATAATCCATCACAATAACGTGAAGGATGTAAACGACGTCCACC
ACCACTGGAACTACGATCACTAGGTACCGTCAAGAGGTACGACCGGCGGATG
TACAAGGACGACTAGTACGAACCGAAGGGGTAGT-5'
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Fig. 4.8: Schematic diagram for primer design: This represents the
strategy of primer design used for the construction of chimera plasmid, as
described in the text. Total number of bases in each primer is 190.

Table 4.3: PCR parameters
Thermo-cycling reaction for Step 2

Step
1
2
3
4
5
6

Temperature, ˚C
98
98
72
35 × 4
72
4
End

Time
30 sec
10 min
2.5 min
10 min
hold

4.3

Results

4.3.1

Analysis of the plasmid construct of pR-Bovine rhodopsin chimera
A chimera of N-T pR-Bovine rhodopsin was cloned into the plasmid pBAD

TOPO TA. The expected size of the chimera plasmid is 5128 bp. This plasmid DNA
isolated from E. coli was electrophoresed on 0.8% agarose gel (Fig. 4.11). Chimera
plasmid shows at least two forms, one at an apparent size of 3 kb (supercoiled) and
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another at an apparent size of about 7 kb (circular). A control plasmid pBAD TOPO TA
containing bovine rhodopsin was also run on the gel. The size of this control plasmid is
5202 bp, which is very close in size to the chimera plasmid. Therefore, to ascertain the
identity of chimera plasmid, chimera was analyzed by two methods.

The first one was a restriction digestion analysis. Two restriction enzyme Nde1
sites are present in the original control plasmid pBAD TOPO TA-bovine rhodopsin; one
of them is located at the N-terminal sequence of bovine rhodopsin. This site is lost in the
chimera plasmid, since that sequence is replaced by N-terminal sequence of pR. When
the control and the chimera plasmids were subjected to digestion with Nde1, two bands
for the control plasmid and only one band for the chimera plasmid were expected. Figs.
4.9 and 4.10 describe the position of Nde1 cuts and the expected band sizes. Fig. 4.11
shows the Nde1 restriction digestion analysis. The expected sizes of bands were obtained;
two bands of sizes 3544 bp and 1658 bp for bovine rhodopsin and one band
corresponding to size 5128 bp for chimera.

The second, more definitive method of analysis was DNA sequencing. The
sequence result of the pR-bovine opsin chimera is shown in Fig. 4.12. These results show
that the N-T pR was cloned and replaced the N-T of bovine rhodopsin gene in the
chimera plasmid.

139

Fig. 4.9a: pBAD-TOPO TA-bovine rhodopsin showing Nde1 restriction sites:
The following sequence shows plasmid pBAD TOPO TA containing Bovine rhodopsin
gene (red). The purple color represents Nde1 restriction recognition sites (CATATG).
There are 2 sites in this sequence. The total size of this plasmid is 5202 bp. Nde1 cuts at
positions 399 and 3943. Therefore two bands are obtained upon Nde1 digestion
corresponding to 3544 bp and 1658 bp.
AAGAAACCAATTGTCCATATTGCATCAGACATTGCCGTCACTGCGTCTTTTACTGGCTCTTCTCGCTAACCAAACCGGTA
ACCCCGCTTATTAAAAGCATTCTGTAACAAAGCGGGACCAAAGCCATGACAAAAACGCGTAACAAAAGTGTCTATAATCA
CGGCAGAAAAGTCCACATTGATTATTTGCACGGCGTCACACTTTGCTATGCCATAGCATTTTTATCCATAAGATTAGCGG
ATCCTACCTGACGCTTTTTATCGCAACTCTCTACTGTTTCTCCATACCCGTTTTTTTGGGCTAGAAATAATTTTGTTTAA
CTTTAAGAAGGAGATATACATACCCATGGGCTCTGGATCCGGTGATGACGATGACAAGCTCGCCCTTtagaggatcccat
ATGAACGGGACCGAGGGCCCAAACTTCTACGTGCCTTTCTCCAACAAGACGGGCGTGGTGCGCAGCCCCTTCGAGGCCCC
GCAGTACTACCTGGCGGAGCCATGGCAGTTCTCCATGCTGGCCGCCTACATGTTCCTGCTGATCATGCTTGGCTTCCCCA
TCAACTTCCTCACGCTGTACGTCACAGTCCAGCACAAGAAGCTGCGCACACCCCTCAACTACATCCTGCTCAACCTGGCC
GTGGCCGACCTCTTCATGGTCTTCGGGGGCTTCACCACCACCCTCTACACCTCTCTGCACGGGTACTTCGTCTTTGGGCC
CACGGGCTGCAACCTGGAGGGCTTCTTTGCCACCTTGGGCGGTGAAATTGCACTGTGGTCCTTGGTGGTCCTGGCCATCG
AGCGGTACGTGGTGGTGTGCAAGCCCATGAGCAACTTCCGCTTCGGGGAGAACCACGCCATCATGGGCGTCGCCTTCACC
TGGGTCATGGCTCTGGCCTGTGCCGCGCCCCCCCTCGTCGGCTGGTCCAGGTACATCCCGGAGGGCATGCAGTGCTCGTG
CGGGATTGACTACTACACGCCCCACGAGGAGACCAACAATGAGTCGTTCGTCATCTACATGTTCGTGGTCCACTTCATCA
TCCCCCTGATTGTCATATTCTTCTGCTACGGGCAGCTGGTGTTCACCGTCAAGGAGGCGGCTGCCCAGCAGCAGGAGTCG
GCCACCACTCAGAAGGCCGAGAAGGAGGTCACCCGCATGGTGATCATCATGGTCATCGCTTTCCTAATCTGCTGGCTGCC
CTACGCTGGGGTGGCGTTCTACATCTTCACCCATCAGGGCTCTGACTTTGGCCCCATCTTCATGACCATCCCGGCTTTCT
TTGCCAAGACTTCTGCCGTCTACAACCCCGTCATCTACATCATGATGAACAAGCAGTTCCGGAACTGCATGGTCACCACT
CTCTGCTGTGGCAAGAACCCGCTGGGTGACGACGAGGCCTCCACCACCGTCTCCAAGACAGAGACCAGCCAAGTGGCGCC
TGCCTAAtcgataagcttaattAAGGGCGAGCTTGAAGGTAAGCCTATCCCTAACCCTCTCCTCGGTCTCGATTCTACGC
GTACCGGTCATCATCACCATCACCATTGAGTTTAAACGGTCTCCAGCTTGGCTGTTTTGGCGGATGAGAGAAGATTTTCA
GCCTGATACAGATTAAATCAGAACGCAGAAGCGGTCTGATAAAACAGAATTTGCCTGGCGGCAGTAGCGCGGTGGTCCCA
CCTGACCCCATGCCGAACTCAGAAGTGAAACGCCGTAGCGCCGATGGTAGTGTGGGGTCTCCCCATGCGAGAGTAGGGAA
CTGCCAGGCATCAAATAAAACGAAAGGCTCAGTCGAAAGACTGGGCCTTTCGTTTTATCTGTTGTTTGTCGGTGAACGCT
CTCCTGAGTAGGACAAATCCGCCGGGAGCGGATTTGAACGTTGCGAAGCAACGGCCCGGAGGGTGGCGGGCAGGACGCCC
GCCATAAACTGCCAGGCATCAAATTAAGCAGAAGGCCATCCTGACGGATGGCCTTTTTGCGTTTCTACAAACTCTTTTTG
TTTATTTTTCTAAATACATTCAAATATGTATCCGCTCATGAGACAATAACCCTGATAAATGCTTCAATAATATTGAAAAA
GGAAGAGTATGAGTATTCAACATTTCCGTGTCGCCCTTATTCCCTTTTTTGCGGCATTTTGCCTTCCTGTTTTTGCTCAC
CCAGAAACGCTGGTGAAAGTAAAAGATGCTGAAGATCAGTTGGGTGCACGAGTGGGTTACATCGAACTGGATCTCAACAG
CGGTAAGATCCTTGAGAGTTTTCGCCCCGAAGAACGTTTTCCAATGATGAGCACTTTTAAAGTTCTGCTATGTGGCGCGG
TATTATCCCGTGTTGACGCCGGGCAAGAGCAACTCGGTCGCCGCATACACTATTCTCAGAATGACTTGGTTGAGTACTCA
CCAGTCACAGAAAAGCATCTTACGGATGGCATGACAGTAAGAGAATTATGCAGTGCTGCCATAACCATGAGTGATAACAC
TGCGGCCAACTTACTTCTGACAACGATCGGAGGACCGAAGGAGCTAACCGCTTTTTTGCACAACATGGGGGATCATGTAA
CTCGCCTTGATCGTTGGGAACCGGAGCTGAATGAAGCCATACCAAACGACGAGCGTGACACCACGATGCCTGTAGCAATG
GCAACAACGTTGCGCAAACTATTAACTGGCGAACTACTTACTCTAGCTTCCCGGCAACAATTAATAGACTGGATGGAGGC
GGATAAAGTTGCAGGACCACTTCTGCGCTCGGCCCTTCCGGCTGGCTGGTTTATTGCTGATAAATCTGGAGCCGGTGAGC
GTGGGTCTCGCGGTATCATTGCAGCACTGGGGCCAGATGGTAAGCCCTCCCGTATCGTAGTTATCTACACGACGGGGAGT
CAGGCAACTATGGATGAACGAAATAGACAGATCGCTGAGATAGGTGCCTCACTGATTAAGCATTGGTAACTGTCAGACCA
AGTTTACTCATATATACTTTAGATTGATTTAAAACTTCATTTTTAATTTAAAAGGATCTAGGTGAAGATCCTTTTTGATA
ATCTCATGACCAAAATCCCTTAACGTGAGTTTTCGTTCCACTGAGCGTCAGACCCCGTAGAAAAGATCAAAGGATCTTCT
TGAGATCCTTTTTTTCTGCGCGTAATCTGCTGCTTGCAAACAAAAAAACCACCGCTACCAGCGGTGGTTTGTTTGCCGGA
TCAAGAGCTACCAACTCTTTTTCCGAAGGTAACTGGCTTCAGCAGAGCGCAGATACCAAATACTGTCCTTCTAGTGTAGC
CGTAGTTAGGCCACCACTTCAAGAACTCTGTAGCACCGCCTACATACCTCGCTCTGCTAATCCTGTTACCAGTGGCTGCT
GCCAGTGGCGATAAGTCGTGTCTTACCGGGTTGGACTCAAGACGATAGTTACCGGATAAGGCGCAGCGGTCGGGCTGAAC
GGGGGGTTCGTGCACACAGCCCAGCTTGGAGCGAACGACCTACACCGAACTGAGATACCTACAGCGTGAGCTATGAGAAA
GCGCCACGCTTCCCGAAGGGAGAAAGGCGGACAGGTATCCGGTAAGCGGCAGGGTCGGAACAGGAGAGCGCACGAGGGAG
CTTCCAGGGGGAAACGCCTGGTATCTTTATAGTCCTGTCGGGTTTCGCCACCTCTGACTTGAGCGTCGATTTTTGTGATG
CTCGTCAGGGGGGCGGAGCCTATGGAAAAACGCCAGCAACGCGGCCTTTTTACGGTTCCTGGCCTTTTGCTGGCCTTTTG
CTCACATGTTCTTTCCTGCGTTATCCCCTGATTCTGTGGATAACCGTATTACCGCCTTTGAGTGAGCTGATACCGCTCGC
CGCAGCCGAACGACCGAGCGCAGCGAGTCAGTGAGCGAGGAAGCGGAAGAGCGCCTGATGCGGTATTTTCTCCTTACGCA
TCTGTGCGGTATTTCACACCGCATATGGTGCACTCTCAGTACAATCTGCTCTGATGCCGCATAGTTAAGCCAGTATACAC
TCCGCTATCGCTACGTGACTGGGTCATGGCTGCGCCCCGACACCCGCCAACACCCGCTGACGCGCCCTGACGGGCTTGTC
TGCTCCCGGCATCCGCTTACAGACAAGCTGTGACCGTCTCCGGGAGCTGCATGTGTCAGAGGTTTTCACCGTCATCACCG
AAACGCGCGAGGCAGCAGATCAATTCGCGCGCGAAGGCGAAGCGGCATGCATAATGTGCCTGTCAAATGGACGAAGCAGG
GATTCTGCAAACCCTATGCTACTCCGTCAAGCCGTCAATTGTCTGATTCGTTACCAATTATGACAACTTGACGGCTACAT
CATTCACTTTTTCTTCACAACCGGCACGGAACTCGCTCGGGCTGGCCCCGGTGCATTTTTTAAATACCCGCGAGAAATAG
AGTTGATCGTCAAAACCAACATTGCGACCGACGGTGGCGATAGGCATCCGGGTGGTGCTCAAAAGCAGCTTCGCCTGGCT
GATACGTTGGTCCTCGCGCCAGCTTAAGACGCTAATCCCTAACTGCTGGCGGAAAAGATGTGACAGACGCGACGGCGACA
AGCAAACATGCTGTGCGACGCTGGCGATATCAAAATTGCTGTCTGCCAGGTGATCGCTGATGTACTGACAAGCCTCGCGT
ACCCGATTATCCATCGGTGGATGGAGCGACTCGTTAATCGCTTCCATGCGCCGCAGTAACAATTGCTCAAGCAGATTTAT
CGCCAGCAGCTCCGAATAGCGCCCTTCCCCTTGCCCGGCGTTAATGATTTGCCCAAACAGGTCGCTGAAATGCGGCTGGT
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GCGCTTCATCCGGGCGAAAGAACCCCGTATTGGCAAATATTGACGGCCAGTTAAGCCATTCATGCCAGTAGGCGCGCGGA
CGAAAGTAAACCCACTGGTGATACCATTCGCGAGCCTCCGGATGACGACCGTAGTGATGAATCTCTCCTGGCGGGAACAG
CAAAATATCACCCGGTCGGCAAACAAATTCTCGTCCCTGATTTTTCACCACCCCCTGACCGCGAATGGTGAGATTGAGAA
TATAACCTTTCATTCCCAGCGGTCGGTCGATAAAAAAATCGAGATAACCGTTGGCCTCAATCGGCGTTAAACCCGCCACC
AGATGGGCATTAAACGAGTATCCCGGCAGCAGGGGATCATTTTGCGCTTCAGCCATACTTTTCATACTCCCGCCATTCAG
AG

Fig. 4.9b: Schematic representation of plasmid pBAD TOPO TA – bovine rhodopsin
digestion with Nde1
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Fig. 4.10a: Chimera plasmid showing Nde1 restriction sites: The following is a
manually generated sequence of N-T pR-bovine rhodopsin chimera in order to show the
Nde1 restriction site. The same color coding is followed. The purple color represents
Nde1 restriction recognition sites (CATATG). There is only one site in this sequence at
position 3869. The total size of the chimera plasmid is 5128 bp. Upon Nde1 digestion,
only one band corresponding to 5128 bp is obtained.
AAGAAACCAATTGTCCATATTGCATCAGACATTGCCGTCACTGCGTCTTTTACTGGCTCTTCTCGCTAACCAAACCGGTA
ACCCCGCTTATTAAAAGCATTCTGTAACAAAGCGGGACCAAAGCCATGACAAAAACGCGTAACAAAAGTGTCTATAATCA
CGGCAGAAAAGTCCACATTGATTATTTGCACGGCGTCACACTTTGCTATGCCATAGCATTTTTATCCATAAGATTAGCGG
ATCCTACCTGACGCTTTTTATCGCAACTCTCTACTGTTTCTCCATACCCGTTTTTTGGGCTAGAAATAATTTTGTTTAAC
TTTAAGAAGGAGATATACATACCCATGAAATTATTACTGATATTAGGTAGTGTTATTGCACTTCCTACATTTGCTGCAGG
TGGTGGTGACCTTGATGCTAGTGATCCATGGCAGTTCTCCATGCTGGCCGCCTACATGTTCCTGCTGATCATGCTTGGCT
TCCCCATCAACTTCCTCACGCTGTACGTCACAGTCCAGCACAAGAAGCTGCGCACACCCCTCAACTACATCCTGCTCAAC
CTGGCCGTGGCCGACCTCTTCATGGTCTTCGGGGGCTTCACCACCACCCTCTACACCTCTCTGCACGGGTACTTCGTCTT
TGGGCCCACGGGCTGCAACCTGGAGGGCTTCTTTGCCACCTTGGGCGGTGAAATTGCACTGTGGTCCTTGGTGGTCCTGG
CCATCGAGCGGTACGTGGTGGTGTGCAAGCCCATGAGCAACTTCCGCTTCGGGGAGAACCACGCCATCATGGGCGTCGCC
TTCACCTGGGTCATGGCTCTGGCCTGTGCCGCGCCCCCCCTCGTCGGCTGGTCCAGGTACATCCCGGAGGGCATGCAGTG
CTCGTGCGGGATTGACTACTACACGCCCCACGAGGAGACCAACAATGAGTCGTTCGTCATCTACATGTTCGTGGTCCACT
TCATCATCCCCCTGATTGTCATATTCTTCTGCTACGGGCAGCTGGTGTTCACCGTCAAGGAGGCGGCTGCCCAGCAGCAG
GAGTCGGCCACCACTCAGAAGGCCGAGAAGGAGGTCACCCGCATGGTGATCATCATGGTCATCGCTTTCCTAATCTGCTG
GCTGCCCTACGCTGGGGTGGCGTTCTACATCTTCACCCATCAGGGCTCTGACTTTGGCCCCATCTTCATGACCATCCCGG
CTTTCTTTGCCAAGACTTCTGCCGTCTACAACCCCGTCATCTACATCATGATGAACAAGCAGTTCCGGAACTGCATGGTC
ACCACTCTCTGCTGTGGCAAGAACCCGCTGGGTGACGACGAGGCCTCCACCACCGTCTCCAAGACAGAGACCAGCCAAGT
GGCGCCTGCCTAAtcgataagcttaattAAGGGCGAGCTTGAAGGTAAGCCTATCCCTAACCCTCTCCTCGGTCTCGATT
CTACGCGTACCGGTCATCATCACCATCACCATTGAGTTTAAACGGTCTCCAGCTTGGCTGTTTTGGCGGATGAGAGAAGA
TTTTCAGCCTGATACAGATTAAATCAGAACGCAGAAGCGGTCTGATAAAACAGAATTTGCCTGGCGGCAGTAGCGCGGTG
GTCCCACCTGACCCCATGCCGAACTCAGAAGTGAAACGCCGTAGCGCCGATGGTAGTGTGGGGTCTCCCCATGCGAGAGT
AGGGAACTGCCAGGCATCAAATAAAACGAAAGGCTCAGTCGAAAGACTGGGCCTTTCGTTTTATCTGTTGTTTGTCGGTG
AACGCTCTCCTGAGTAGGACAAATCCGCCGGGAGCGGATTTGAACGTTGCGAAGCAACGGCCCGGAGGGTGGCGGGCAGG
ACGCCCGCCATAAACTGCCAGGCATCAAATTAAGCAGAAGGCCATCCTGACGGATGGCCTTTTTGCGTTTCTACAAACTC
TTTTTGTTTATTTTTCTAAATACATTCAAATATGTATCCGCTCATGAGACAATAACCCTGATAAATGCTTCAATAATATT
GAAAAAGGAAGAGTATGAGTATTCAACATTTCCGTGTCGCCCTTATTCCCTTTTTTGCGGCATTTTGCCTTCCTGTTTTT
GCTCACCCAGAAACGCTGGTGAAAGTAAAAGATGCTGAAGATCAGTTGGGTGCACGAGTGGGTTACATCGAACTGGATCT
CAACAGCGGTAAGATCCTTGAGAGTTTTCGCCCCGAAGAACGTTTTCCAATGATGAGCACTTTTAAAGTTCTGCTATGTG
GCGCGGTATTATCCCGTGTTGACGCCGGGCAAGAGCAACTCGGTCGCCGCATACACTATTCTCAGAATGACTTGGTTGAG
TACTCACCAGTCACAGAAAAGCATCTTACGGATGGCATGACAGTAAGAGAATTATGCAGTGCTGCCATAACCATGAGTGA
TAACACTGCGGCCAACTTACTTCTGACAACGATCGGAGGACCGAAGGAGCTAACCGCTTTTTTGCACAACATGGGGGATC
ATGTAACTCGCCTTGATCGTTGGGAACCGGAGCTGAATGAAGCCATACCAAACGACGAGCGTGACACCACGATGCCTGTA
GCAATGGCAACAACGTTGCGCAAACTATTAACTGGCGAACTACTTACTCTAGCTTCCCGGCAACAATTAATAGACTGGAT
GGAGGCGGATAAAGTTGCAGGACCACTTCTGCGCTCGGCCCTTCCGGCTGGCTGGTTTATTGCTGATAAATCTGGAGCCG
GTGAGCGTGGGTCTCGCGGTATCATTGCAGCACTGGGGCCAGATGGTAAGCCCTCCCGTATCGTAGTTATCTACACGACG
GGGAGTCAGGCAACTATGGATGAACGAAATAGACAGATCGCTGAGATAGGTGCCTCACTGATTAAGCATTGGTAACTGTC
AGACCAAGTTTACTCATATATACTTTAGATTGATTTAAAACTTCATTTTTAATTTAAAAGGATCTAGGTGAAGATCCTTT
TTGATAATCTCATGACCAAAATCCCTTAACGTGAGTTTTCGTTCCACTGAGCGTCAGACCCCGTAGAAAAGATCAAAGGA
TCTTCTTGAGATCCTTTTTTTCTGCGCGTAATCTGCTGCTTGCAAACAAAAAAACCACCGCTACCAGCGGTGGTTTGTTT
GCCGGATCAAGAGCTACCAACTCTTTTTCCGAAGGTAACTGGCTTCAGCAGAGCGCAGATACCAAATACTGTCCTTCTAG
TGTAGCCGTAGTTAGGCCACCACTTCAAGAACTCTGTAGCACCGCCTACATACCTCGCTCTGCTAATCCTGTTACCAGTG
GCTGCTGCCAGTGGCGATAAGTCGTGTCTTACCGGGTTGGACTCAAGACGATAGTTACCGGATAAGGCGCAGCGGTCGGG
CTGAACGGGGGGTTCGTGCACACAGCCCAGCTTGGAGCGAACGACCTACACCGAACTGAGATACCTACAGCGTGAGCTAT
GAGAAAGCGCCACGCTTCCCGAAGGGAGAAAGGCGGACAGGTATCCGGTAAGCGGCAGGGTCGGAACAGGAGAGCGCACG
AGGGAGCTTCCAGGGGGAAACGCCTGGTATCTTTATAGTCCTGTCGGGTTTCGCCACCTCTGACTTGAGCGTCGATTTTT
GTGATGCTCGTCAGGGGGGCGGAGCCTATGGAAAAACGCCAGCAACGCGGCCTTTTTACGGTTCCTGGCCTTTTGCTGGC
CTTTTGCTCACATGTTCTTTCCTGCGTTATCCCCTGATTCTGTGGATAACCGTATTACCGCCTTTGAGTGAGCTGATACC
GCTCGCCGCAGCCGAACGACCGAGCGCAGCGAGTCAGTGAGCGAGGAAGCGGAAGAGCGCCTGATGCGGTATTTTCTCCT
TACGCATCTGTGCGGTATTTCACACCGCATATGGTGCACTCTCAGTACAATCTGCTCTGATGCCGCATAGTTAAGCCAGT
ATACACTCCGCTATCGCTACGTGACTGGGTCATGGCTGCGCCCCGACACCCGCCAACACCCGCTGACGCGCCCTGACGGG
CTTGTCTGCTCCCGGCATCCGCTTACAGACAAGCTGTGACCGTCTCCGGGAGCTGCATGTGTCAGAGGTTTTCACCGTCA
TCACCGAAACGCGCGAGGCAGCAGATCAATTCGCGCGCGAAGGCGAAGCGGCATGCATAATGTGCCTGTCAAATGGACGA
AGCAGGGATTCTGCAAACCCTATGCTACTCCGTCAAGCCGTCAATTGTCTGATTCGTTACCAATTATGACAACTTGACGG
CTACATCATTCACTTTTTCTTCACAACCGGCACGGAACTCGCTCGGGCTGGCCCCGGTGCATTTTTTAAATACCCGCGAG
AAATAGAGTTGATCGTCAAAACCAACATTGCGACCGACGGTGGCGATAGGCATCCGGGTGGTGCTCAAAAGCAGCTTCGC
CTGGCTGATACGTTGGTCCTCGCGCCAGCTTAAGACGCTAATCCCTAACTGCTGGCGGAAAAGATGTGACAGACGCGACG
GCGACAAGCAAACATGCTGTGCGACGCTGGCGATATCAAAATTGCTGTCTGCCAGGTGATCGCTGATGTACTGACAAGCC
TCGCGTACCCGATTATCCATCGGTGGATGGAGCGACTCGTTAATCGCTTCCATGCGCCGCAGTAACAATTGCTCAAGCAG
ATTTATCGCCAGCAGCTCCGAATAGCGCCCTTCCCCTTGCCCGGCGTTAATGATTTGCCCAAACAGGTCGCTGAAATGCG
GCTGGTGCGCTTCATCCGGGCGAAAGAACCCCGTATTGGCAAATATTGACGGCCAGTTAAGCCATTCATGCCAGTAGGCG
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CGCGGACGAAAGTAAACCCACTGGTGATACCATTCGCGAGCCTCCGGATGACGACCGTAGTGATGAATCTCTCCTGGCGG
GAACAGCAAAATATCACCCGGTCGGCAAACAAATTCTCGTCCCTGATTTTTCACCACCCCCTGACCGCGAATGGTGAGAT
TGAGAATATAACCTTTCATTCCCAGCGGTCGGTCGATAAAAAAATCGAGATAACCGTTGGCCTCAATCGGCGTTAAACCC
GCCACCAGATGGGCATTAAACGAGTATCCCGGCAGCAGGGGATCATTTTGCGCTTCAGCCATACTTTTCATACTCCCGCC
ATTCAGAG

Fig. 4.10b: Schematic representation of plasmid pBAD TOPO TA N-T pR-bovine
rhodopsin chimera digestion with Nde1 restriciton enzyme
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Fig. 4.11: Agarose gel analysis of Nde1 digested plasmids: plasmid pBAD
TOPO TA-bovine rhodopsin and pBAD TOPO TA N-T pR-bovine rhodopsin
were digested with restriction enzyme Nde1 at 37˚C for 1 hour. The digested
product was loaded on 0.8% agarose gel and run against undigested control
plasmids. Lane 1 contains undigested bovine rhodopsin plasmid; lane 2 contains
digested bovine rhodopsin plasmid, lane 3 has digested chimera plasmid and lane
4 shows undigested chimera plasmid. Lane 5 was loaded with 1 kb ladder (NEB).
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Fig. 4.12: Sequence result of chimera plasmid pBAD TOPO TA N-T pR-Bovine
rhodopsin chimera: a) The following is a result obtained from sequencing of the
chimera plasmid (SUNY Upstate DNA Sequencing Facility). The underlined portion is
the sequence of pR included in the primers, the bold red region corresponds to the
sequence of bovine rhodopsin present in the primers.
GACGCTTTTNATCGAAACTCTCTACTGTTTCTCCATACCCGTTTTTTGGGCTAGAAATAATTTTGTTTAACTTTAAGAAG
GAGATATACATACCCATGAAATTATTACTGATATTAGGTAGTGTTATTGCACTTCCTACATTTGCTGCAGGTGGTGGTGA
CCTTGATGCTAGTGATCCATGGCAGTTCTCCATGCTGGCCGCCTACATGTTCCTGCTGATCATGCTTGGCTTCCCCATCA
ACTTCCTCACGCTGTACGTCACAGTCCAGCACAAGAAGCTGCGCACACCCCTCAACTACATCCTGCTCAACCTGGCCGTG
GCCGACCTCTTCATGGTCTTCGGGGGCTTCACCACCACCCTCTACACCTCTCTGCACGGATACTTCGTCTTTGGGCCCAC
GGGCTGCAACCTGGAGGGCTTCTTTGCCACCCTGGGCGGTGAAATTGCACTGTGGTCCTTGGTGGTCCTGGCCATCGAGC
GGTACGTGGTGGTGTGCAAGCCCATGAGCAACTTCCGCTTCGGGGAGAACCACGCCATCATGGGCGTCGCCTTCACCTGG
GTCATGGCTCTGGCCTGTGCCGCGCCCCCCCTCGTCGGCTGGTCCAGGTACATCCCGGAGGGCATGCAGTGCTCGTGCGG
GATTGACTACTANACGCCCCACGAGGAGACCAACAATGAGTCGTTCGTCATCTACATGTTCGTGGTCCACTTCATCATCC
CCCTGATTGTCATATTCTTCTGCTACGGGCAGCTGGTGTTCACCGTCAAGGAGGCGGCTGCCCAGCAGCAGGAGTCGGCC
ACCACTCAGAAGGCCGAGAAGGAGGTCACCCGCATGGTGATCATCATGGTCATCGCTTTCCCTAATCTGCTGGCTGCCCT
ACGCTGGGGTGGNGGTTCTACATCTTCACCCATCAGGGGCTCTGAANTTTGGNCCCATCTTCATGACCATCCCCGGCTTT
CTTTGCCAAGANTTCTGCCGTCTACAACCCCGTCATCTANATCATGATGAAAAAGCAGTTCNGGAACTGCATGGTCACCA
CTCTCTGCTGNGGNAAAAACCCNCTGGGGGANAACAAGNCCCTCCCCCACCGTNTCCAAAANAAAAACCAGCCAAGNGGG
CCTGCCTANNGAAAAGCTAAANAAGGGNAGNNTGAAGGAANGCTATCCCTNACCCNNTCTCGGTCCCNATTNACCGGAAC
GGTANNATCNCATCCNTTGNGTTNANNGGCNCNACNTGCNTGTTTGGGANAAANAAATTTCCCCCGAANNAATAANNNAA
CNNAAGGGNTGNAAANAAATTGCTGGGGGANANGNGGGGGCCCCNTACCCTGCCAANCAAAAAAACCCNANCCAAGGGGG

4.3.2

Attempt at heterologous expression of chimera protein in E. coli
The plasmid pBAD TOPO TA containing pR-Bovine opsin chimera was

transfected into E. coli UT5600 cells. These cells are protease-deficient which allows for
efficient expression of foreign protein. Three transfected colonies were picked, and
grown in LB medium supplemented with ampicillin (50 µg/ml). The culture was grown
to OD600 of about 1. It was then induced with L-arabinose (0.2%) and retinal (a mix of
photoisomers of all-trans and 11-cis retinal) was added in order to produce a fully
functional protein covalently bound to its chromophore.

The 11-cis retinylidene Schiff base chromophore of bovine rhodopsin absorbs at a
λmax= 500 nm and therefore, cells expressing properly-folded rhodopsin should appear
orangish-red. A slightly brown coloration of the cells was seen. An attempt was made to
isolate the protein by lysing the cells. A UV-vis spectrum of the extract revealed a strong
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absorbance at 280 nm. The characteristic absorbance of retinal bound bovine rhodopsin at
500 nm was not clearly visible.

4.4

Follow-up Experiments

4.4.1

To detect the expression of chimera protein
Expression of chimera protein can be assessed by Western blot using just a

fragment of the proteorhodopsin.

4.4.2

To detect the location of chimera protein
Western blot only indicates that the expression of a mammalian rhodopsin, bovine

rhodopsin. It does not necessarily demonstrate that the protein is translocated and inserted
into the membrane. Several techniques can be utilized to investigate whether the chimera
protein is integrated into the membrane.

Differential centrifugation: It is first of all important to know that the protein
fractionates with the bacterial inner membrane fraction. To that end, the crude cellular
extract will be subjected to a technique known as differential centrifugation that includes
use of high speed centrifugal force. For this purpose, the cells expressing chimera protein
and bovine rhodopsin (control) will first need to be disrupted. This can be done by
various methods such as liquid shear pressure (French press), ultrasonication, osmotic
shock, glass bead milling, Freeze-thaw, and enzymatic lysis (lysozyme). Cell disruption
yields a suspension of plasma membrane/vesicles/microsomes, cell debris, intact cells,
nuclei, soluble proteins and cell organelles. This suspension will be subjected to
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differential centrifugation where it is first centrifuged at a lower speed (10,000 × g) to
remove the cell debris, nuclei and intact cells. The supernatant will be centrifuged at a
higher speed (20,000 × g) to remove other contaminants. The supernatant fraction
resulting from this speed will finally be subjected to ultracentrifuge, that is, at very high
speeds such as 150,000 × g. The pellet obtained would contain the membrane fraction
including microsomes (endoplasmic reticulum vesicles). Various fractions of
supernatants and pellets will be loaded on SDS-PAGE and the chimera protein (or bovine
rhodopsin) will be detected by Western blot. The protein bands would show up in the
lower speed supernatant (possibly pellet too due to the unbroken cells), and in the
supernatant of the medium speed (20, 000 × g). The most intense band would be expected
to show up in the high-speed (ultracentrifuge) pellet. In order to ascertain the identity of
the membrane fraction, a marker enzyme that is plasma-membrane specific can be
detected.

Sucrose gradient: An alternative or additional method to differential
centrifugation is density gradient centrifugation. The medium speed pellet from above
will be layered on top of a sucrose gradient and centrifuged at high speed. The membrane
pellet will settle in the gradient at a point where its density matches that of the sucrose
density. The detection of the protein will be done similarly as mentioned above.

GFP- or immunolocalization: In addition to membrane fractionation, cellular
localization of the pR can be determined with some direct microscopy methods. For
example, green fluorescent protein (GFP) can be tagged at C-terminal end and the cells
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can be observed under a fluorescence microscope. Another similar technique known as
immunoflourescence can also be employed which utilizes an antibody designed against
the protein (or the polyHis tag) that is chemically linked to a fluorophore. The
fluorophore can be visualized under a fluorescence microscope.

4.4.3

Purification of chimera protein with citrate
Despite the absence of a significant similarity in the sequence of pR and bovine

rhodopsin, a close examination of the first intracellular loop of both the proteins shows
that they are somewhat similar. They both contain positively charged amino acid
residues, lysine and arginine. Citrate interacts with pR at the positively charged residues
found in the first intracellular loop (chapter 2). Therefore, citrate can be used for the
purification of chimera protein. For the first trial, same protocol as used for pR
purification will be attempted. The concentration and pH can be altered if needed.

Combination of phosphate and citrate will also be used to purify the chimera. The
purification process will be monitored by UV-vis spectra as well as SDS-PAGE. The
percent yield and purity will be calculated from the λmax absorption.
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4.5

Future Experiments
If the follow-up experiments fail to show expression of the chimera protein, some

of the following modifications can be attempted, not necessarily in that order.
4.5.1

Modification of expression experiments
Preliminary screening: Several different strains of E. coli will be screened to

transfect the chimera protein. After growing the best E. coli cells containing chimera
protein N-T pR-bovine rhodopsin to OD600=1, several different temperatures such as
15°C, 22°C, and 37°C, will be tried for inducing the protein. Freshly made solution of
11-cis retinal (in acetone) will be added to aid the formation of a holoprotein.

4.5.2 Modification of cell wall lysis
The extraction buffer used for cell lysis will be buffered at several different pH
units to keep the protein stable. Several different detergents can also be screened to
improve the lysis of the cells and also to solubilize the chimera protein into the detergent.

4.5.3

Alteration in the size of the leader sequence
If the protein is not inserted into the membrane, then the length of N-T pR

sequence will be increased to assure the membrane incorporation of the chimera.

4.5.4

Stabilization of membrane proteins by Genetic Engineering
It has been shown that some point mutations, individual or in combination, have a

dramatic effect on the thermostability of the membrane proteins. For example, a random
mutagenesis on E. coli diacylglycerol kinase (DGK) yielded 12 thermostabilising
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mutations [11]. Later the same group showed that similar stability was conferred upon
bacteriorhodopsin (BR) by using mutations [12]. This method was also applied to the
GPCRs such as turkey β1-adrenergic receptor (β1AR) [13], adenosine A2a receptor (A2a
R) [14], and the neurotensin receptor (NTR) [15]. Thermostability was also found to
improve the solubility of proteins in the detergents that are otherwise not suitable for the
protein. Random mutagenesis will be performed on the chimera protein and a stable
temperature will be found. The stability of the protein can be assayed using UV-vis
spectrophotometry as bovine rhodopsin shows maximum absorption at 500 nm.

4.6

Conclusions
This study will need further examination to make a definitive conclusion. A

higher level of expression, proper native folding as judged by its characteristic absorption
maximum, and confirmed cellular localization of the chimera protein will be the primary
prerequisites. The purification of the chimera can then be attempted using the wellestablished protocol using citrate method of purification. Assuming the expression,
isolation and purification of chimera follow the steps of pR purification, this study can be
extended toward the heterologous expression of pharmaceutically important membrane
proteins in E. coli. If the N-terminal portion of pR can significantly improve the
expression of GPCRs in bacteria such as E. coli, then it will not only facilitate in
increasing the amount of protein in a shorter time but also help in the expression of
proteins that are difficult to express. This will eventually aid in providing large amounts
of proteins required for structural studies and thereby, understanding the structure of the
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GPCRs and their ligand binding sites. A well-resolved ligand-binding site of a receptor
will benefit in designing ligand-site specific drugs.
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Appendix
2.9

UV-visible spectra of pR

Fig. 2.9.1: UV-vis absorbance spectra of pR at different stages of purification: Cells
containing pR TCM- were subjected to lysis using lysis buffer as described in materials
and methods of chapter 2. The lysate was treated with 100 mM citrate buffer, pH 5.5. The
precipitate was redissolved in 50 mM Tris buffer, also containing 3% OG, pH 9. The
figure shows four such rounds. Curve A shows an A280 nm/520 nm ratio of 6.5; curve B
shows a ratio of 4.8, curve B shows a ratio of 5.5; curve C shows 4.8 and curve D shows
3.25. Such partially purified pR samples were used for testing pR precipitation with
several anions.

Fig. 2.9.2: Absorption maximum varies for acidic and basic pR species:
Proteorhodopsin TCM without the poly-His tag (on the left) and with the tag (on the
right) were partially purified with citrate buffer, as described in Chapter 3. Aliquots of the
sample were treated with universal buffer adjusted to different pH. All the samples were
in 3% OG. UV-vis spectra were recorded. The pR sample in more acidic buffers exhibits
an absorption maximum near 540 nm whereas the sample buffered at alkaline pH shows
λmax near 520 nm.
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Fig. 2.9.3: UV-vis spectra of pR TCM- mutants: Quadruple mutant
(R51Q/R53Q/K57Q/K59Q) was purified by loading the cell lysate on the hydroxyapatite
column while the other mutants were partially purified using citrate as described in text.
Curve A represents double mutant K125Q/K126Q, curve B represents single mutant
K172, curve C is that of quadruple mutant, curve D shows spectrum of single mutant
R51Q, and curve E shows the spectrum of single mutant K244Q.
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2.10

Western Blot of pR expressed in E. coli

Fig. 2.10: Western Blot of pR expressed in E. coli: UT5600 E. coli cells transfected
with plasmid pBAD TOPO TA containing pR TCM with, and without the polyHis-tag
were induced with 0.2% L-arabinose and 5 µM retinal was added. The Cultures were left
at 16ºC overnight under shaking conditions, 200 rpm. Cells were harvested and lysed
using the lysis buffer described in chapter 2. Whole cell extract was precipitated with
equal volume of 50% TCA. The resulting waxy pellet was washed with water and then
treated with 50:50 mixture of chloroform:methanol. After drying it overnight in
SpeedvacR, SDS-PAGE loading buffer was added and the samples were loaded on 4-12%
gradient gel. The proteins were Western blotted on the nitrocellulose membrane, blocked
with 5% milk prepared in Tris-buffered saline with Tween (TBST) and incubated with
anti-His Antibody conjugated to horseradish peroxidase (HRP) overnight at 4ºC. The blot
was washed 8 times with 10-15 mL TBST for 15 minutes/wash. It was then treated with
Chemiluminescent reagents (Pierce) and the signal was detected with BioRad gel
documentation system. To visualize the molecular weight markers, the blot was
incubated with Ponceau stain and detected similarly. Molecular weight marker, lane M, is
Novex® Sharp Protein Standard, Invitrogen. Lane 3 is pR TCM without His-tag, and lane
2 is pR TCM with His6-tag.
Acknowledgements for Fig 2.9: Anti-His antibody conjugated to HRP was kindly provided by Dr. Robert
Doyle. SDS-PAGE gradient gel, Western blotting unit, molecular weight marker, chemiluminescent
reagents and the BioRAd gel documentation system were generously provided by Dr. Michael Cosgrove. I
thank both of them along with Brian Huta (helped me use Dr. Doyle’s Western blotting unit, unfortunately
the results were or poor quality), Valerie Vought, Dr. Anamika Patel and Melody Sanders (for their help
with the above blot).
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2.11

Flash Spectroscopy data
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Fig. 2.11: Flash photolysis: Flash-induced transient absorbance changes in pRcontaining DOPC liposomes (buffered at pH 8.5) show the decay of the M intermediate.
These data were obtained from samples containing increasing amounts of citrate, as
labeled. In part A, the measured absorbance data were fit to a first-order kinetic equation,
A400(t)= B + A0 e-kt, by using the solver function in Excel, optimizing the values of B, A0
and k. The fitted exponential curve is superimposed on the measured transient absorbance
at 420 nm. The residual trace (lightly-dotted line at x = zero) demonstrates the quality of
the fit. Part B shows a log plot of absorbance against time. This plot yielded a straight
line signifying a first-order exponential decay of the M intermediate. The decay constant,
k, calculated from the slope of this curve matches that obtained from the non-linear leastsquares optimization. (In B, and for the exponential fitting procedure in A, all digitized
points up to the commencement of the M decay phase, corresponding to a total of ~8 ms
of time, were omitted in order to allow the approximation of a single-exponential
process.)

2.12

pR-citrate aggregation

Based on the lack of interaction with R51 (as measured by results with the single site
mutant R51Q), and the possible involvement of R53 (as measured by the insensitivity to
citrate of multi-site mutations involving this residue, as well as the inability of the single
site mutant R53Q to fold properly), the phenomenon of citrate-induced pR aggregation is
thus best explained by considering a homology model of three molecules of pR and two
molecules of citrate (Fig. 2.12). The three pR molecules can be bridged by two citrate
molecules, via salt bridges to both lysines and one arginine of the first intracellular loop
of pR (Fig. 2.12). For example, an arginine (R53) of one pR (purple) can H-bond to one
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carboxylate group of a citrate, while the two other carboxylate groups of the same citrate
can be H-bonded to the lysines (K57 and K59) of a neighboring pR (green). This model
indicates how multivalent citrate anions might bind to multiple pR molecules
simultaneously, and thus lead to citrate-induced aggregation of pR.

Fig. 2.12: Model of pR-citrate aggregation: a. Three molecules of pR, shown in purple,
green and red, are bridged by citrate molecules, shown in pink and red, interacting via
53
salt bridges to lysines and arginines of loop IC1 on each pR (blue). For example, Arg
of one pR (purple) is H-bonded to one carboxylate group of a citrate. The two other
carboxylate groups of the same citrate are H-bonded to the lysines (Lys57 and Lys59) of a
neighboring pR (green). This model indicates how multivalent citrate anions might bind
to multiple pR molecules simultaneously, and thus to lead to citrate-induced aggregation
of pR, b. Magnified image of the pR-citrate interactions.

The references to the construction of homology model and its manipulation are described
in Chapter 2.
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2.13

Interaction of pR with diverse ions

2.13.1 Precipitation of pR by Lithium salts
Citrate buffer and buffers of other diverse anions were prepared with lithium as
the counter-ion, and the pR precipitation was examined.
Preparation of 250 mM citrate-LiOH buffer, with 10 mM Tris-Cl, pH 7.5
250 mM citric acid was dissolved in minimum amount of dH2O. Tris-Cl buffered
at pH 7.5 was added to a final concentration of 10 mM. This solution was then
titrated with 1 M LiOH solution to attain pH 7.5.

Table 2.13.1: Determination of OG concentration at which pR exhibits the
broadest range of precipitation with citrate buffer with lithium as the
counterion, buffered at pH 7.5, also containing 10 mM Tris-Cl, pH 7.5
Conc. Of
OG

0.5% 0.6% 0.7% 0.8%

0.9% 1.0%

Conc. Of
citrate
buffer
5 mM
++
++
+
10 mM
++
++
++
+
50 mM
++
++
++
100 mM
++
++
+
150 mM
 ++ depicts complete precipitation of pR with no color in the
supernatant, + depicts about 50% precipitation, and – shows no
precipitation with all the color in the supernatant.
Conclusion: 0.7% OG was chosen for the examination of precipitation of pR by
other Lithium salts.
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2.13.2 Preparation of buffers of Lithium salts
The following buffers of Lithium were prepared to test the effect of Lithium on
the precipitation of pR:
1. LiCl in 10 mM Tris-Cl, pH 7.5
2. Li2SO4 in 10 mM Tris-Cl, pH 7.5
3. Lithium acetate in 10 mM Tris-Cl, pH 7.5
4. Phosphate buffer with 10 mM Tris-Cl, titrated with 1M LiOH to pH 7.5
(prepared with phosphoric acid) – Higher concentration could not be
prepared as Li-phosphate precipitated, only 100 mM was made.
5. Glutamate with 10 mM Tris-Cl, titrated with 1M LiOH to pH 7.5
(prepared with glutamic acid)
6. Aspartate with10 mM Tris-Cl, titrated with 1M LiOH to pH 7.5 (prepared
with aspartic acid)
7. Succinate with 10 mM Tris-Cl, titrated with 1M LiOH to pH 7.5 (prepared
with succinic acid)
8. Cis-aconitate with with 10 mM Tris-Cl, titrated with 1M LiOH to pH 7.5
(prepared with cis-aconitic acid)

Note: Other lithium salts with anions such as isocitrate, ATP, ADP, and G6P
could not be prepared in similar fashion because these are available only as salts of
sodium, rather than as free acids.
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Table 2.13.2: Determination of concentration of Lithium salts required to
induce pR precipitation at 0.7% OG
Buffer
with 10
mM
Tris-Cl,
pH 7.5
LiCl

10
mM

-

20
mM

-

30 mM

40 mM

+
(<50%)
++
-

+ (90%)

50 mM

++

100 mM

150 mM

++

++

Li2SO4
++
++
++
++
+
Lithium
ND
- (<5%)
+ (50%)
+ (90%)
++
acetate
Lithium
++
++
++
++
++ (85
ND
phospha
mM)
te
Lithium
ND
+
++
+ (90%)
+ (90%) + (90%)
glutamat
(60%)
e
Lithium
ND
+
++
++
++
+ (50%)
aspartate
(60%)
ND
++
++
++
++
+ (90%)
Lithium
succinat
e
Lithium
+
ND
ND
ND
++
++
cis(50%)
aconitat
e
• ++ indicates complete precipitation of pR with no color in the supernatant,
+ indicates approximately about 50%-90% precipitation, and – indicates
no precipitation retaining all the color in the supernatant
• ND means “not determined”

Conclusion: Diverse anions with lithium as the counter-ion tend to precipitate pR.
However, they do so at a lower concentration of OG than that shown by the respective
sodium salts.
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•

2.13.3 Precipitation of pR by potassium salts

Table 2.13.3: Determination of pR precipitation by salts of Potassium: Anions were
buffered to pH 7.5, also contained 10 mM Tris-Cl at pH 7.5, and a sodium counterion.
The concentration of OG is maintained at a constant 1%.

Anion tested

Acetate (potassium)
Phosphate
(potassium)
Chloride (potassium)

pR precipitation
(Min.
concentration,
mM)
ND
40 (++)

Physiologically
- indexed
concentration

Physiological
concentration
(mM)14, 15, 25, 30

N/A
7.530

N/A
5.3

•

50 (++) ND at 100
555.5
0.09
mM
++ indicates complete precipitation of pR, + indicates partial precipitation leaving
significant color in the supernatant, - indicates lack of precipitation with all the
color in the supernatant.
The references for concentrations for physiologically important anions available
are labeled as superscripts. Concentration of phosphate is from Streptococcus
bovis [30] and concentration of chloride is from marine bacteria Pseudomonad
[25]. All others are from E. coli. (References refer to Chapter 2)
N/A refers to data Not Available.

•

2.13.4 Precipitation with bromide as the anion

•

•

The aim was to determine if the effect of chloride in the process of pR precipitation could
be minimized. Since bromide is placed towards the right side of chloride in the
Hofmeister series of anions, it is expected to show less salting-out effect. A buffer of 10
mM Tris was pH adjusted with HBr to pH 7.5, to test the precipitation of pR.
Additionally, since all the anions are the sodium salts, it was necessary to examine if
sodium bromide by itself or buffered with Tris-Br would induce pR precipitation. Tris-Br
buffer or NaBr buffer/solution were prepared as follows:
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Tris-Br buffer, pH 7.5: 220 mM Tris was dissolved in minimum dH2O. It
was titrated with HBr (conc.) to attain a pH of 7.5
NaBr solution: 200 mM NaBr was prepared with dH2O
NaBr buffered with Tris-Br: Tris-Br buffer was added to the reaction
tubes to a final concentration of 10 mM followed by addition of NaBr to
the required concentration. This ensured a constant concentration of the
Tris-Br buffer.

Table 2.13.4: Determination of pR precipitation with Bromide at pH 7.5
and at 1% OG
Precipitant tested:
10 mM 50 mM 100 mM 150 mM
Buffer/solution
Tris-Br
+
+
+
NaBr solution
++
++
NaBr buffered with Tris-Br
+
+
+
• ++ indicates complete precipitation of pR, + indicates partial precipitation
leaving significant color in the supernatant, - indicates lack of precipitation
with all the color in the supernatant.

3.8

Purity of pR can be predicted by the A280/520 ratio
There is an inverse relationship between A280/520 ratio and the purity of

proteorhodopsin. As the purity of pR increases, the ratio decreases: the sample contains
less impurities and more pR leading to higher A520 absorption for the same A280 value.
The contribution of pR toward A280 also increases with purification. Fig. 3.8 shows a plot
of purity (%) of pR against the A280/520 ratio. The calculation of purity was performed
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using equation 1 (Table 3.5) and the values of ratio were ranged from 2-32. Ratio of 2
corresponds to the maximum theoretical purity of pR obtained in our lab [1].

Fig. 3.8: Dependence of purity on A280/520 ratio: Purity (%) is plotted against A280/520
ratio. The values of ratio are obtained from Table 3.4, the purity (%) values are obtained
from equation 1. For comparison purposes, A280/520 ratio of 2, a theoretical ratio that has
been obtained for pure pR in our lab [1] is also included. It corresponds to a100% purity.
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Table 3.8: Derivation of equation
Plot of % purity against A280/520 ratio
Assume A280
Assume A520
Theoretical ratio A280/520 for pure pR
A280 due to contaminant proteins
mg/ml contaminant proteins (A280 = 1 =
1mg/ml
mg/ml of pR (A520/50000*30000)***
total protein contaminants + pR)
therefore, total protein (contaminants + pR)
%purity of pR in total protein

R
1
2
= R-2
= R-2
0.6
(R-2) + 0.6
=R-1.4
(0.6/R-1.4)*100
= 60/R-1.4
where R denotes
Ratio A280/520
R [Ratio(A280/520)]

Theoretical value for pure pR
D
C
B
A

2
2.8
3.3333
6.3636
26.66

Equation 1
% purity
100
42.85714
31.03502
12.088
2.375297

*** Molar extinction coefficient = 50,000 M-1 cm-1
Molecular weight of pR = 30,000 mg/mL (or g/L).

3.9

N-terminal sequencing results
Purification of pR with citrate or with a combination of citrate and phosphate

yields some contaminants. A band corresponding to 30,000 Da from an SDS-PAGE of
pR purification was excised and N-terminal sequencing was carried out using Edman
degradation (Iowa State University Protein Facility). The result showed the following
sequence:
V/A, D/N, F/L, H/M, Q, Y, A, R, S?/Q?, I?
The detailed N-terminal peptide sequence report is attached at the end of this
subsection 3.9.4. The most likely sequence was suggested to be VDFLHQYARSI (See
detailed results). This sequence was subjected to BLASTp [2] to identify the protein from
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the database. The sequence alignment yielded numerous hits, mainly including
maltoporins. Since pR is expressed in E. coli (Strain UT5600), interest was concentrated
on E. coli hits (Table 3.9.1). It was found that the sequence matched (90%) to the LamB
protein of E. coli as shown below.

VDFHQYARS ---N-terminal sequence result
VDFH YARS ---showing the match
VDFHGYARS ---E. coli maltoporin sequence from BLAST

The protein sequence of lamB is shown in Fig. 3.9.1., and the details
corresponding to this protein, such as, the protein accession number, the authors and
publication of this sequence, are provided in Fig. 3.9.2. LamB is expressed with an Nterminal leader sequence that is cleaved off during the translocation into the membrane.
The sequence of the entire protein containing the leader sequence is shown in Fig. 3.9.3.

LamB protein is a specific type of porin called maltoporin. Porins are a class of
proteins that belong to β-barrel proteins. Maltoporins are therefore β-barrel proteins that
are found in the outer membrane of gram negative bacteria including E. coli. They are
homo-trimers that form water-filled channels that allow passive diffusion of small
molecules (<600 Da) [3]. Specifically, LamB is part of the maltose regulon that encodes
proteins required for uptake and metabolism of maltose and other linear maltodextrins [3,
4].

The relative molecular weight (Mr) is 142 kDa. However, it appears as a band at
~95 kDa on SDS-PAGE that has been suggested to possess a compact or folded form.
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Similarly, the compact monomer has been found to run at ~35-37 kDa, depending upon
the concentration of acrylamide in the SDS-PAGE [4]. About 80% folded trimer appears
at ~66 kDa, and denatured monomer runs at 45 kDa [4].

Based on above information, it appears that the majority of the contaminants in
pR preparation arise from the presence of LamB maltoporin. Since maltoporins are
residents of outer membrane of E. coli, it can be speculated that removal of the outer
membrane during pR purification would eliminate maltoporin contamination. This would
yield a fairly pure protein with a purity of >90% using a combination of citrate and
phosphate as described in the text.

In order to remove the outer membrane of E. coli, penicillin or lysozyme can be
used in the presence of EDTA while also maintaining iso-osmotic conditions by using
sucrose. Isolation of resulting spheroplasts (cells lacking outer membrane) can be done
using centrifugation at higher speeds.
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Table 3.9.1: BLAST hits from alignment of N-terminal sequence result against
reference sequence database: The result obtained from N-terminal sequencing was
BLASTed against the protein database of reference sequences using BLASTp
algorithm. The results containing E. coli hits were selected
E
Max Total Query
Links
Accession
Description
score score coverage value
ZP_07185557.1

LamB porin [Escherichia coli MS 69-1]
>ref|ZP_08356844.1| maltoporin (Maltose26.9
inducible porin) (Lambda receptorprotein)
[Escherichia coli M718]

26.9

90%

17

ZP_06660163.1

maltoporin [Escherichia coli B185]

26.9

26.9

90%

17

YP_002405410.1 maltoporin [Escherichia coli 55989]

26.9

26.9

90%

17

YP_002295602.1 maltoporin [Escherichia coli SE11]

26.9

26.9

90%

17

ZP_02903949.1

maltose-inducible porin [Escherichia
albertii TW07627]

26.9

26.9

90%

17

NP_290670.1

maltoporin [Escherichia coli O157:H7
EDL933] >ref|NP_313046.1| maltoporin
[Escherichia coli O157:H7 str. Sakai]
>ref|ZP_02775854.1| maltose-inducible
porin [Escherichia coli O157:H7 str.
EC4113] >ref|ZP_02780195.1| maltoseinducible porin [Escherichia coli O157:H7
str. EC4401] >ref|ZP_02799382.2| maltoseinducible porin [Escherichia coli O157:H7
str. EC4196] >ref|ZP_02805437.2| maltoseinducible porin [Escherichia coli O157:H7
str. EC4076] >ref|ZP_02791285.2| maltoseinducible porin [Escherichia coli O157:H7
str. EC4486] >ref|ZP_02785890.2| maltoseinducible porin [Escherichia coli O157:H7
str. EC4501] >ref|ZP_02809640.2| maltoseinducible porin [Escherichia coli O157:H7
str. EC869] >ref|ZP_02823327.2| maltoseinducible porin [Escherichia coli O157:H7 26.9
str. EC508] >ref|ZP_03081185.1|
maltoporin [Escherichia coli O157:H7 str.
EC4024] >ref|ZP_03250829.1| maltoseinducible porin [Escherichia coli O157:H7
str. EC4206] >ref|ZP_03255079.1| maltoseinducible porin [Escherichia coli O157:H7
str. EC4045] >ref|ZP_03261262.1| maltoseinducible porin [Escherichia coli O157:H7
str. EC4042] >ref|YP_002273557.1|
maltose-inducible porin [Escherichia coli
O157:H7 str. EC4115]
>ref|ZP_03441540.1| maltose-inducible
porin [Escherichia coli O157:H7 str.
TW14588] >ref|YP_003080875.1|
maltoporin [Escherichia coli O157:H7 str.
TW14359] >ref|YP_003502271.1|
maltoporin precursor [Escherichia coli
O55:H7 str. CB9615]

26.9

90%

17
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NP_756858.1

maltoporin [Escherichia coli CFT073]
>ref|YP_543545.1| maltoporin [Escherichia
coli UTI89] >ref|YP_859628.1| maltoporin
[Escherichia coli APEC O1]
>ref|YP_002331805.1| maltoporin
[Escherichia coli O127:H6 str. E2348/69]
>ref|YP_002394020.1| maltoporin
[Escherichia coli S88]
>ref|YP_002400534.1| maltoporin
[Escherichia coli ED1a]
>ref|ZP_04004763.1| maltoporin
[Escherichia coli 83972]
>ref|ZP_04534075.1| maltoporin
26.9
[Escherichia sp. 3_2_53FAA]
>ref|ZP_07180104.1| LamB porin
[Escherichia coli MS 45-1]
>ref|ZP_07194092.1| LamB porin
[Escherichia coli MS 185-1]
>ref|ZP_07449995.1| maltoporin
[Escherichia coli NC101]
>ref|ZP_08350973.1| maltoporin (Maltoseinducible porin) [Escherichia coli M605]
>ref|ZP_08361536.1| maltoporin (Maltoseinducible porin) [Escherichia coli TA206]
>ref|ZP_08386364.1| maltoporin (Maltoseinducible porin) [Escherichia coli H299]

26.9

90%

17

ZP_03000669.1

maltose-inducible porin [Escherichia coli
53638] >ref|ZP_07133992.1| LamB porin
[Escherichia coli MS 115-1]

26.9

26.9

90%

17

maltoporin [Escherichia coli SMS-3-5]
>ref|ZP_03048831.1| maltose-inducible
porin [Escherichia coli E110019]
>ref|YP_002410330.1| maltoporin
[Escherichia coli IAI39]
>ref|ZP_06651609.1| conserved
YP_001746426.1
26.9
hypothetical protein [Escherichia coli
B354] >ref|ZP_07152941.1| LamB porin
[Escherichia coli MS 21-1]
>ref|ZP_08366600.1| maltoporin (Maltoseinducible porin) (Lambda receptorprotein)
[Escherichia coli TA143]

26.9

90%

17

YP_672105.1

maltoporin [Escherichia coli 536]
>ref|ZP_03033493.1| maltose-inducible
porin [Escherichia coli F11]
>ref|ZP_07175041.1| LamB porin
[Escherichia coli MS 200-1]

26.9

26.9

90%

17

ZP_03044172.1

maltose-inducible porin [Escherichia coli
E22] >ref|ZP_03059296.1| maltoseinducible porin [Escherichia coli B171]
26.9
>ref|YP_003224609.1| maltose outer
membrane porin [Escherichia coli O103:H2
str. 12009]

26.9

90%

17

YP_312948.1

maltoporin [Shigella sonnei Ss046]
>ref|YP_691468.1| maltoporin [Shigella

26.9

90%

17

26.9
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flexneri 5 str. 8401] >ref|YP_001465537.1|
maltoporin [Escherichia coli E24377A]
>ref|YP_001460823.1| maltoporin
[Escherichia coli HS]
>ref|YP_001726919.1| maltoporin
[Escherichia coli ATCC 8739]
>ref|ZP_03029272.1| maltose-inducible
porin [Escherichia coli B7A]
>ref|YP_002389506.1| maltoporin
[Escherichia coli IAI1]
>ref|YP_002415177.1| maltoporin
[Escherichia coli UMN026]
>ref|YP_003232038.1| maltose outer
membrane porin [Escherichia coli O26:H11
str. 11368] >ref|YP_003237152.1| maltose
outer membrane porin [Escherichia coli
O111:H- str. 11128] >ref|ZP_06646772.1|
lamB [Escherichia coli FVEC1412]
>ref|ZP_06664749.1| maltoporin
[Escherichia coli B088]
>ref|ZP_06988088.1| maltoporin
[Escherichia coli FVEC1302]
>ref|ZP_07098165.1| LamB porin
[Escherichia coli MS 107-1]
>ref|ZP_07103702.1| LamB porin
[Escherichia coli MS 119-7]
>ref|ZP_07118062.1| LamB porin
[Escherichia coli MS 198-1]
>ref|ZP_07124042.1| LamB porin
[Escherichia coli MS 84-1]
>ref|ZP_07140275.1| LamB porin
[Escherichia coli MS 182-1]
>ref|ZP_07208840.1| LamB porin
[Escherichia coli MS 124-1]
>ref|ZP_07223201.1| LamB porin
[Escherichia coli MS 78-1]
>ref|ZP_07591760.1| porin LamB type
[Escherichia coli W] >ref|ZP_07690255.1|
LamB porin [Escherichia coli MS 145-7]
>ref|ZP_07788346.1| maltoporin
[Escherichia coli 1827-70]
>ref|ZP_08371730.1| maltoporin (Maltoseinducible porin) [Escherichia coli TA271]
>ref|ZP_08380822.1| maltoporin (Maltoseinducible porin) [Escherichia coli H591]
>ref|ZP_08393167.1| phage lambda
receptor protein [Shigella sp. D9]

NP_418460.1

maltose outer membrane porin (maltoporin)
[Escherichia coli str. K-12 substr.
MG1655] >ref|YP_001732813.1|
maltoporin [Escherichia coli str. K-12
26.9
substr. DH10B] >ref|ZP_03069347.1|
maltose-inducible porin [Escherichia coli
101-1] >ref|YP_002928942.1| maltose
outer membrane porin (maltoporin)

26.9

90%

17

169

[Escherichia coli BW2952]
>ref|YP_003038169.1| maltoporin
[Escherichia coli 'BL21-Gold(DE3)pLysS
AG'] >ref|ZP_04871107.1| maltoseinducible porin [Escherichia sp. 1_1_43]
>ref|YP_003047080.1| maltoporin
[Escherichia coli B str. REL606]
>ref|ZP_07145223.1| LamB porin
[Escherichia coli MS 187-1]
>ref|ZP_07160863.1| LamB porin
[Escherichia coli MS 116-1]
>ref|ZP_07169764.1| LamB porin
[Escherichia coli MS 175-1]
>ref|ZP_07183347.1| LamB porin
[Escherichia coli MS 196-1]
>ref|ZP_07244983.1| LamB porin
[Escherichia coli MS 146-1]
>ref|ZP_08345891.1| maltoporin (Maltoseinducible porin) (Lambda receptorprotein)
[Escherichia coli H736]
ZP_07779537.1

maltoporin [Escherichia coli 2362-75]

26.9

26.9

90%

17

ZP_05937728.1

maltose outer membrane porin (maltoporin)
[Escherichia coli O157:H7 str. FRIK2000]
26.9
>ref|ZP_05949515.1| maltose outer
membrane porin (maltoporin) [Escherichia
coli O157:H7 str. FRIK966]

26.9

90%

17

Fig. 3.9.1: Sequence of lamB protein from E. coli
GenBank: CAA02071.1
>gi|4529934|emb|CAA02071.1| lamB [Escherichia coli]
VDFHGYARSGIGWTGSGGEQQCFQTTGAQSKYRLGNECETYAELKLGQEVWKEGDKSFYFDTNVAYSVAQ
QNDWEATDPAFREANVQGKNLIEWLPGSTIWAGKRFYQRHDVHMIDFYYWDISGPGAGLENIDVGFGKLS
LAATRSSEAGGSSSFASNNIYDYTNETANDVFDVRLAQMEINPGGTLELGVDYGRANLRDNYRLVDGASK
DGWLFTAEHTQSVLKGFNKFVVQYATDSMTSQGKGLSQGSGVAFDNEKFAYNINNNGHMLRILDHGAISM
GDNWDMMYVGMYQDINWDNDNGTKWWTVGIRPMYKWTPIMSTVMEIGYDNVESQRTGDKNNQYKITLAQQ
WQAGDSIWSRPAIRVFATYAKWDEKWGYDYTGNADNNANFGKAVPADFNGGSFGRGDSDEWTFGAQMEIW
W
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Fig. 3.9.2: Accession number, author, and publication details of lamB [Escherichia
coli]
GenBank: CAA02071.1

LOCUS
DEFINITION
ACCESSION
VERSION
DBSOURCE
KEYWORDS
SOURCE
ORGANISM

CAA02071
421 aa
linear
PAT 20-JUN-1996
lamB [Escherichia coli].
CAA02071
CAA02071.1 GI:4529934
embl accession A31943.1
.
Escherichia coli
Escherichia coli
Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacteriales;
Enterobacteriaceae; Escherichia.
REFERENCE
1 (residues 1 to 421)
AUTHORS
Hofnung,M., Bouges-Bocquet,B. and Guesdon,J.L.
TITLE
Vector modified by at least a part if not the whole of gene Lam B
and microorganisms transformed with this vector and made capable of
synthesizing a determined external membrane protein, encoded by an
insert also included in said vector
JOURNAL
Patent: EP 0146416-A1 26-JUN-1985;
INSTITUT PASTEUR; INSERM; CENTRE NATIONAL DE LA RECHERCHE
SCIENTIFIQUE (CNRS)
FEATURES
Location/Qualifiers
source
1..421
/organism="Escherichia coli"
/db_xref="taxon:562"
Protein
<1..>421
/name="lamB"
Region
1..421
/region_name="Maltoporin-like"
/note="The Maltoporin-like channels (LamB porin) form a
trimeric structure which facilitate the diffusion of
maltodextrins and other sugars across the outer membrane of
Gram-negative bacteria. The membrane channel is formedby an
18-strand antiparallel beta-...; cd01346"
/db_xref="CDD:30073"
Site
order(3,9,11..13,40..42,58,60,64..66,68,81..82,84..86,88,
100,102..104,106,123..127,151..155,168,170,319,351..352,
361,363,415,417,419,421)
/site_type="other"
/note="trimer interface"
/db_xref="CDD:30073"
Site
order(8,41,43,82,106,109,116,118,121)
/site_type="other"
/note="sugar binding site [chemical binding]"
/db_xref="CDD:30073"
CDS
1..421
/gene="lamB"
/coded_by="A31943.1:<1..>1263"
/transl_table=11
ORIGIN
1 vdfhgyarsg igwtgsggeq qcfqttgaqs kyrlgnecet yaelklgqev wkegdksfyf
61 dtnvaysvaq qndweatdpa freanvqgkn liewlpgsti wagkrfyqrh dvhmidfyyw
121 disgpgagle nidvgfgkls laatrsseag gsssfasnni ydytnetand vfdvrlaqme
181 inpggtlelg vdygranlrd nyrlvdgask dgwlftaeht qsvlkgfnkf vvqyatdsmt
241 sqgkglsqgs gvafdnekfa yninnnghml rildhgaism gdnwdmmyvg myqdinwdnd
301 ngtkwwtvgi rpmykwtpim stvmeigydn vesqrtgdkn nqykitlaqq wqagdsiwsr
361 pairvfatya kwdekwgydy tgnadnnanf gkavpadfng gsfgrgdsde wtfgaqmeiw
421 w
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Fig. 3.9.3: Sequence of LamB porin showing the N-terminal leader sequence
fromLamB porin [Escherichia coli M863]: The leader sequence is shown in bold
italicized letters.
GenBank: EGB61149.1
>gi|323965697|gb|EGB61149.1| LamB porin [Escherichia coli M863]
MMITLRKLPLAVAVAAGVMSAQAMAVDFHGYARSGIGWTGSGGEQQCFQTTGAQSKYRLGNECETYAELK
LGQEVWKEGDKSFYFDTNVAYSVAQQNDWEATDPAFREANVQGKNLIEWLPGSTIWAGKRFYQRHDVHMI
DFYYWDISGPGAGLENIDVGFGKLSLAATRSSEAGGSSSFASNNIYDYTNETANDVFDVRLAQMEINPGG
TLELGVDYGRANLRDNYRLVDGASKDGWLFTAEHTQSVLKGFNKFVVQYATDSMTSQGKGLSQGSGVAFD
NEKFAYNINNNGHMLRILDHGAISMGDNWDMMYVGMYQDINWDNDNGTKWWTVGIRPMYKWTPIMSTVME
IGYDNVESQRTGDKNNQYKITLAQQWQAGDSIWSRPAIRVFATYAKWDEKWGYDYNGSSSTNPYYGKAVP
ADFNGGSFGRGDSDEWTFGAQMEIWW

Fig. 3.9.4: N-terminal peptide sequence report: The excised band corresponding to
~35 kDa was sequenced at the Iowa State University Protein Facility. The details of the
report are described therein.
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Iowa State University
Protein Facility
PROTEIN/PEPTIDE SEQUENCE
REPORT
Date:
To:

July 30, 2007
Farhana Syed

Sample Number:
Sample Name:

3570
ECO CIT 35k #3

Sample Preparation:

The sample was washed 6 times with DI

water and loaded onto a filter for sequence analysis.
Instruments:
from

494 Procise Protein Sequencer/140C

Analyzer

Applied Biosystems, Inc.
Sequencing Method:

Edman Degradation

Cycle Number
Acid

Amino

1

v, A

2

D, N

3

F, L

4

H,
Q

5
y

6

A

7

R

8

cycle.

M

9

S?,

10

I?

Q?

The major amino acid is listed first for each
If you have any questions, feel free to call me.

Prepared by:

Joel

Tel:

protein@iastate.edu
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